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Abstract 
This project was expected to contribute to the understanding of abscisic acid 
(ABA) perception in plants through identification of new ABA-binding proteins. The 
novel, biotinylated ABA derivative PBI686 (of biological activity comparable to natural 
ABA) has served as an affinity probe for isolation of ABA-binding proteins. 
Photoaffinity labeling in conjunction with affinity chromatography (streptavidin-biotin 
based) was used for specific identification of target proteins from complex mixtures of 
cytosolic and membrane-bound proteins. Proteins of interest were identified by Mass 
Spectrometry through peptide mass fingerprinting and MS/MS ion search.  
Ribulose bisphosphate carboxylase/oxygenase (Rubisco) was identified as an ABA 
binding partner, and its interaction with ABA was initially confirmed by its ability to 
block the photoaffinity labeling reaction with PBI686. In addition, Surface Plasmon 
Resonance (SPR) experiments with ABA and Rubisco were performed, which provided 
further evidence for selective interaction between the two binding partners, with a very 
small preference towards (+)-ABA over (-)-ABA. SPR has also yielded the value of 
equilibrium dissociation constant (KD) being 5 nM for (+)-ABA and 7 nM for (-)-ABA. 
This was further confirmed by [3H] (±)-ABA binding assays, which have also shown that 
non-radiolabeled (+)-ABA and (-)-ABA (at concentration 1000 fold higher) were able to 
displace [3H] (±)-ABA from binding to Rubisco. Compounds other than ABA such as PA 
(phaseic acid) or trans-(+)-ABA were not able to displace [3H] (±)-ABA, which has 
suggested the selectivity of binding. 
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Further, Rubisco enzymatic activity in the absence of ABA was compared to that in 
the presence of ABA at various concentrations. The results have clearly indicated the 
effect of ABA on Rubisco’s enzymatic activity. This was reflected on the enzyme’s Km 
values being increased by seven fold in the presence of 10 mM ABA and 1 mM substrate 
(RuBP). The interpretation of changes in enzyme kinetics upon inhibition by ABA most 
resembles allosteric inhibition. 
The biological function of this newly discovered interaction is interpreted as 
ABA’s ability to regulate plant growth during abiotic stress by its direct action on the 
photosynthetic machinery - hypothesis often suggested in the literature. 
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1.  Introduction 
1.1.   Introduction to plant hormones –roles, effects and          
signaling mechanisms 
 
Fundamental for the process of plant growth and development are a small number 
of plant hormones or phytohormones. This group includes auxins, cytokinins, the 
gibberellins (GAs), abscisic acid (ABA), ethylene, the brassinosteroids (BRs), jasmonates 
(JA), and salicylic acid (SA), each of which acts at low concentrations to regulate many 
aspects of plant growth and development. 
 
 
 
 
 
 
 
 
Figure 1. Structures of representative examples of plant hormone classes. 
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Each hormone is associated with a range of functions in plants. Ethylene gas 
promotes fruit ripening, senescence, and responses to pathogens and abiotic stresses.1 
Auxin regulates cell division and expansion, vascular differentiation, lateral root 
development, and apical dominance.2 Cytokinins are adenine derivatives first identified 
by their ability to promote cytokinesis, a process in which cytoplasm of a single 
eukaryotic cell is divided to form two daughter cells.3 JA modulates pollen development 
and responses to pathogen infection.4 The BRs regulate cell expansion and 
photomorphogenesis (light regulated development).5 GAs are diterpenoid compounds 
that promote germination, stem elongation, and the induction of flowering.6  Salicylic 
acid (SA) mediates plant defense against pathogens, it is involved in the systemic 
acquired resistance [SAR], in which a pathogenic attack on older leaves causes the 
development of resistance in younger leaves.7 Finally, ABA promotes seed dormancy and 
most importantly, is involved in several stress signaling pathways.8 
The transduction pathways are well known for some of them (and will be described 
further) and still not understood for others. This chapter will briefly introduce each 
hormone and its binding proteins or receptors (if any) discovered to date. It is important 
to stress the difference between a receptor and binding protein; although all receptors are 
binding proteins of a given ligand, not all binding proteins are receptors. The most 
common characteristics of a receptor are: stereospecificity of ligand binding, reversibility 
of binding, interaction of a receptor with a ligand initiates cellular response.9 There are 
four major classes of receptors: Peripheral membrane receptors, transmembrane 
receptors, G protein-coupled receptors and metabotropic receptors. 
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Peripheral membrane receptors are proteins that only temporarily are associated 
with the membrane. These receptors attach to integral membrane proteins, or penetrate 
the peripheral regions of the lipid bilayer. The regulatory protein subunits of many ion 
channels and transmembrane receptors, for example, may be defined as peripheral 
membrane proteins. Unlike integral membrane proteins, peripheral membrane proteins 
are usually found in water-soluble fraction of proteins, of all the proteins extracted during 
a protein purification procedure. The reversible attachment of peripheral receptors to 
biological membranes was found to regulate cell signaling and many other important 
cellular events, through various mechanisms.10 Association between many enzymes and 
biological membranes often brings them into close proximity with their lipid 
substrate(s).11  Membrane binding also promotes dissociation, rearrangement, or 
conformational changes within many protein structural domains, and downstream 
activation of their biological activity.12  
Transmembrane receptors are integral membrane proteins, which are typically 
located within a cell's plasma membrane.12 Binding of a signaling molecule on one side 
of the membrane, transmembrane receptors induce a response on the other side. Because 
of that transmembrane receptors play a unique and important role in cellular 
communications and signal transduction. Transmembrane receptors are usually composed 
of two or more protein subunits which operate collectively and may dissociate when 
ligands bind. The polypeptide chains of transmembrane receptors cross the lipid bilayer 
up to seven times.  
G protein-coupled receptors (GPCRs), also called seven transmembrane domain 
receptors, 7TM receptors.13 They form a large protein family of transmembrane receptors 
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capable of sensing molecules outside the cell and activating inside signal transduction 
pathways which lead to cellular responses.14 G protein-coupled receptors are specific for 
eukaryotes, (yeast, plants, and animals). Binding of ligands (light sensitive compounds, 
odors, pheromones, hormones and neurotransmitters) which vary in size (small molecules 
peptides, proteins) activates these receptors.  G protein-coupled receptors are activated by 
an external signal such as binding of a ligand or other signal mediator, which leads to 
conformational change in the receptor, hence activation of a G protein. Downstream 
effect depends on the type of G protein.   
Metabotropic receptors belong to a group of membrane receptors located at the 
surface or in vesicles of eukaryotic cells.15 Metabotropic receptors are indirectly linked 
with ion-channels on the plasma membrane of the cell through signal transduction 
mechanisms, often G proteins. Hence, they are a type of G Protein Coupled Receptor. 
Metabotropic receptors, when activated, a series of intracellular events are triggered that 
results in ion channel opening which involve a range of second messenger chemicals. 
Ligand-induced conformational changes in receptors result in physiological, 
metabolic or transcriptional changes which constitute the biological activity of the 
ligands. Ligand binding proteins on the other hand may exhibit only a few of the 
functions of receptors. Lack of stereospecificity, enzymatic activity (with exemptions), 
no association with other signal transduction-related proteins, or any downstream effects 
of interaction with a ligand, are examples of binding protein features. Enzyme-inhibitor 
interactions are an example of such non-receptor type of binding. 
The following sections will focus on the discoveries of putative receptors or 
binding proteins (and their associated functions) of all plant hormones. 
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1.2. Auxins  
 
The term auxin by convention refers to indole-3-acetic acid (IAA) although this 
particular molecule, structurally resembling tryptophan, represents only one auxin. There 
are other derivatives of tryptophan also regarded as auxins such as: indole-3-butyric acid 
(natural hormone), 4-chloroindole-3-acetic acid (4-CI-IAA, natural hormone), and other 
synthetic compounds that are not derivatives of tryptophan such as 2,4-
dichlorophenoxyacetic acid (2,4-D,common synthetic herbicide) or α-naphthalene acetic 
acid (α-NAA, synthetic hormone). The primary auxin in plants is indole-3-acetic acid 
(IAA). Its structure is shown in Figure 1. Auxins are often used to promote initiation of 
adventitious roots and are the active ingredient of the commercial preparations used in 
horticulture to root stem cuttings.16,17 They can also be used to promote uniform 
flowering, to promote fruit set, and to prevent premature fruit drop.  Used in high doses, 
auxin stimulates the production of ethylene. Some synthetic auxins such as 2,4-D and 
2,4,5-trichlorophenoxyacetic acid (2,4,5-T) have been used as herbicides.  There are other 
compounds with auxin activity found such as indole-3-butyric acid, phenyl acetic acid, 
and 4-chloro-IAA but little is known about their physiological functions.18 Tryptophan 
was found to be a precursor of IAA in its biosynthesis19. IAA occurs not only in the free 
form but also conjugated to amino acids, peptides, and carbohydrates. These IAA 
conjugates are biologically inactive and appear to serve as IAA storage forms. IAA was 
found to have various functions in plant tissues such as inducing transcriptional 
responses, changes in cell division, expansion and differentiation.20 Crucial to 
understanding the molecular bases of auxin action was the elucidation of how auxin is 
perceived. Literature reports evidence for both plasma membrane and intracellular sites 
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of auxin perception. Ray et al. has reported the auxin receptor called ABP1 (auxin 
binding protein 1), as a protein that binds biologically active auxins with high affinity.21-
23 ABP1 was isolated by affinity chromatography methods using sepharose 4B covalently 
modified by tryptophan (coupling of tryptophan to Sepharose 4B was performed 
according to standard procedure for the covalent attachment of primary amines to CNBr-
activated resin)24 and purified for the first time by Löbler and Klämbt.25 This led to 
functional studies of ABP1, examination of its cell biology and its structure. The affinity 
to auxin 1-naphthylacetic acid (NAA) was found to be 57 nM. The protein sequence of 
ABP1 reveals little functional information. Consistent with the presence of C-terminal 
KDEL endoplasmatic retention motif, the majority of ABP1 is ER localized. However, a 
small fraction escapes to the cell surface, and several lines of evidence implicate plasma 
membrane associated ABP1 in early auxin-mediated electrophysiologic responses.21 
Genetic approaches to elucidate ABP1 function have found that its over-expression 
promotes auxin-mediated cell expansion.26 Furthermore, Arabidopsis abp1 knock out 
mutants exhibit an early embryo-lethal phenotype, indicating that ABP1 is an essential 
gene.27 However the biological function of ABP1 remains undetermined and it does not 
appear to be involved in known signaling pathways.  
Recent reports have also indicated that the TIR1 (transport inhibitor response) F-
box protein is an auxin receptor. It was found that radiolabeled IAA added to crude 
Arabidopsis extracts co-purifies (by immunoprecipitation) with SCF (ubiquitin ligase)TIR1 
–Aux/IAA complex.28 Auxin regulates transcription through stimulating the degradation 
of Aux/IAA proteins.28,29 There are literature reports that auxin acts by promoting an 
interaction between the Aux/IAA proteins and the ubiquitin protein ligase SCFTIR1. In 
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Arabidopsis, the Aux/IAA proteins are encoded by a family of genes comprised of 29 
members.30 Most of these proteins have four common conserved regions designated 
domains I to IV. Domain II, which includes the conserved amino-acid residues GWPPV, 
is involved in the degradation of luciferase reporter protein31 and interacts with SCFTIR1, 
indicating that domain II is the auxin degron (specific sequence of amino acids in a 
protein that directs the starting place of degradation).32 Mutations within domain II result 
in stabilization of the affected Aux/IAA protein and alter auxin response.29,33 It is still not 
understood how auxin promotes the interaction between Aux/IAA and SCFTIR1. Substrate 
recognition by other cullin-based E3 ligases requires substrate modification such as 
phosphorylation or proline hydroxylation and glycosylation.34,35 Recent reports suggest 
however that none of these mechanisms are involved in auxin-induced Aux/IAA 
degradation.32 The current understanding is that the substrate recognition requires an 
auxin-dependent modification of TIR1 or an associated protein and not the substrate. This 
concept has been proven by Dharmasiri et al. 36 using biochemical methods based on in 
vitro interaction assay between IAA and TIR1 and concludes that auxin regulates 
degradation of the Aux/IAA proteins by direct binding to TIR1. The interaction of auxins 
with  SCFTIR1 was examined by performing competitive binding experiments with active 
auxins (IAA, 1-NAA, and 2,4-D) and related compounds. The active auxins competed 
efficiently with [3H]-IAA for binding but benzoic acid and tryptophan-related molecules 
having no auxin activity – were not capable of competing with [3H]-IAA (Figure 2). 
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Figure 2. Competition for binding to SCFTIR1 complex incubated with [3H]-IAA 
with or without cold IAA. Black squares – unlabeled IAA, white squares -2,4-D, black 
triangles -1-NAA, white circles –benzoic acid, black circles –tryptophan. (figure copied 
from Dharmasiri et al.36 with permission). 
 
Dharmasiri reports that the auxin receptor binding site is localized within the SCF-
TIR1 complex, and Scatchard analysis indicated the equilibrium dissociation constant KD 
of the auxin-receptor complex gave a value of 84 nM. It was also demonstrated that IAA 
has a higher affinity for the receptor than other biologically active auxins such as 2,4-D 
or 1-NAA. It is concluded that IAA promotes the interaction between Aux/IAA and TIR1 
at nanomolar concentrations whereas 2,4-D and 1-NAA are active at micromolar levels. 
These results provided strong evidence that TIR1 is an auxin receptor which regulates 
degradation of Aux/IAA proteins and changes in expression of auxin-regulated genes  
(Figure 6). 
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Figure 3. Auxins interact with SCF complexes carrying a transport inhibitor 
response protein 1 (TIR1) or the related auxin-binding factors (ABFs). This catalyses the 
destruction of Aux/IAA proteins, which directly inhibit the genes that are responsible for 
the auxin response. The inhibitory effect of Aux/IAA is thus relieved, allowing auxin 
responses to occur. (figure and caption adapted from Callis J. et al.37) 
  
To date it is not clear however how auxin stimulates the interaction between 
SCFTIR1 and its substrates. One explanation is that auxin binds TIR1 and induces a 
conformational change which favors Aux/IAA binding. Alternatively auxin might bind to 
both TIR1 and the Aux/IAA cooperatively which leads to SCTTIR1 – substrate complex 
stabilization.  
SCF family of E3 ligases play an important role in cellular regulation.38  In a group 
of characterized SCFs, substrate recognition normally proceeds through phosphorylation 
Auxin 
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within the substrate degron sequence. The discovery of binding interaction between IAA 
and SCFTIR1 complex brings new input to understanding of SCFTIR1 –substrate 
recognition process and SCF regulation. There are numerous reports suggesting the 
existence of proteins involved in polar auxin transport (regulated plant hormone 
transport). It is suggested that it involves proteins located in various parts of the cell such 
as cytoskeleton, plasma membrane and cell wall.39 The first auxin transporter protein 
ZmPIN1a  has been recently reported by Gallavotti et al.40 
The structure of auxin-binding protein 1 (ABP1) from maize has been determined 
by Woo et al.,41 which revealed its auxin-binding site. The structure confirmed that ABP1 
belongs to a storage protein superfamily and it is classified as a transmembrane receptor 
(associated with ER). The binding pocket of ABP1 is of hydrophobic character with a 
zinc ion deep inside the pocket coordinated to three histidines and one glutamate. Auxin 
binds within this pocket, with its carboxylate group binding the zinc and its aromatic ring 
binding hydrophobic residues including Trp151. There is a single disulfide bond between 
Cys2 and Cys155. No conformational rearrangement of ABP1 was observed when auxin 
bound to the protein in the crystal, but examination of the structure revealed a possible 
mechanism of signal transduction. Up till now ABP1 stands as one of the rare examples 
of a receptor protein that has been crystallized in complex with a plant hormone, 
revealing its binding site in detail.42 
1.3. Cytokinins   
 
Cytokinins play an important role in many physiological and developmental 
processes in the plant, such as regulation of shoot and root growth, leaf senescence, 
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chloroplast development, stress response and pathogen resistance.43 Literature provides 
evidence of two different types of cytokinin hormonal activities in plants. One activity is 
responsible for regulating cell division and sink strength (as the ability of a sink organ to 
import assimilates for its growth, development and maintenance), and second activity is 
based on long-distance signaling, in which cytokinins may serve primarily as a root-to-
shoot signal and may regulate physiological (for example nitrogen-dependent) 
processes.43 
The most abundant naturally occurring cytokinins are adenine derivatives 
substituted at N6-position with an isoprenoid side chain.  
 
 
 
 
 
 
 
Figure 4. Chemical structures of some naturally occurring cytokinins carrying an 
isoprenoid or aromatic side chain. 
 
In addition cytokinin molecules carrying an aromatic side chain were detected in 
several plant species and usually display a high biological activity in different 
bioassays.44 
It was found that the cytokinin signal is perceived in Arabidopsis by three 
membrane-located histidine kinase receptors (AHK2, AHK3, CRE1/AHK4) and all of 
them were identified by genetic methods.45-47  The cytokinin signaling system consists of 
two proteins – hence the name two-component system (TCS) – a membrane bound 
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receptor kinase, which senses the signal and autophosphorylates, and a response 
regulator, which upon phosphorylation by the receptor kinase, activates the transcription 
of its target genes or initiates another output reaction48 After binding of cytokinin to the 
extracellular ligand-binding domain, the so-called  CHASE domain, a dimer of the 
receptor histidine kinase (AHK) transphosphorylates itself at a conserved histidine 
residue. The signal is then transferred within the receptor protein to an aspartate residue 
in the response regulator domain. Subsequently, the phosphoryl group is transferred to a 
histidine phosphor-transfer protein (AHP), which then translocates to the nucleus, where 
it activates the B-type response regulators (ARRs) by phosphorylation of an aspartate 
residue. These response regulators activate the transcription of their genes which regulate 
the activity of cytokinin signaling and link the cytokinin signaling pathway with other 
cellular signaling pathways.49 Cytokinin receptors consist of an input domain, a histidine 
kinase domain and a receiver domain (similar to other plant histidine kinases). In 
phylogenetic tree of the Arabidopsis histidine kinase domains, all AHK protein, AHK2, 
AHK3 and CRE/AHK4, cluster together, indicating their close evolutionary 
relationship.50 It is generally concluded that cytokinin receptors are located in plasma 
membrane but so far there is no evidence supporting that.  
Figure 5 depicts cytokinin regulated processes associated with given receptors. 
Biochemical binding assays and response studies performed in heterologous host showed 
that the cytokinin receptors differ in their binding specificities with different cytokinins. 
In in vitro binding studies CRE1/AHK4 bind the bases tZ and iP (Figure 4) (KD ~ 4.5 
nM) very well.51 
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Figure 5. Contributions of different cytokinin receptors and receptor combinations 
to cytokinin-regulated processes (figure adapted from Riefler et al.52). 
 
Studies comparing the ligand specificities of CRE1/AHK4 and AHK3 using 
bacterial assay confirmed the preference of both receptors for the bases of iseprenoid-
type cytokinins.53 In addition it was also reported that CRE1/AHK4 has a narrow 
spectrum of ligands while AHK3 recognizes a much wider range of cytokinins, with 
much lower relative affinity.53 This difference allows for recognition of the different 
cytokinin signals at the level of receptors and allows various cytokinins to induce 
partially specific cellular responses. 
The Crystal structure of another cytokinin binding protein CSBP (cytokinin 
specific binding protein) complexed with zeatin has been recently reported by Pasternak 
et al.54 The binding site consists of an antiparallel β-sheet wrapped around a C-terminal 
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α-helix, with two short α-helices closing a cavity formed within the protein core. The 
zeatin molecule was found to be located deep in the cavity with conserved conformation 
and protein–ligand interactions. Despite the crystal structure and binding affinity of 
CSBP to zeatin, no function has been assigned to this protein to date. 
1.4. Gibberellins  
 
Chemically, all known gibberellins are diterpenoid acids that are synthesized by the 
terpenoid pathway in plastids and then modified to their biologically-active form in the 
endoplasmatic reticulum and cytosol. All gibberellins are derived from the ent-
gibberelline skeleton, but are synthesized via ent-kaurene. The gibberellins were named 
GA1....GAn in order of their discovery. Gibberellic acid, which was the first gibberellin to 
be structurally characterized, is GA3 (Figure 1). As of 2003, there were 126 GAs 
identified from plants, fungi and bacteria. Active gibberellins show many physiological 
effects, each depending on the type of GA present as well as the species of plant. Some of 
the physiological processes stimulated by gibberellins are: stem elongation and 
bolting/flowering in response to long days, breaking of seed dormancy, induction 
maleness of flowers, seedless fruit development, delay senescence in leaves and citrus 
fruits.55  Substantial progress has been made in identification of GA-binding protein and 
receptors in recent years. In particular a central role of DELLA proteins (family of five 
homologs comprised of GAI, RGA, RGL1, RGL2 and RGL3) recognized as repressors 
of GA-mediated responses56.  Ueguchi-Tanaka et al. have also recently reported the 
identification of a soluble GA receptor from rice57 through the discovery of gibberellin 
insensitive gene DWARF1. Biochemical studies have suggested the presence of both 
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soluble cytoplasmic and plasma membrane-localized GA receptors in plants but the 
necessary components could not be identified.58 The identification and characterization of 
rice GA-insensitive dwarf (gid) mutants has proved instrumental in elucidating the GA-
signaling cascade. The gid1 mutants displayed a severe GA-insensitive phenotype, 
including defects in feedback regulation of GA biosynthesis that result in the 
accumulation of much higher levels of bioactive GAs than wild-type plants.57 The gid1 
mutations are recessive, indicating that GID1 encodes a positive regulator of GA 
signaling. This is further supported by the demonstration that transgenic plants over-
expressing GID1 exhibit GA-hypersensitive phenotype.  The GID1 gene was isolated by 
positional cloning and demonstrated to encode a polypeptide of 354 amino acids with 
significant homology to members of the Hormone Sensitive Lipase (HSL) family.57 It 
appears unlikely that GID1 exhibits HSL activity due to the fact that a histidine residue, 
essential for HSL activity, in GID1 is replaced by valine. Biochemical and genetic 
evidence indicates strongly that GID1 functions as GA receptor. Thus, recombinant GID1 
bound a radiolabeled, bioactive GA analogue, 16,17-dihydro [3H4]GA4 with moderate 
affinity (KD ~ 1.4 x 10-6 M). GID1 ligand specificity was also examined by competition 
between [3H4]-16,17-dihydro-GA4 and ten GAs (with differing biological activity. Table 
1 lists the concentration of each GA required for 50% inhibition (IC50) of [3H4]-16,17-
dihydro GA4 binding to GST-GID1. GST-GID1 exhibited moderate affinity for 
biologically active GAs such as GA4, 15,17-dihydro-GA4, GA1 and GA3, but 
substantially lower affinity for biologically inactive GAs. 
Ueguchi-Tanaka et al.57 have recently reported the study of molecular interactions 
between GBs and GID1. By replacing conserved residues of GID1 receptor with Alanine, 
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it was found that there are many regions/blocks in GID1 responsible for GA binding 
activity. There were 12 blocks essential for GA binding activity. These blocks were 
scattered throughout the GID1 molecule. This result is consistent with the above 
prediction that almost the entire GID1 protein is important for its GA binding activity. 
 
 
 
 
 
 
 
 
                                        
 
 
 
  Figure 6. Structures of GAs with different biological activity.  
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Table 1. Competition for [3H4]-16,17-dihydro GA4 binding to GID1 by GAs. 
(Table adapted from Ueguchi et al.57).  
 
GAs                                                     IC50                          Relative percentage 
Biologically active GAs   
GA4 2 x 10-7  M 100 
H2-GA4                                                     1 x 10-6  M 20 
GA1      4 x 10-6  M 5 
GA3      4 x 10-6  M 5 
Weakly biologically active   
GA35 1 x 10-5  M 2 
GA37   2 x 10-5  M 1 
Biologically inactive GAs   
GA4-Me                                  3 x 10-5  M 0.6 
GA9   2 x 10-4  M 0.1 
GA51    >2 x 10-4  M <0.1 
3-epi-GA4                                               >2 x 10-4  M <0.1 
 
A simplified model of GA signaling pathway, including biosynthesis and signal 
transduction is depicted on Figure 7. 
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Figure 7. Proposed mechanism of regulation of GA-responsive growth and 
development.59 see description in text. 
 
It has been reported57 that in the absence of bioactive GAs, DELLA proteins 
repress GA-dependent growth by suppressing the expression of primary GA-response 
genes. This repression is relieved when GA levels are elevated as a consequence of 
environmental, developmental and hormonal signals. This occurs either by increased GA 
biosynthesis or reductions of its inactivation. Elevation of GA levels causes GID1-
mediated ubiquitiation of the DELLA proteins through an SCF E3 Ub ligase, followed by 
degradation by the 25S proteasome. Decreased DELLA protein levels induce changes in 
the expression of primary GA-response genes, and therefore promotes GA-dependant 
plant growth and development. These responses include feed back regulation of GA 
inactivation 
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metabolism, which means that GA signaling leads to down-regulation of the expression 
of GA-biosynthesis genes, and on the other hand GA-inactivating genes are up-regulated. 
The possible contribution of membrane receptors, for which there is considerable indirect 
evidence, remains unclear, and so do immediate targets for DELLA proteins and the 
mechanism by which they regulate transcription. A major challenge is the identification 
of genes that are regulated by GA signaling, directly or indirectly, and to determine how 
their activity translates into the physiological consequences of GA action. 
1.5. Ethylene 
 
Ethylene is a gaseous plant hormone that affects numerous developmental 
processes and vigor responses, including germination, flower and leaf senescence, fruit 
ripening, leaf abscission, root nodulation, programmed cell death, and responsiveness to 
stress and pathogen attack.60,61 A well-known effect of ethylene on plant growth is the so-
called “triple response” of etiolated dicotyledonous seedlings. This response is 
characterized by the inhibition of hypocotyl and root cell elongation, radial swelling of 
the hypocotyl, and exaggerated curvature of the apical hook. This highly specific 
ethylene response occurs at an early developmental stage (3 days post-germination), 
permitting large mutant populations of seedlings to be screened rapidly for ethylene 
response defects. Over the past decade, genetic screens that are based on the triple-
response phenotype have been extensively conducted on Arabidopsis by many 
laboratories. More than a dozen unique mutants have been identified and these can be 
divided into three distinct categories: constitutive triple-response mutants (i.e. ethylene 
overproduction1 [eto1], eto2, eto3, constitutive triple response1 (ctr1) and responsive to 
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antagonist1 [ran1]/ctr2); ethylene-insensitive mutants (i.e. ethylene receptor1 [etr1], etr2, 
ethylene insensitive2 [ein2], ein3, ein4, ein5, and ein6); and tissue-specific ethylene-
insensitive mutants (i.e. hookless1 [hls1], ethylene insensitive root1 [eir1], and several 
auxin-resistant mutants). Genetic and molecular analyses of the above mutants have 
defined a mainly linear ethylene response pathway primarily from hormone perception at 
the membrane to transcriptional regulation within the nucleus.60-62  
In Arabidopsis, ethylene is perceived by a family of five membrane-associated 
receptors, (ETR1, ETR2, ERS1, ERS2 and EIN4).63-65 which are highly analogous to 
bacterial two-component regulators.66 Based on structural similarities, this receptor group 
can be divided into two categories. The first is the type-I subfamily, which includes 
ETR1 and ERS1. These two proteins contain an N-terminal ethylene binding domain (a 
sensor domain) and also a highly conserved C-terminal histidine (His) kinase domain. 
Second, type-II receptors which include ETR2, ERS2 and EIN4 share a common N-
terminal ethylene-binding domains as well as a degenerate His kinase domain which 
lacks one or more elements that are necessary for catalytic activity. In addition ETR1 
(type-I), ETR2 and EIN4 (type-II) contain an additional receiver domain at C-terminal 
whose function is still unknown. A major breakthrough in understanding the mechanism 
of ethylene signaling was the discovery of ethylene perception site which is located at the 
endoplasmic reticulum (ER).67,68 Previous reports suggested that the ethylene receptors 
might be localized at the plasma membrane. Recently however, Arabidopsis ETR1 has 
been shown credibly, on the bases of both sucrose density-gradient fractionation and 
immunogold electron microscopy, to associate with the ER. The N-terminal membrane-
spanning sensor domain of ETR1 is adequate for the ER association. Ethylene treatment 
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or introduction of the etr1-1 mutation did not affect the ER localization of ETR1. 
Importantly, CTR1 (ETR1 binding protein)  has also been found to be localized at the 
ER.68 CTR1 consists an N- -terminal domain of unknown function, and a C-terminal 
kinase domain that is most related to Raf-like mitogen-activated protein kinase (MAPK) 
kinase. Previous yeast two-hybrid and pulldown experiments showed that the amino-
terminal domain of CTR1 can interact with the His kinase domains of ETR1 and ERS1.69 
Because CTR1 has no trans-membrane domain or membrane attachment motifs, it is 
possible that its ER localization might result from direct interaction with the ER-
associated receptors. This hypothesis predicts that the removal of ethylene receptors or 
disruption of the interaction between CTR1 and these receptors would decrease the level 
of ER-associated CTR1. To test this possibility, a series of single, double, and triple 
receptor mutants have been examined to assess the effect of functional receptors on the 
ER localization of CTR1.68 Whereas most single receptor mutations had little effect on 
the level of ER-bound CTR1, double and triple combinations of receptor mutations 
resulted in reduced levels of ER-bound CTR1. Moreover, the levels of ER-bound CTR1 
correlated with the strength of the constitutive- ethylene-response phenotypes in the 
multiple receptor mutants. In addition, a missense mutation in the amino-terminal domain 
of CTR1 (CTR1-8) was found to disrupt the interaction of CTR1 with ETR1. This 
mutation did not affect the kinase activity or the level of the CTR1 protein, but conferred 
phenotypes that were as severe as those of CTR1-kinase-dead mutants. Accordingly, the 
CTR1-8 protein was primarily soluble, suggesting that an association with ER-bound 
receptors is required for CTR1 function.70,71 The proof of CTR1–ETR1 interaction in 
vivo comes from two lines of evidence. Affinity purification of CTR1 from the 
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Arabidopsis ER-membrane fraction results in the co-purification of ETR1, demonstrating 
the presence of ETR1 and CTR1 in the same protein complex.68 Genetic evidence is also 
available to support the proposition that CTR1 function may be regulated by its 
association/dissociation with the ethylene receptors.72 Figure 8 (adapted from Guo et 
al.73) represents a model for signaling by the ethylene receptor-CTR1 complex. 
As mentioned before, there are two types of ethylene receptors in Arabidopsis. 
Type-I includes ETR1 and ERS1 which possess a conserved histidine kinase domain (red 
on Figure 8). Type-II group of receptors which are ETR2, ERS2 and EIN4, include a 
degenerate histidine kinase domain (orange on Figure 8) which lacks catalytic activity. 
The N-terminal sensor domains of the receptors contain a copper cofactor required to 
maintain ethylene binding ability and are ER associated. It was found that the interaction 
between the N-terminal domain of CTR1 (green on Figure 8) was of higher affinity with 
type-I receptors than type-II receptors. 
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Figure 8. Proposed signaling mechanisms of the ethylene receptors and CTR1 at the 
ER (figure adapted from Guo et al.73). 
 
Figure 8a represents a situation in the absence of ethylene where the receptors are in 
functionally active state and are able to interact with CTR1. Association of CTR1 with ER-
bound receptors activates CTR1 and represses the ethylene response through a mechanism 
that requires its C-terminal domain (Ser/Thr kinase domain, purple on Figure 8). Loss of 
function in multiple receptors (in LOF mutants) causes the dissociation of CTR1 from the 
ER. CTR1 is therefore inactivated via self-association using a negative regulatory domain 
(previously shown for Raf kinases). As a consequence, the repression of ethylene responses 
is relieved. Ethylene, (Figure 8b) when present, binds to the sensor domain of the receptor 
and leads to conformational changes which inactivate the receptor. CTR1 is released from 
ER at this point and becomes inactivated. Mutations within the receptor cause disruption in 
ethylene binding which are assumed to lead to constitutive receptor-CTR1 interaction and the 
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repression of downstream components in the ethylene signaling pathway. Despite the 
substantial evidence showing that CTR1 is directly regulated by ethylene receptors, the 
biochemical basis of such regulation is still elusive. It is also known that ethylene can 
modulate responses to other plant hormones such as JA, salicylic acid, auxin, ABA, and 
cytokinin however the mechanisms controlling each of these hormone-hormone interactions 
are still unkown.74 
The ethylene binding domain (EBD) found in ETR receptors has been studied in detail 
by Wang et.al75 who employed site directed mutagenesis to alter ethylene binding capability 
of EBD domain. This was achieved by amino acid substitutions in 37 partially or completely 
conserved residues of the EBD and the effects assayed by ethylene binding and signaling. 
Mutations within residues located in mid-regions of Helices I and II eliminated ethylene 
binding and conferred constitutive signaling. This was consistent with the inverse-agonist 
model of ethylene receptor signaling and suggested that these residues define the ethylene 
binding pocket. Most mutations clustered near the cytoplasmic ends of Helices I and III, gave 
normal ethylene binding activity yet still conferred constitutive signaling. Therefore, these 
residues may play a role in turning off the signal transmitter domain of the receptor. By 
contrast, only two mutations were loss of function with respect to signaling. These results 
provided insight into the structure and function of the EBD and indicated a conserved role of 
the EBD as a negative regulator of the signal transmitter domain. 
Wang et al.75 have recently reported the identification of important regions for ethylene 
binding and signaling in the transmembrane domain of the ETR1 from Arabidopsis.  
The ethylene binding domain (EBD) of the Arabidopsis thaliana ETR1 receptor was 
modeled as three membrane-spanning helices. Ethylene binding activity was investigated in 
25 
 
different kingdoms and bioinformatic analyses of the EBD were performed. Ethylene binding 
was found to be restricted to land plants, and also a group of cyanobacteria but was not found 
in other organisms. Thirty seven amino acid substitutions of partially or completely 
conserved residues of the EBD were made and the effects assayed against ethylene binding. 
Mutations of residues within Helices I and II midregions eliminated ethylene binding and 
conferred constitutive signaling, consistent with the inverse-agonist model of ethylene 
receptor signaling and also indicated that these residues are part of the ethylene binding 
pocket. The largest class of mutations, clustered near the cytoplasmic ends of Helices I and 
III, exhibited normal ethylene binding activity yet still conferred constitutive signaling. It is 
suggested that these residues play a role in turning off the signal transmitter domain of the 
receptor. With respect to signaling, only two mutations led to a loss of function. These 
findings provided more information about the structure and function of the EBD and 
indicated a conserved role of the EBD as a negative regulator of the signal transmitter 
domain. 
1.6. Jasmonates  
 
Jasmonic acid (JA) and metabolites, such as its methyl ester (MeJA) or amino acid 
conjugates of JA, all of them named jasmonates were recognized as important signals in 
plant responses to biotic and abiotic stress.76 The term jasmonate includes the biologically 
active intermediates in the pathway for jasmonic acid biosynthesis, as well as the biologically 
active derivatives of jasmonic acid. These compounds are widely distributed in plants and 
affect a variety of processes77 including fruit ripening, production of viable pollen, root 
growth, tendril coiling, plant response to wounding and abiotic stress, and finally defenses 
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against insects and pathogens.78  Jasmonates originate from precursors such as 12-
oxophytodienoic acid (ODPA), and dinor-ODPA (dnODPA) which are jointly called 
octadecanoids. These JA precursors are produced within the lipoxygenase (LOX) pathway 
which is initiated by oxygenation of free or esterified polyunsaturated fatty acids (PUFAs), 
leading to many different products collectively named oxylipins. More recently, 
octadecanoids and some other oxylipins were recognized to be JA-independent signals in 
plant stress responses. Apart from studies on oxylipin biosynthesis, a growing interest is 
given to their perception and signal transduction. Transgenic approaches and analyses of 
mutants led to basic knowledge on JA signaling, specifically cross-talk with other plant 
hormones (signaling) such as salicylate, ethylene and abscisic acid. Since identification of the 
first JA-insensitive male sterile mutant79 the knowledge on the role of jasmonates in 
developmental processes has been steadily increasing. 
The JA signal is assumed to be transduced through the activation of receptors that bind 
these molecules, however, no receptors have thus far been identified. Arabidopsis defense 
responses are induced by jasmonic acid and ODPA. VSP (vegetative storage protein) 
transcription and stamen development are induced by jasmonic acid but not by ODPA.80 This 
suggests that in Arabidopsis , there at least two JA signal transduction pathways, one for 
recognition of either jasmonic acid or ODPA for defense responses, and a second for 
recognition of jasmonic acid, but not ODPA, for stamen development. The JA signal 
pathway regulates aspects of development and diverse responses to stress. A major challenge 
is to devise assays which will identify genes that perceive the primary stress signal. In 
tomato, the primary stress signal is transmitted via peptide signal molecules, but in 
Arabidopsis, it is not yet known how the wound stress signal is transmitted, and elucidation 
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of this still remains as a goal of future research.81 It is still unknown how JAs are perceived, 
and identification of the JA receptor(s) therefore remains a significant challenge. JA, SA and 
ethylene signaling pathways interact cooperatively and antagonistically in a variety of 
responses. A particular challenge is therefore to discover which points of the JA signaling 
pathway interact with outputs from the SA and ethylene signal pathways, and vice versa. The 
current understanding of the JA signaling pathway reveals a great complexity, and therein the 
opportunity for multiple control sites and flexibility of function.81,82 
1.7. Salicylic acid  
 
Various physiological processes have been associated with SA and include flowering, 
thermogenesis (heat generation), stomatal closure, and leaf abscission.83 Exogenous 
acetylated SA was first shown in tobacco to protect against tobacco mosaic virus (TMV) and 
was found to be noticeably associated with the induction of pathogen-related proteins 
(PRs).84 Also, SA is found in plants after pathogen infection, locally inducing SA 
endogenous signal for systematic acquired resistance (SAR).85 These findings initiated 
studies on molecular mechanism of plant defense. Shortly after the discovery of SA it was 
recognized as a hormone, and many hypotheses in hormone research were employed to study 
and understand its molecular action. The primary entry point in such research was the finding 
of SA receptor. Binding studies in tobacco using radiolabeled SA have revealed the identity 
of the first receptor/binding protein: catalase SABP (salicylic acid binding protein). The 
enzyme was found to be inactivated upon binding SA (KD of 14 µM) which resulted in an 
increase of intracellular H2O2 concentration. This phenomenon was interpreted as activation 
of defense gene expression or as an antimicrobial barrier at the site of invasion.86  SA, and its 
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functional analogue 2,6-dichloroisonicotinic acid were found to be inhibitors of ascorbate 
peroxidase (APX) which also is considered as H2O2-scavenging enzyme. The inhibition of 
both catalase and APX, but not of guiacol peroxidases, (being involved in cell-wall 
biosynthesis) supports a model in which SA-induced defense responses are mediated through 
elevated levels of H2O2 or coupled to alterations of the cell redox state.87 However, the 
hypothesis that SA acts via inhibition of catalase was questioned for several reasons and 
H2O2 was placed upstream of SA in the signal transduction pathway.88 Shortly after another 
SABP (SABP2) protein was found in tobacco that exhibits high affinity for SA (KD of 90 
nM).89 This protein exhibits esterase and an SA-inducible lipase activity.90 Tobacco SABP2 
knock-out mutants exhibited loss in local and systemic-induced resistance to TMV.90 SABP2 
was assigned to the α/β hydrolases superfamily by 3D analysis of its crystal structure. It was 
also confirmed that it is capable of MeSA binding to the enzyme catalytic site containing 
Ser-His-Asp motif. It is assumed that SABP2 may participate in the control of intracellular 
SA levels rather than being a true receptor for SA. That is because MeSA was found to have 
higher affinity to SABP2 than SA.91  
Another SABP, SABP3 was found in the soluble fraction of purified tobacco leaf 
chloroplasts, with carbonic anhydrase function (CAN).92 SA was found to bind to CAN with 
moderate affinity (KD of 3.7 µM) with its enzymatic activity being unaffected by the presence 
of SA. Binding kinetics of SAPB3 and SA are depicted on Figure 9. Apart from carbonic 
anhydrase activity CAN also exhibits antioxidant properties. A recombinant SAB3/CAN 
together with its homologue SABP2 from tobacco complements a yeast mutant sensitive to 
oxidative stress.  CAN knock-out mutants in Nicotiana bethamiana exhibited suppressed 
29 
 
response in plant-pathogen interaction. These results lead to the conclusion that, all three 
proteins interacting with SA have antioxidant activities. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Tobacco leaf chloroplasts contain a specific moderate-affinity SA-binding 
activity that can be used to discriminate between biologically active and inactive SA analogs. 
(A) Saturation-binding assays showing saturable specific binding of [3H]SA to a soluble 
chloroplast protein(s). Scatchard analysis of the binding data suggests a single class of 
binding site. KD and BMAX values were calculated by using single binding-site hyperbolic 
nonlinear regression analysis. (B) Competition binding assays with SA analogs showing a 
positive correlation between binding affinity and biological activity. SA (▼) and its active 
analogs 5-chlorosalicylic acid (■) and 2,6-dihydroxybenzoic acid (▲) showed similar 
affinity for SABP3 compared with the inactive SA analogs 4-hydroxybenzoic acid (♦) and 4-
aminosalicylic acid (●)  (figure and caption copied from Slaymaker at.al92 with permission). 
 
Slaymaker et al. 92 has proposed that the ability of SA to inhibit both cytosolic and 
chloroplast antioxidant enzymes might be a part of its molecular action. SA may activate a 
positive feedback loop for SA production due to its ability to increase the level of reactive 
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oxygen species (ROS), which can then lead to induction of defense responses following 
pathogen infection.92 SA exhibits the ability to form free radicals upon inhibition of heme-
containing enzymes, such as peroxidase or catalase. This led to the new  “free radical” 
hypothesis concerning SA action.93,94 According to that hypothesis, SA action is related to 
the effect of free radicals on lipid peroxidation, the products of which might activate defense 
reactions.95 However, the relationship between free radicals and induction of resistance still 
needs to be further evaluated. 
In summary, the discovery of tobacco CANs as SA-binding proteins which at the same 
time exhibit antioxidant activity raised new questions regarding SA function in plant defense, 
as well as CAN function in chloroplasts.  Of particular interest was the validation of CAN 
antioxidant activity in plants, its nature, and finally determination of whether this activity is 
truly altered by SA. The results reported so far suggest that SA has many effects on the 
physiology of plants and does that by interacting with multiple effector protein(s) that are not 
of typical receptor nature.  
1.8. Brassinosteroids  
 
Brassinosteroids (BR) are steroidal plant hormones. The first brassinosteroid was 
discovered in 1973, when it was shown that pollen from Brassica napus promotes stem 
elongation and cell divisions and that the biologically active molecule was a steroid the 
authors named Brassins.96 Since their discovery, over 70 BR compounds have been isolated 
from plants.97 BRs are involved in numerous plant processes such as:  promotion of cell 
expansion and cell elongation98 and share a signaling pathway with auxin in this process.99 
BRs were found to have a role in cell division and cell wall regeneration.98 
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Another observed function of BRs is promotion of vascular differentiation; BR signal 
transduction has been studied during vascular differentiation100  It is also required for pollen 
elongation and pollen tube formation.101 It was also reported that BRs provide protection to 
plants during abiotic stress such as chilling and drought.98 BRs induce a signaling cascade at 
plasma membrane upon binding to BRI1 (Brassinosteroid insensitive 1) receptor. The BRI1 
gene encodes a leucine rich repeat receptor-like kinase (LRR-RLK)102. Mutants of this gene 
were identified by genetic screens for plants showing dwarfism and lack of root growth 
inhibition upon treatment with BRs.103 The importance of BRI1 in BR signaling has been 
highlighted in many literature reports, and there is substantial evidence that BRs bind directly 
to BRI1.104  Kinoshita et al.104 has confirmed the BR-BRI1 interaction and identified the BR 
binding site using photoaffinity labeling.  
 
 
 
 
 
Figure 10.  Structure of photoaffnity probe BPCS, castasterone O-{2-[2-[2-(2 
 biotinylaminoethoxy)ethoxy]ethoxy]-4-[3-(trifluoromethyl)-3H-diazirin-3-yl].104 
 
Biotin-tagged castasterone (BPCS), a biosynthetic precursor of brassinolide (the most 
active brassinosteroid) with a photoaffinity label  (phenyldiazirine) incorporated in its 
structure was used to identify the BR binding domain within BRI1. The structure of this 
photoaffinity probe is depicted in Figure 10. Previous studies have shown that the 
extracellular domain, especially the island domain (ID), might be responsible for BR 
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perception.105 In order to identify the BPCS-binding region in BRI1 Kinoshita et al.104 
expressed five BRI1 fragments surrounding the ID as glutathione S-transferase (GST) fusion 
proteins in E.coli, and performed photoaffinity crosslinking using three recombinant protein 
fragments.  LRR21-ID-LRR22 and ID-LR22 showed strong binding signals, but the ID 
alone, LR21-ID and LR22 alone did not bind BPCS. BRR21 alone and the intracellular 
domain of BRI1, including its serine/threonine kinase domain, also did not bind BPCS. These 
results indicated that both the ID and LRR22, which immediately flanks the ID on its C-
terminal side (ID-LRR22), are crucial for BPCS binding. 
 
 
 
 
 
 
 
Figure 11. ID-LRR22 in the extracellular domain of BRI1 is sufficient for BPCS 
binding. a – structures of BRI1 and BRI1 fragments. KD, kinase domain. b- BPCS binding in 
BRI1 domains purified from E.coli protein bank visualized by biotin-sensitive Western 
detection system (figure and caption copied from Kinoshita et al.104 with permission). 
 
Binding studies using BPCS, [3H]-labeled brassinolide and recombinant BRI1 
fragments showed that the minimal binding domain for bassinosteroids consists of a 70-
amino acid domain located between LRR21 and LRR22 in the extracellular domain of BRI1, 
together with C-terminal flanking LRR (LR22). These results have shown that 
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brassinosteroids bind directly to the 94-amino acid region comprising ID-LR22 in the 
extracellular domain of BRI1 and have defined a new binding domain for steroid hormones 
with KD  = 15-55 nM. Discovery of other LRR-RLKs interacting with radiolabeled BRs and 
similar to BRI1 suggested that BRI1 is not the only BR receptor.100 Autophosphorylation of 
BRI1 was found to be stimulated by BRs, and its status is also modulated through interaction 
with another LRR-RLK brassinosteroid-associated kinase 1 (BAK1).106 
Identification of BAK was based on its ability to suppress the bri1 dwarfing phenotype 
when over-expressed, and via a yeast 2-hybrid screen.107  Based on that evidence it is 
postulated that BRs induce BRI1 and BAK1 to form an activated receptor complex via the 
change in phosphorylation status of this complex. This kind of mechanism closely resembles 
the animal receptor kinase signaling.  BAK1 is thought to be a component of the BR receptor 
complex.108,109 BAK1 interacts with BRI1 both in vitro and in vivo, and they phosphorylate 
each other in vitro. Results of both gain-of-function and loss-of function experiments support 
a positive role for BAK1 in BR signaling.109 The molecular mechanism by which BR 
activates the receptor kinases is unclear. However in vivo interaction between BRI1 and 
BAK1 has been confirmed, but the effect of BR on this interaction is not known. Thus, the 
hypothesis remains to be tested that ligand binding might activate the kinases by inducing 
receptor heterodimerization, as known for the receptor tyrosine kinases and the transforming 
growth factor β receptor kinases in animals.107 Because BR treatment did not increase 
receptor phosphorylation nor association between BRI1 and BAK1 co-expressed in yeast 
cells108, and in addition BR binding activity was not detected for recombinant BRI1 proteins 
expressed in non-plant cells105  It is postulated that either proper modification of the receptor 
kinases or additional proteins are required for BR binding and signaling. The BRS1 serine 
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carboxypeptidase is thought to be responsible for proteolysis of an extracellular component 
of the BR receptor complex.110 
Biochemical purification of all proteins associated with the BRI1–BAK1 receptor 
kinase complex should provide further insight into the molecular mechanism of the BR 
receptor function. 
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Figure 12. A diagram of the brassinosteroid (BR) signal transduction pathway in 
Arabidopsis. BR is perceived by the receptor complex containing BRI1 and BAK1, which 
are leucine-rich-repeat receptor-like kinases (LRR-RLKs) that interact with each other. 
Activation of the receptor kinases by BR binding leads to the dephosphorylation and 
accumulation of the nuclear proteins BZR1 and BZR2/BES1, possibly by inhibiting the 
negative regulator BIN2. In the absence of BR, the BIN2 kinase phosphorylates BZR1 and 
BZR2/BES1, and targets them for degradation by the ubiquitin-dependent proteasome 
pathway. BZR1 and BZR2/BES1 regulate BR-target genes differently; these targets include 
the BR biosynthetic gene CPD, which is feedback inhibited by BR through BZR1, and genes 
encoding enzymes for cell wall synthesis that are probably regulated by both BZR1 and 
BZR2/BES1. The vacuolar H+-ATPase (V-ATPase) is also a mediator of certain BR 
responses. The serine carboxypeptidase BRS1 is proposed to process an unknown 
extracellular factor that contribute to the activation of the BR receptors. (figure and caption 
adapted from Wang and He111) 
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1.9. Abscisic acid  
 
The plant hormone abscisic acid (ABA) is responsible for many developmental and 
physiological processes in plants and also it is a key hormone in plant environmental stress 
response.112-118 ABA induction of embryo-specific genes in developing seeds leads to 
accumulation of storage proteins and lipids, desiccation tolerance and prevention of 
germination. Plant response to environmental stresses, such as drought, high salinity or low 
temperature results in increase of ABA levels where it is involved in induction of stress-
related genes as well as control of water relations by regulation of stomatal closure. In order 
to understand the physiological changes in plants caused by ABA it is necessary to identify 
and characterize its binding proteins.  A major difficulty with discovering ABA receptors is 
that no genetic mutations have been identified that are directly related to ABA receptor loss-
of-function. 
There is little experimental evidence to date that illustrates the nature of ABA 
perception. Discovery of ABA receptors associated with specific functions would allow the 
creation of transgenic plants with recombinant ABA receptors. This would allow controlled 
alterations to ABA perception and plant growth regulation or environmental stress response. 
In addition from the chemical point of view the structural information about ABA-binding 
proteins would give an opportunity to develop new ABA-analogs as plant growth 
regulators.119,120 
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1.9.1.   ABA perception 
 
 
Binding of ABA to its receptor protein(s) is considered as the first step in ABA’s signal 
transduction.113,121 Three recently reported ABA receptors,122-124 were disputed due to 
contradictory results reported by various research groups (see further section for 
discussion).125,126 
Neither genetic nor biochemical approaches have identified other protein candidates 
that would meet the requirements of a functional receptor protein, especially those related to 
abiotic stress.127  Several lines of indirect evidence have suggested that there are multiple 
ABA receptor types.128 The existence of structurally different ABA-receptor proteins has 
been suggested by the observation that optically pure ABA isomers can substitute for natural 
(S)-ABA in some ABA-regulated responses.129 (R)-ABA and the three isomers (trans bond 
at C-4 C-5, and either a single or double bond at the C-2' C-3' double bond) with the same 
configuration at C-1' as natural ABA were found to be effective germination inhibitors. 
Biologically active and inactive ABA (Figure 13) analogs exhibited differential effects on 
ABA-responsive gene expression, which has been thoroughly studied by Huang et al.130 
Schwartz et al. 131 suggested on the basis of indirect evidence that both intracellular and 
extracellular ABA receptors can exist. The intracellular location of ABA-receptor was 
suggested by the induction of ABA-responses by cytoplasmic application of ABA 132 and 
identification of ABA-binding sites from cytosolic protein fractions.133 Many individual 
components of ABA transduction pathway have been identified but the complete process has 
not yet been described. Therefore it is unknown what process follows the interaction of ABA 
with its receptor and if there are any other proteins, which recognize ABA.  Although other 
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plant hormone receptors such as those for auxin and ethylene have been identified, less 
progress in identification an analysis of ABA receptors is reported. 128,134,135 Shortly after 
submission of this thesis the discovery of two new ABA receptors have been reported.149, 168 
 
1.9.2.   ABA-binding proteins in ABA catabolism 
 
Catabolism of ABA has been widely reported and many ABA metabolites (Figure 13) 
have been fully characterized, although most enzymes that catalyze formation of ABA 
metabolites are not yet identified and isolated. The principal pathway for enzymatic 
deactivation of ABA is the most characterized process, catalyzed by cytochrome P450 
monooxygenase enzyme, ABA-8’hydroxylase.136-138 ABA is oxidized on the 8’ position, 
which yields 8’-hydroxy-ABA, which then isomerizes to form the biologically inactive 
metabolite phaseic acid (PA). The gene encoding ABA-8’-hydroxylase has been cloned and 
the enzyme was produced in several expression systems (insect cells, yeast) and exhibited its 
activity towards oxidation of ABA by efficient conversion to phaseic acid (PA).139 There are 
other metabolic enzymes in the ABA catabolic pathway such as reductases and 
monooxygenases which lead to formation of ABA 1’,4’-diols and dihydrophaseic acid (DPA) 
or putative 7’-hydroxylase yielding 7’-hydroxy-ABA respectively. In addition, the enzyme 
catalyzing ABA glucose ester formation appears to be a conventional glucosyltransferase 
employing UDP-glucose as co-substrate. 140,141 Zhou et al.142 described a new pathway of 
ABA oxidation via 9'-hydroxylation. This pathway results in the formation of 9'-hydroxy 
ABA which cyclizes to neo-phaseic acid. This indicates the existence of another ABA 
metabolic enzyme, ABA-9’-hydroxylase. ABA-8’-hydroxylase and ABA-glucosyltransferase 
are the only ABA metabolic enzymes identified to date. 
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Figure 13. Major ABA catabolic pathways: glucosylation, 8’, 7’ and 9’-hydroxylation. 
 
1.9.3.   ABA-binding proteins and receptors  
 
Transport of ABA across plant cell membranes has been of interest to many scientists 
for many years. 143-145  There are several proposed mechanisms of ABA transport. It is 
postulated that ABA accumulates in cells due to acid trapping.146 This occurs because of the 
lipophilic character of ABA as a neutral molecule at acidic pH which allows ABA to cross 
cell membranes from acidic apoplasts into the cytosol.  In other words a passive uptake of 
ABA becomes one of the possible mechanisms.147 Since ABA accumulates through passive 
uptake in the cells it implies the existence of a mechanism for subsequent export from the 
cells. In the absence of an export mechanism, the cells in which ABA is biosynthesized 
would accumulate ABA to high and undesired levels (in the absence of turnover). By 
analogy to other hormones like IAA, ABA is expected to have a specific carrier protein (not 
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reported to date) which actively exports it from the cell. Dietz and Hartung have suggested 
that ABA-glucose ester is the exported form of ABA.148  An extracellular glucosidase 
released ABA from its glucose conjugate. It was shown that barley xylem sap has β-
glucosidase activity which releases ABA from its physiologically inactive glucose ester. 
They hypothesized the possibility of ABA-glucose ester being a long-distance transport form 
of ABA although there are not characteristics concerning β-glucosidase.  
As mentioned previously three new putative ABA receptors have been 
reported122,124,149 and those include an RNA binding protein FCA by Razem et al. 149 (paper 
withdrawn), the G-protein coupled receptor GCR2 by Liu et al.122, and finally the Mg-
chelatase H subunit reported by Shen et al.124 All three papers have been questioned by 
various research groups, and some contradictory results to those were recently 
published.125,150,151    
Using genetic methods, Shen et al.124 have previously identified an ABA-binding 
protein from broad bean called ABAR and suggested that this protein may be potentially 
involved in stomatal signaling because the gene encoding the H subunit of Mg-chelatase 
(CHLH) was a major component in chlorophyll biosynthesis and plastid-to-nucleus 
signaling. This group has recently advanced further124 and showed that Arabidopsis 
ABAR/CHLH binds ABA stereospecifically, mediates ABA signaling in seed germination as 
well as post-germination growth and stomatal movement, which suggests the possibility that 
ABAR/CHLH is an ABA receptor. Other functions of CHLH have been previously reported, 
mostly the enzymatic functions as a subunit of the Mg-chelatase involved in producing 
photosynthetic apparatus152 but also  this protein has an important function plastid-to-nucleus 
signaling and its mediation.153 Shen et al. have shown that purified yeast-expressed 
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Arabidopsis ABAR exhibits specific and saturable binding of ABA, with 1:1 protein:ligand 
molar ratio, and equilibrium dissociation constant (KD) of 32 nM.  
 
 
 
 
 
 
 
Figure 14. ABAR binds ABA. a, Saturable ABA-specific binding (filled circles) to the 
pure yeast-expressed ABAR. Open circles, non-specific binding. b, Scatchard plot of binding 
data in a. B, [3H]ABA bound; F, free [3H]ABA. The parameters of the curve are KD = 32 
nM; Bmax 51.28 mol mol-1; R2=0.98. c, Displacement of [3H](+)-ABA binding by (+)-ABA 
and (-)-ABA. Filled triangles, in vitro (+)-ABA binding (mol mol-1); open triangles, in vitro 
(-)-ABA binding (mol mol-1); filled circles, (-)-ABA pull-down assay (d.p.m.); open circles, 
(+)-ABA pull-down assay (d.p.m.) (figure and caption copied from Shen et al.124with 
permission) 
Purified ABAR binds ABA stereospecifically, which was confirmed by the efficient 
displacement of [3H] (+)-ABA binding by the physiologically active form of (+)-ABA but 
not by less active analogs (-)-ABA and inactive trans-ABA.  
Muller et al. have further evaluated the barley magnesium chelatase and its large 
subunit (H) in particular.125 In contrast to Shen et al. Muller’s findings suggested that ABA 
had no effect on the magnesium chelatase activity nor did the enzyme show ABA binding 
ability. Magnesium chelatase mutants showed wild-type response with respect to post-
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germination growth and stomatal aperture. It was shown that barley CHLH did not exhibit 
saturation kinetics with radiolabeled ABA, however the Arabidopsis equivalent was  found to 
bind ABA with binding ratio of one ABA molecule per H-subunit and  equilibrium 
dissociation constant of 32 nM.  Magnesium chelatase from barley and  Arabidopsis share 
82% sequence identity although the differences in ABA response  between the two almost 
identical proteins cannot be explained at this point. The  possibility of CHLH being an ABA 
receptor is currently unclear.  Most recently  Pandey et al.154  have reported the discovery of 
two GPCR-type G proteins (GTG1 and  GTG2) as ABA receptors. It was found that 
Arabidopsis mutants lacking both GTG1  and GTG2 exhibit, ABA hypersensitivity and bind 
ABA stereospecifically. Apart from  their apparent receptor functions both proteins also 
show GTPas activity. GDP-bound  forms of GTGs showed greater ABA binding than did the 
GTP-bound forms. It was  suggested that GTPase activity of both GTGs can be inhibited by 
GPA1 and its knockout mutants (gpa1) exhibited ABA–hypersensitivity. Pandey et al. 
predict that it is the GTP-bound form of GTG rather than GTP-bound form that is responsible 
for signal relay. It was postulated that the two new GTG proteins can function as both, G 
proteins and new  membrane ABA receptors. GTG1 and GTG2 showed saturable and 
specific binding of ABA, and equilibrium dissociation constants of 35.8 nM and 41.2 nM 
respectively. Both GTG1 and GTG2 showed more efficient ABA binding in the presence of 
GDP, as compared to binding in the presence of GTP or ATP, which is illustrated in Figure 
15. 
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Figure 15. Specific ABA binding by GTG1 and GTG2 reported by Pandey et al..154 
(A) Both GTG1 and GTG2 show saturable ABA binding with increasing concentrations of 
3H-ABA. No binding was detected when BSA instead of GTG1 or GTG2 was used or by 
using H-benzoic acid (BnzA) instead of 3H-ABA. Equilibrium dissociation constants for 
GTG1 are KD = 35.8 ± 2.6 nM, and for GTG2 KD= 41.2 ± 3.1 nM. (B) ABA binding by 
GTG1 and GTG2 is competed by (±)-ABA but not by the biologically inactive stereoisomer, 
(-)-ABA. (C) GTG1 and GTG2 bind ABA more efficiently in the presence of GDP (5 mM) 
as compared with GTP (5 mM) or ATP (5 mM), (D) GPA1 does not bind ABA alone nor 
affects the efficiency of binding of GTG1 or GTG2 when added together in the reaction mix 
in the presence of 5 mM GDP. No binding of ABA by both GTG1 and GTG2 is observed in 
the presence of EDTA (2 mM). Also, heat-denatured GTG proteins do not bind ABA. (E) 
proposed model for mechanism of action of GPA1 and GTG proteins. Question marks 
indicate aspects of the model inferred from, but not directly demonstrated by, experimental 
results to date. (figure and caption copied from Pandey et al.154 with permission). 
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Pandey et al. suggested that the GTGs are ABA receptors and that GPA1 controls GTG 
in such way that GTP-bound GPA1 downregulates ABA binding, therefore ABA-signal 
transduction by the GTGs (Figure 15E). On the other hand, the authors suggest that GDP-
bound GTGs bind ABA which induces the ABA signaling cascade.  
It was also shown that single gtg mutant plants were indistinguishable from wild-type, 
however the double gtg1 gtg2 mutant exhibited significant differences, which were mostly 
related to ABA signaling, both at early and adult stages. The double mutant gtg1 gtg2 
phenotype was complemented with introduction of either the GTG1 or the GTG2 genes, 
which suggested idleness in GTG function. The gtg1 gtg2 mutant exhibited hyposensitivity 
to ABA in seed germination and post-germination growth assays. About 50% of the wild-
type Arabidopsis seeds germinated on a medium with 1 µM ABA. The germination 
percentage of gtg1 gtg2 mutant seeds was 80%. About 40% germination was obtained with 2 
µM ABA for gtg1 gtg2 mutants. At this concentration of ABA no wild-type seeds have 
germinated. 
ABA induction of stomatal closure in gtg1 gtg2 mutant plants were found to be ABA 
hyposensitive, and showed only a 17% decrease in stomatal aperture in contrast to an 40% 
decrease in wild-type plants. On the other hand, ABA inhibition of stomatal opening 
remained similar to that of wild-type plants. 
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1.9.4.  Affinity-based approaches to identify ABA-binding    
proteins 
 
Despite numerous attempts to isolate and characterize ABA-binding proteins none of 
the applied techniques have provided researchers with satisfactory amount of evidence. Many 
research groups have tried affinity-based methods to purify ABA binding proteins but, 
although apparently promising results have been obtained, the lack of reproducibility has 
been a major problem. A primary drawback with affinity approaches (photoaffinity labeling, 
affinity columns etc.) is that they usually require derivatizing ABA by attachment to an 
affinity matrix or by photochemical labeling. This can result in a substantial loss in hormonal 
activity, which is reflected by reduced affinity of the ABA derivative for the receptor protein. 
This effect has been observed for derivatives in which the free carboxyl group at C-1 is 
modified. Chemically, C-1 derivatives are the easiest derivatives to make but blocking the 
carboxyl group to form an ester or compromise hormonal activity.155,156 Zhang et al. 157 has 
reported isolation of 42-kDa ABA-specific binding protein from epidermis of broad bean 
leaves. ABA has been linked to sepharose through a C-1 carbon and affinity chromatography 
was used as a method for capturing ABA binding protein (Figure 16) The function and 
sequence of the isolated protein have not yet been described. 
 
Figure 16. C-1-derivatized ABA by Zhang et al. 
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Other groups have tried to modify ABA at positions chemically available for 
modification which are also crucial for ABA biological activity.  Pedron et al. 158 modified 
ABA at the C-4’ and C-1 positions by conjugation to a carrier protein (BSA) that is 
recognized by anti-BSA antibodies (Figure 17A). The C-4’ modification was done by linking 
through a hydrazone-type bonding which was later reported to be very unstable under 
biological conditions 159 and may could have been hydrolyzed to yield ABA.  The same type 
of ABA modification was also reported by Yamazaki et al.. 160 who used biotinylated ABA 
(bio-ABA) to attempt to localize ABA-binding proteins on stomatal guard cells (Figure 17B). 
The putative ABA-binding proteins were visualized by fluorescence microscopy and 
confocal laser scanning microscopy using “bio-ABA” and fluorescence-labeled avidin. C-4’ 
modification of ABA is likely to reduce ABA’s activity. 159 
 
A 
 
 
 
B 
 
 
Figure 17.  Modification of ABA at C-1 and C-4’. A- carrier protein coupled to ABA 
via C-4’ and C-1 by Pedron et al. B- biotinylated ABA modified at C-4’ by Yamazaki et 
al.160 
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The approach to identification of ABA-binding proteins described in further parts of 
this thesis is based on development of affinity probes in which modification of ABA 
molecule will not affect its biological activity.  In other words ABA-derivatives (Figure 18) 
designed for this purpose contain the important features of the ABA molecule. This means 
that positions which are essential for biological activity such as configuration at C-1’, 
carboxyl (C-1) and ketone (C-4’) groups are not modified. A bicyclic analogue of ABA 
named tetralone-ABA and its derivatives exhibited a high level of activity in biological 
assays.161 In tetralone-ABA derivative replacement of vinyl methyl group with an aromatic 
ring allows the molecule to retain biological activity. The presence of aromatic ring blocks 
the ring closure subsequent to 8-hydroxylation, a reaction similar to formation of phaseic 
acid. Biological activity of tetralone-based ABA derivatives prompted the design of a 
tetralone-based analog containing biotin. The synthesis of tetralone-based biotinylated ABA 
analogs was previously reported.162,163 These derivatives were used in this project as organic 
probes to identify ABA-binding target proteins and their structural features will be further 
described. 
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2. Results and Discussion 
2.1.   Introduction of new multifunctional probe PBI 686, 
and its validation by affinity chromatography methods 
using known ABA-binding proteins 
 
Affinity-based methods employing a biologically active derivative of ABA have the 
potential to identify ABA binding proteins including receptors. To date, probes constructed 
from derivatives of ABA linked through either the carboxyl group or the ketone have been 
employed to isolate proteins from plant extracts. 157,158,160 An inherent problem with these 
probes is that alterations of ABA at C-1 and C-4’ result in substantial loss in hormonal 
activity, presumably because of reduced affinity for ABA receptors. As mentioned 
previously, Zhang et al.157 reported the isolation of a 42 kDa ABA-binding protein from the 
epidermis of broad bean leaves by affinity chromatography with ABA linked by an ester to 
sepharose through C-1. The function and sequence of the isolated protein have not yet been 
determined.  
The first objective of this project was to validate the newly designed probe (PBI 686) 
and check whether it can be recognized by known ABA-binding proteins. 
The second objective was to identify ABA –binding proteins using PBI 686 as a tool  
which incorporates all the functional groups of ABA required for binding and activity.  
Structure-activity studies to probe the requirements of the ABA molecule for perception and 
action in assays in a variety of plant tissues led to the conclusions that the following features 
of the ABA molecule should be maintained: stereochemistry at C-1’, the vinyl carbon group 
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on the cyclohexenone ring, the acid functional group on the side chain and the ketone on the 
ring.164  
 
 
 
 
Figure 18. (+)-ABA, and bicyclic analogues  PBI 410 and 686. 
 
These requirements are met in a biologically active bicyclic analog PBI 410 (Figure 
18), in which an aromatic ring replaced the planar vinyl methyl group.163 It was anticipated 
that an affinity probe PBI 686 could be developed with biotin group attached through a tether 
to the aromatic ring without sacrificing biological activity. The synthesis of a bioactive 
biotinylated bicyclic ABA probe (PBI 686) was reported earlier.162 The C-1 carboxylic acid 
group, vinyl carbon and the C-4’ carbonyl group, which are crucial for ABA’s activity, 
remain unmodified.  
ABA induces synthesis and modification of genes involved in storage lipid deposition 
in Brassica napus. Cultured microspore-derived embryos of B. napus are responsive to ABA 
and are a convenient system for probing hormonal regulation of gene expression and lipid 
synthesis.165 The activity of analog PBI 686 to induce 3-ketoacyl-CoA synthase (FAE) 
expression in microspore-derived embryos of B. napus was compared to ABA.  At 10 µM, 
analog PBI 686 was more potent than ABA in inducing mRNA for the FAE gene at 72 h, 
whereas the untreated control at 72 h did not exhibit any signal (Figure 19). 
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Figure 19. (A) Northern analysis of FAE expression with ABA analog treatment (B) 
RNA loading for (+)-ABA and (+) PBI 686. (Experiment performed by Dr. Ashok Jadhav). 
 
An affinity matrix was prepared using the biotinylated probe PBI 686 and streptavidin-
linked sepharose, and employed in two experiments validating the probe for binding to 
ABA–specific proteins. Binding of the probe to an anti-ABA monoclonal antibody (mAb) 
raised against (+) ABA166,167 was tested first. According to the literature the anti-(+) ABA 
mAb did not cross-react with (-)-ABA but the cross-reactivity with (±) PBI410 (Figure 18) 
was found to be 23% relative to (+)-ABA (100%) and (±)-ABA (50%).166,167 The mAb was 
retained by the column  upon  buffer wash, and was released when racemic ABA was applied 
as the eluting agent at the same pH (Figure 20, panel A lane 2 vs lane 3). The unmodified 
column without the probe did not retain the antibody. 
 
 
 
 
 
Figure 20. A-SDS-PAGE of fractions collected from column modified with PBI 686 
(M) - protein MW standard (from top: 97.4, 66.2, 45.0, 31.0 kDa), (1)- solution of anti-ABA 
monoclonal antibody, (2) - buffer wash, (3)-5mM (±)-ABA wash, B-fractions collected from 
unmodified column used as control. (4)- solution of anti-ABA monoclonal antibody, (5)-
buffer wash, (6)-5 mM (±)-ABA wash. 
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The affinity probe described above was also used to isolate a membrane-bound protein, 
ABA-8’-hydroxylase.139,169 The Arabidopsis gene is encoded by CYP707A1, the cDNA open 
reading frame of which was transferred to pYeDP60 for expression in the WAT11 strain of 
Saccharomyces cerevisiae.170 The yeast expression vector, pYeDP60, was generously 
provided by Denis Pompon (CNRS-Centre de Génétique Moléculaire). The solubilized 
microsomal fraction was applied to the affinity column and the CYP707A1 enzyme was 
found to be eluted with ABA (Figure 21). No specific binding of proteins to the column in 
protein preparations from yeast transformed with only the pYePD60 (Figure 21) was 
observed.  BSA, which is present in the microsomal protein extraction buffer in high 
quantity, was difficult to remove from the column and was therefore found in all column 
eluates.  Q-TOF mass spectrometry (MS/MS ion search with tryptic peptides) confirmed the 
presence of the ABA 8’-hydroxylase enzyme in crude yeast microsomal extracts as well as in 
fractions from the column eluted with ABA. Peptide sequences derived from the purified, 
trypsinized protein were compared with published sequences and as expected, corresponded 
to CYP707A1. The peptide coverage map and search score chart are presented on Figure 22. 
Tryptic digest contained a number of peptides which represented 69% of the predicted 
amino-acid sequence. This is direct evidence that ABA 8’-hydroxylase bound to the probe 
PBI 686 on the affinity column and validated the probe as being recognized by an authentic 
ABA-binding protein. 
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Figure 21. SDS-PAGE of fractions collected from the column modified with PBI 686. 
(M) – protein MW standard (from top: 97.4, 66.2, 45.0, 31.0 kDa), (1) - crude microsomal 
protein extract from yeast cells expressing CYP707A1, (2) - buffer wash, (3) -10 mM (±) 
ABA wash, (4) - crude microsomal protein extract from yeast cells with pYeDP60 (control), 
(5) - buffer wash, (6) -10 mM (±) ABA wash. 
 
 
 
 
 
 
1. gi|18415271 Mass: 53288 Score: 1073, Peptides matched: 37 CYP707A1 
(cytochrome P450, family 707, subfamily A); oxygen binding 
[Arabidopsis thaliana] 
 
P450 peptide coverage map: 
     1 MDISALFLTL FAGSLFLYFL RCLISQRRFG SSKLPLPPGT MGWPYVGETF  
    51 QLYSQDPNVF FQSKQKRYGS VFKTHVLGCP CVMISSPEAA KFVLVTKSHL  
   101 FKPTFPASKE RMLGKQAIFF HQGDYHAKLR KLVLRAFMPE SIRNMVPDIE  
   151 SIAQDSLRSW EGTMINTYQE MKTYTFNVAL LSIFGKDEVL YREDLKRCYY  
   201 ILEKGYNSMP VNLPGTLFHK SMKARKELSQ ILARILSERR QNGSSHNDLL  
   251 GSFMGDKEEL TDEQIADNII GVIFAARDTT ASVMSWILKY LAENPNVLEA  
   301 VTEEQMAIRK DKEEGESLTW GDTKKMPLTS RVIQETLRVA SILSFTFREA  
   351 VEDVEYEGYL IPKGWKVLPL FRNIHHSADI FSNPGKFDPS RFEVAPKPNT  
   401 FMPFGNGTHS CPGNELAKLE MSIMIHHLTT KYSWSIVGAS DGIQYGPFAL  
   451 PQNGLPIVLA RKPEIEV 
Figure 22. MS/MS ion search results and peptide sequence coverage map of P450 
eluted from the affinity column by (±)-ABA. 
  M        1          2        3       M         4         5          6
P450 
P450  
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2.2.  Initial screening for novel ABA-binding proteins in 
Arabidopsis microsomal fractions using PBI686 
 
Using the approach described in previous section it was attempted to isolate new ABA-
binding proteins from microsomal protein fractions of Arabidopsis (see experimental section) 
which were applied on streptavidin affinity column previously modified by the probe PBI 
686.  Arabidopsis was chosen due to the fact that entire genome of this plant has been 
sequenced which also indicates that most proteins are identified for this plant.  
Fractions eluted with 10 mM (±)-ABA contained some new candidate proteins. These 
three most frequently identified are:  83 kDa Cytochrome c oxidase subunit II PS17 
(Arabidopsis thaliana, gi|109892850) and 107.6 kDa RNA-binding protein of the Puf family 
(Arabidopsis thaliana, gi|9293981), and 60.5 kDa putative phototropic-responsive protein, 
(Arabidopsis thaliana, gi|15229647). All three proteins showed low MS/MS ion search 
scores, which is most likely due to their low abundance in total protein extracts. This is 
confirmed by the presence of mostly one tryptic peptide on MS spectrum, thus marginal 
sequence coverage. Figure 23 illustrates MS/MS ion search results for proteins eluted from 
affinity column (two fractions) with ABA. 
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1. gi|109892850 Mass: 83100, Score: 75, Peptides matched: 4,(Putative 
cytochrome c oxidase subunit II PS17) 
 
2. gi|205830697 Mass: 1394, Score: 72, Peptides matched: 1 , (Unknown 
protein) 
 
3. gi|15229647 Mass: 60495, Score: 52, Peptides  
matched: 1  (phototropic-responsive protein, putative [Arabidopsis 
thaliana]) 
  
4. gi|15229647    Mass: 60495    Score: 52     Peptides matched: 1, 
phototropic-responsive protein, putative [Arabidopsis thaliana] 
 
5. gi|9293981    Score: 41     Peptides  matched: 1, RNA binding 
protein-like [Arabidopsis thaliana] 
 
Figure 23. MS/MS ion search results (Mascot) of proteins (Arabidopsis crude 
microsomal extract) eluted from the affinity column by ABA. 
3                        2   1 
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The five proteins mentioned in Figure 23 are potential candidates; however, their low 
identity scores were not sufficient to pursue further studies on their interaction with ABA. 
However the low identity scores should not exclude them from future research, especially 
because it is expected for potential receptor proteins to be in low abundance in total protein 
extracts. 
Despite the use of large tissue quantities for microsomal protein extractions (50-100 g), 
attempts to obtain higher amounts of putative ABA-binding proteins were unsuccessful. 
Therefore, from this point on, photoaffinity labeling was used as an alternative method for 
identification of putative ABA binding proteins. 
 
2.3.   Photoaffinity labeling (PAL) using probe PBI 686 
 
 
Galardy and co-workers171 were among the first research groups to introduce the use of 
aryl ketone derivatives for photolabeling peptides and proteins (e.g bovine serum albumin 
known to bind carboxyl terminal tetrapeptide of gastrin) with aryl-azido and aryl ketone 
derivatives of pentagastrin. In addition, the model photoreactions of acetophenone and 
benzophenone with N-acetylated glycine methyl ester were investigated and the 
photoaddition products isolated (Figure 24) 
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Figure 24. Products of photoaddition reaction of acetophenone and benzophenone to 
Ac-Gly-OMe reported by Galardy and co-workers.171 
 
Products 1 and 2 were isolated and characterized by NMR. Photolysis of acetophenone 
and Ac-Gly-OMe yielded an insertion product with 6% yield, whereas benzophenone 
reaction gave compound 2 with 30% yield. Both reactions were run for equivalent times. The 
isolation of photoaddition products of both acetophenone and benzophenone with Ac-Gly-
OMe demonstrated the ability of aryl ketone photoaffinity probes to covalently bind to amino 
acid residues. The results of these model reactions and the successful labeling of albumin 
with ketone derivatives of pentagastrin indicated that aryl ketones may be useful 
photoaffinity probes. It was also suggested that aryl ketones have an advantage over other 
photoaffinity probes (arylazido) because the ketone triplet state is nearly inert to reaction 
with water. Thus little ketone photoaffinity label will be lost to hydrolysis in a biological 
labeling experiment and the label need not be used in excess. 
Acetophenones are often reported as polymerization initiators 172,173 and unlike 
benzophenones, are rarely referred to as protein photochemical labeling reagents.  In the 
literature there are reports on one application of acetophenone as protein labeling reagent. 
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Zor et al. 174 used the acetophenone derivative of Guanidine triphosphate  (GTP) as an 
alternative to its benzophenone equivalent which exhibited a significant loss of binding 
affinity to the target protein. They used acetophenone-GTP as a photoaffinity label to isolate 
and identify GTP-binding proteins.  
PBI 686 incorporates an acetophenone moiety which similarly to benzophenone reacts 
exclusively from its corresponding triplet state.175 As  reported previously,162 the probe PBI 
686 was found to be suitable for isolation of new ABA-binding proteins using affinity 
chromatography approach. This probe incorporates three important functionalities: structural 
resemblance to ABA with biological activity, a biotin purification handle, and a photo-
activable acetophenone moiety. Biological activity has been evaluated 162, 163 and compared 
to ABA, the functionality of biotin tag has been validated by affinity chromatography with 
known ABA-binding proteins.162 This approach was based on isolation of new proteins using 
non-covalent interactions between PBI686 immobilized on the column and putative ABA –
binding proteins in crude cell lysates. It was observed that when using known proteins which 
were applied on affinity column in large quantities, there was a great loss of binding during 
the column washings. It was still possible to identify the specific proteins in ABA eluates, 
however utilizing this method to isolate non-overexpressed, endogenous proteins may not 
have been a method of choice.  It was anticipated that utilizing the probe for photoaffinity 
labeling would reduce the loss of bound proteins during affinity chromatography. The 
proposed mechanism (analogous to benzophenone) of photoaffinity labeling which utilizes 
PBI 686 is depicted on Figure 25. 
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Figure 25. Proposed photoaffinity labeling mechanism of PBI 686. 
 
2.4.   PAL labeling of peptides  
 
 
To validate the photolabeling ability of the probe and identifying labeled proteins by 
MS methods it was investigated using a model system by studying its reaction with short 
peptides rather than proteins. Prior to that the MS analysis of the probe under different 
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ionization conditions (MALDI-TOF, LC/MS) were performed to predict the structure of 
adducts in terms of their mass increase. The theoretical monoisotopic mass of PBI 686 
molecular ion in a positive ionization mode (MALDI-TOF, high resolution, mass accuracy 
20 ppm) m/z equals 729.3528 although it was not observed on a MALDI spectrum. Instead a 
molecular ion representing the sodium adduct m/z  = 751.3347 and second, the probe 
dehydration product m/z = 711.3422 (Figure 26). Additionally low resolution LC/MS 
experiments (mass accuracy 1Da) were performed (Figure 27) to verify results by MALDI-
TOF. In negative ionization mode LC/MS, a peak corresponding to the deprotonated 
molecular ion appears as m/z = 727. On the other hand the positive ionization mode LC/MS 
reveals all three: m/z = 711, 729 and 751 ions. The difference between MALDI-TOF 
(positive mode) and LC/MS (positive mode) is most likely due to the fact that during the 
collection of MALDI spectrum the sample is ionized from a solid state (co-crystallized with 
matrix, α-cyano-4-hydroxycinnamic acid) and therefore sodium adducts are observed. In 
LC/MS spectrometry on the other hand sample is prepared in slightly acidic solution, which 
reduces the amount of sodium salts.  
The subsequent experiments will employ MALDI-TOF as a tool for investigating the 
crosslinking reaction of PBI 686 and it is therefore important to have the information about 
the mass of its molecular ion. As discussed above it is expected that the m/z ratio 
corresponding to PBI686-modified substrates (peptide or protein) will be increased by either 
711.3422 or 751.3347 Da. (Figure 27) 
Photolabeling with PBI 686 was first investigated by performing reactions with various 
short synthetic peptides (prepared by Don Schwab, PBI/NRC).  Three peptides were used: 
RPPGF (P1), SVPNSEELRF (P2), TDRAKRKAVSLSKVC (P3).  MALDI-TOF spectra of 
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adducts to individual peptides are presented on Figure 28-32. Each peptide was irradiated 
with the probe at 1:1 molar ratio (1 mM each in phosphate buffer or methanol: water 50/50) 
at room temperature with UV light for 20 minutes. The UV light source used was Hanovia 
medium pressure quartz mercury-vapor lamp (450W) UV power at 1m distance of 300 
watts/square inch. The lamp emits UV light in 254 to 350 nm range. The lamp is placed in a 
quartz immersion well which is cooled by water. Since the probe activation wavelength 
should be higher than the polypeptide UV absorption (<300 nm), Pyrex filter was used to 
block lower wavelength light (λ<320 nm). Reaction solutions were placed in Pyrex tubes at 
10 cm distance from the lamp. This kind of experiment was expected to provide strictly 
qualitative information about nature of the binding mode. P1 was reacted with PBI 686 first 
and MALDI-TOF spectrum (low resolution, linear mode, mass accuracy 300 ppm) of the 
reaction mixture indicated the presence of crosslinking product (Figure 28). As expected the 
reaction yielded an adduct ion m/z = 1301.69 corresponding to a single addition of the probe 
to the peptide, as well as signals corresponding to the residual unreacted PBI 686. 
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Figure 26. MALDI-TOF spectrum of PBI 686 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. LC/MS spectra of PBI 686 in negative (ES-) and positive (ES+) ionization 
mode. 
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Figure 28. Low resolution (linear mode) MALDI-TOF spectrum of the product 
resulting from crosslinking reaction between Bradykinin fragment (peptide P1) and PBI686. 
Spectrum internally calibrated using exact (monoisotopic) mass of Bradykinin fragment, 
573.3144 Da. Error calculation: 1301.6599 Da (theoretical) vs. 1301.69 Da (experimental) 
error = 20 ppm.            
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Figure 29. Low resolution (linear mode) MALDI-TOF spectrum of SVPNSEELRF peptide P2 (partially purified). Internal 
calibration using exact (monoisotopic) mass of SVPNSEELRF 1177.5848 Da. Molecular ion [M+H]+ (external calibration); 
1176.6557 Da, data not shown. 
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Figure 30. Low resolution (linear mode) MALDI-TOF spectrum of the product resulting from crosslinking reaction between 
peptide P2 (SVPNSEELRF) and PBI686. Spectrum internally calibrated using exact (monoisotopic) mass of SVPNSEELRF 
1177.5848 Da.   
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Figure 31. Section of low resolution (linear mode) MALDI-TOF spectrum of the product resulting from crosslinking reaction 
between peptide P2 (SVPNSEELRF) and PBI686. Spectrum internally calibrated using exact (monoisotopic) mass of P2,  1177.5848 
Da.  Error calculation: 1861.94 Da (theoretical) vs.1862.46 Da (experimental) error = 280 ppm. 1905.93 Da (theoretical) vs.1906.49 
Da (experimental) error = 290 ppm. 
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Figure 32. Low resolution (linear mode) MALDI-TOF spectrum of peptide P3 (TDRAKRKAVSLSKVC, partially purified). 
Spectrum externally calibrated. Error calculation: 1661.9479 Da (theoretical) vs. 1661.9419 Da (experimental) error = 36 ppm. 
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Figure 33. Low resolution (linear mode) MALDI-TOF spectrum of the products resulting from crosslinking reaction between 
peptide P3 (TDRAKRKAVSLSKVC) and PBI686. Spectrum internally calibrated using exact (monoisotopic) mass of 
TDRAKRKAVSLSKVC = 1661.9479 Da. Error calculation: 2346.3036 Da (theoretical) vs.2346.2641 Da (experimental) error = 16 
ppm 2344.2880 Da (theoretical) vs.2344.7076 Da (experimental) error = 180 ppm. 
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Based on literature reports it is assumed the reaction yields an insertion product 
targeting α-C-H bond. The identity of amino acid residue to which the binding occurs cannot 
be revealed using this technique but on the other hand it was not the objective of this 
experiment. Low quantities of the product in a crude reaction mixture did not allow their 
characterization by NMR spectroscopy. However using mass spectra only it was possible to 
confirm product formation upon UV exposure and establish its molecular weight. 
Apart from an adduct, MALDI-TOF spectrum of reaction mixture between P1 and PBI 
686 (Figure 28) has also indicated the presence of an additional signal (1255.64 Da) that was 
46 Da lower than molecular ion. A difference of 46 mass units could be due to loss of water 
and carbon monoxide, often observed for carboxylic acids in positive ionization mode.176 
Peptide P2 (10 amino acid residues SVPNSEELRF) has been also successfully 
crosslinked with the probe (Figure 29), with the MALDI-TOF spectrum showing new signals 
in crude reaction mixture. In contrast to peptide P1, adducts of peptide P2 did not exhibit a 
loss of 46 mass units but rather 44. Figure 29 shows the presence of two types of adduct 
molecular ions. The first signal m/z = 1906.4890 corresponds to simple PBI686 addition (728 
Da mass increase) and the second, m/z = 1862.4624 corresponds to decarboxylated form of 
the m/z = 1906.4890 product. Decarboxylation of the crosslinking product is not expected to 
happen during sample ionization. In the literature it is only reported to occur when carboxylic 
acids are ionized in negative ion mode. It is therefore concluded that the decarboxylation 
may occur during crosslinking reaction prior to MS sample analysis. Bossio  and co-workers 
177,178,179 have  previously reported that a photoactivated benzophenone is capable of 
decarboxylating carboxylic acid groups that are in close proximity of a newly  formed C-C 
bond resulting  from PAL. Two synthetic peptides (Ac-Bpa-Ala10-Lys and Ac-Bpa-Gly10-
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Lys) were modified by benzophenone (Bpa) on the N-terminal amino acid. The 
photoactivation of benzophenone led to decarboxylation of the C-terminal residue of both 
peptides. The degree of decarboxylation was found to be 50-fold less for an α-helical alanine-
based peptide than for flexible glycine-based peptide. These results suggested that close 
contact between the photoexcited benzophenone and C terminus is necessary for 
decarboxylation, implicating hydrogen atom abstraction as the photochemical mechanism.  
This confirms the possibility of peptide crosslinking with decarboxylation in these 
experiments. Although, it seems to be dependent on the structure of the peptide being 
modified, more specifically on the presence of carboxylic groups in peptide side-chain. 
Peptide P1 does not have a single amino acid with carboxylic group on its side-chain and the 
only -COOH group present is the C-terminal one. It can be decarboxylated if the probe binds 
to the C-terminal residue. This doesn’t seem to be the only process in this reaction as the 
major product signal indicates the presence of non-decarboxylated product (m/z = 
1301.6599). In the case of peptide P2, the decarboxylated product is found to be the major 
one which is explained by the presence of -COOH groups within peptide side chains 
belonging to two glutamic acid residues. To confirm decarboxylation, an additional 
experiment was performed with a 15 amino acid residue peptide that also included side chain 
carboxylic groups in its sequence. Peptide P3 (TDRAKRKAVSLSKVC, Exact mass m/z = 
1661.9479, Figure 32) in combination with UV irradiation and PBI 686 clearly yields 
decarboxylated product (m/z = 2346.2641). In addition 46 mass unit difference of signal m/z 
= 2344.7076 suggests the presence of a simple adduct with loss of water and carbon 
monoxide (46 Da loss) which again most likely occurs during sample ionization. 
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These experiments have established that the probe PBI 686 is capable of reacting with 
hydrogen atom-donating amino acid residues which results in covalent bond formation. It 
was also observed that acetophenone moiety incorporated in the probe structure is capable of 
decarboxylating amino acid residues possessing carboxylic groups on their side-chain.  
 
2.5.   Development of experimental conditions for PAL of 
ABA-binding proteins. Probe validation using anti-
ABA monoclonal antibodies 
 
The next step in investigating photoaffinity labeling for future isolation of ABA-
binding proteins was determining its specificity. This investigation was undertaken to 
evaluate the ability of the probe to bind covalently to proteins having an ABA-binding site. 
For this purpose the binding between the probe and a known ABA-binding protein: the anti-
ABA monoclonal antibody166 (mAb, 60 kDa) produced in mice, was investigated.180 
Application of the ABA monoclonal antibody to quantify levels of ABA by ELISA assays in 
plant tissues was previously reported.180 
To evaluate the nature of binding we performed photoaffinity labeling of ABA mAb 
(source: Dr. Gary Banowetz, National Forage Seed Production Research Center, Oregon, 
USA) at different protein-ligand molar ratios. Additionally experiments evaluating ligand 
selectivity towards proteins were performed. This means that apart from ABA mAb, a second 
protein, (Ovalbumin, 45 kDa) unrelated to ABA was added to the reaction mixture. Figure 34 
schematically represents the experiment.  
Proteins from the reaction mixture were applied on SDS-PAGE gel which was 
developed by the far-Western detection system.181 This detection method is significantly 
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different from the traditional Western blots. The major difference is that in far-Western 
system, no primary or secondary antibodies are used. Since proteins photolabeled with PBI 
686 carry biotin, this allows direct detection of protein bands by co-incubating the blot 
membrane with streptavidin-conjugated horseradish peroxidase (HRP). Binding of biotin to 
this system causes a chemiluminescent reaction of Lumigen PS-3 (Acridan substrate) with 
HRP. This reaction is based on the oxidation of the cyclic diacylhydrazide. 
 
 
 
 
 
 
 
 
  
 
Figure 34. Photoaffinity labeling of ABA mAb. 
 
Combined HRP and peroxide catalyzed oxidation of the Acridan substrate generates 
thousands of acridinium intermediates per minute. These intermediates react with peroxide 
(from H2O2) under slight alkaline conditions to produce a high intensity chemiluminescence 
with maximum emission at a wavelength of 430 nm. The resulting light is detected on 
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autoradiography film. This technique allows detection of bands which correspond to probe-
modified proteins. Figure 34 schematically illustrates the experiment. 
In the first set of experiments ABA mAb and ovalbumin were mixed at concentration 
of 30 µg/mL each (molar ratio approx. 1:1) at pH 7.5 in phosphate buffer. PBI 686 was 
added to a final concentration of 60 µM and with or without (±) ABA at 60 µM. ABA was 
expected to partially block the specific photoaffinity labeling by competing for ABA binding 
sites with PBI 686. In this set of experiments the protein-ligand molar ratio was 1:120 
(Figure 35A). 
In the second set of experiments (Figure 35B) this ratio (protein/ligand) was lowered 
by increasing the concentration of both proteins (67 µg/mL each) and decreasing the molar 
concentration of photolabile ligand to 30 µM. In addition three samples contained (±) ABA 
at 30, 300 µM and 1 mM. 
Finally in the third experiment set (Figure 35C), the protein-ligand ratio was further 
lowered, this time by lowering the concentration of the probe and maintaining the same 
protein concentration. In this set the protein-ligand ratios ranged from 1:10 to 1:1. 
This set of experiments has clearly demonstrated that the molar ratio between protein 
and photolabile ligand is crucial for specific binding. At high ligand concentrations 
(protein:ligand 1:120) crosslinking appears between the probe and both proteins ABA mAb 
and ovalbumin. This indicates that upon UV irradiation, non-specific labeling of ovalbumin 
is also observed. The amount of non-specific crosslinking decreases as the protein: ligand 
ratio decreases. At protein:ligand ratio of 1:10 non-specific binding of the probe to 
ovalbumin becomes negligible (Figure 35C). 
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Figure 35. ABA mAb photolabeling by probe PBI686. A-D:  far-Western blot analysis 
of anti-ABA (60 kDa) mixed with Ovalbumin (45 kDa), PBI686  and ABA at different 
proportions and irradiated with UV. M-protein MW marker (from top 97, 66, 45 kDa). 
 
A - protein:ligand ratio 1:120: 
1 – ABA mAb, ovalbumin,  60 µM PBI686.   
2 – ABA mAb, ovalbumin, 60 µM PBI686, 60 µM (±) ABA.  
 
B - protein:ligand ratio 1:30: 
3 - ABA mAb, ovalbumin, 30 µM PBI686;   
4 - ABA mAb, ovalbumin, 30 µM PBI686, 30 µM (±) ABA;  
5 - ABA mAb ovalbumin, 30 µM PBI686, 300 µM (±) ABA;  
6 - ABA mAb, ovalbumin, 30 µM PBI686, 1mM (±) ABA;  
 
C - protein:ligand ratio 1:10 (7-8), 1:5 (9-10) and 1:1 (11) 
7 - ABA mAb, ovalbumin, 10 µM PBI686;  
8 - ABA mAb, ovalbumin, 10 µM PBI686, 100 µM (±) ABA;   
9 - (protein:ligand ratio 1:5) ABA mAb, ovalbumin, 5 µM PBI686;  
10- (protein:ligand ratio 1:5): ABA mAb, ovalbumin, 5 µM PBI686, 100 µM (±) ABA;   
11 - (protein:ligand ratio 1:1) - ABA mAb,  ovalbumin, 1 µM PBI686. 
 
Far-Western blotting was the only technique that allowed identification of the 
photoaffinity labeled antibody. Since the yield of this particular photoaffinity reaction is 
unknown,  the analysis of reaction mixtures is only qualitative. The low resolution and 
sensitivity of MALDI-TOF experiments in high mass range (entire protein, approx 60 kDa) 
did not allow the determination of the m/z ratio of the adduct signal. Also, a tryptic digest of 
the antibody would not provide any useful information due to the antibody amino acid 
sequence not being present protein search databases. 
anti-ABA 
M 1 2 M 3 4 5 6 M 7 8 9 10 11
ovalbumin 
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In summary, the experimental conditions used for specific photoaffinity labeling of 
proteins (such as anti-ABA) included: protein/ligand mole ratio between 1 and 1/5, 1 h 
incubation time at 4 °C prior to UV-irradiation and 10-20 min UV irradiation with medium 
pressure UV mercury lamp at lamp-sample distance of 10 cm. 
 
2.6.  Photolabeling and identification of cytosolic proteins in 
Arabidopsis leaf extracts 
 
 
After confirming the ability to carry out selective photoaffinity labeling, the next step 
was to use this approach to identify new ABA-binding proteins.  A procedure was developed 
and optimized which allowed isolating proteins binding to ABA. A series of experiments 
were performed with crude protein extracts from Arabidopsis thaliana (wild type Columbia) 
leaf tissue using cytosolic extracts. When microsomal proteins were to be included, the 
extraction buffer contained non-ionic detergent (DHPC) to keep them solubilized (see next 
chapter). Usually large amounts of plant tissue (50-100g) were used in order to obtain 
sufficient protein for analysis after purification. Most commonly, the volume of a total crude 
extract was >100 mL and proteins were concentrated before incubation with the probe and 
crosslinking.  Ammonium sulfate was used for precipitation as a mild method of protein 
concentration which allowed maintenance of protein activity, crucial for this experiment. The 
proteins concentrated by this method were then re-dissolved in a small amount (2-3 mL) of 
phosphate buffer pH 7.6, with 20 mM NaCl and protease inhibitors. Solutions were then de-
salted to remove excess ammonium sulfate then split into several Pyrex test tubes and 
incubated with PBI686. The incubation period allowed the binding process to reach a steady 
state equilibrium and was followed by UV irradiation for 15 min. Immediately after 
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irradiation, the solutions were cooled in an ice bath and applied to a streptavidin affinity 
column (at 4 °C). 
Concentrated crude protein extracts irradiated with PBI686 were applied to a 
streptavidin sepharose affinity column. This allowed separation of biotinylated proteins from 
non-labeled ones. Streptavidin exhibits extremely high affinity to biotin which allows the 
tagged proteins to remain on the column while other proteins can be washed out with running 
buffer. In the final stage of separation the PBI686-tagged proteins were eluted from the 
column with denaturing agent:  8M guanidine hydrochloride at pH 2.0. Collected protein 
fractions were then immediately desalted (PD-10 desalting columns, GE Healthcare) to 
remove guanidine hydrochloride, and pH was adjusted to 7.6.  
 Figure 36 represents an FPLC chromatogram from the experiment described above.  
The crude protein extract containing 50.6 mg of protein was applied, on the column (matrix 
volume: 1 mL  of HiTrapTM sepharose-streptavidin), which was then washed with 25 mL (25 
column volumes) of running buffer and finally 8M guanidine hydrochloride (pH 2.2). The 
fractions from peak at 41 mL were collected, pooled together, concentrated and protein 
concentration measured (SPN protein assay kit from G-biosciences) resulting in 64 µg of 
protein.  
In the first set of experiments (peak A, Figure 37) 50 g of fresh plant leaf tissue and 10 
µM PBI 686 were used, which yielded at least four proteins in eluted fractions. 
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Figure 36. FPLC chromatogram on sepharose-streptavidin matrix. Crude protein 
extract, UV irradiated in the presence of 10 µM PBI 686. 
 
The second type of experiment (experiment B, peak B, Figure 37) was performed in 
the presence of 10 µM PBI 686 with addition of 200 µM PBI 410. The structure of the latter 
is presented in Figure 18. Compound PBI 410 has a high structural resemblance to PBI 686. 
Both compounds are assumed to have very similar binding affinity to a given protein and 
more importantly both are photolabile.   PBI 410 was added at 20 fold excess (Figure 37-B) 
with respect to concentration of PBI 686 in order to cause partial blocking of the crosslinking 
reaction of PBI 686. This effect has in fact been observed by measuring the protein amounts 
in eluted fractions and simple comparison of FPLC chromatograms (Figure 37). Finally the 
third experiment (experiment C, peak C, Figure 37) was performed using the same conditions 
as the above but without addition of PBI 686 or PBI 410. Meaning the crude protein extract 
was obtained from 50 g of tissue concentrated and irradiated with UV light. It was found that 
the peak of eluted proteins has further decreased and only 18 µg of protein was collected.   
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In summary the amount of protein remaining bound to the column matrix is clearly 
dependent on the presence of the probe. Moreover the competitor PBI 410 is capable of 
partial blocking the crosslinking reaction which leads to decreased amount of specific 
proteins in collected fractions.   
All of these experiments strongly suggest that among all proteins in crude extracts 
there are also ones that can specifically bind the probe, and are possibly to be ABA-binding 
proteins.  
At this point it was important to carefully examine the content of the eluted fractions 
and identify the proteins present by PMF (Peptide Mass Fingerprinting) methods. 
 
 
 
 
 
 
 
 
 
Figure 37. Overlapped (and shifted for clarity) FPLC traces of proteins eluted from the 
column in the presence (after PAL) and absence of PBI 686. Peak C – non-specific proteins 
(18 µg) bound to the column matrix in the absence of PBI 686. Peak B – specific and non-
specific proteins (24 µg) bound to the column matrix (UV irradiation in the presence of 10 
µM PBI 686 and 200 µM PBI 410). Peak A - specific and non-specific proteins (64 µg) 
bound to the column matrix (UV irradiation in the presence of 10 µM PBI 686 only). 
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A 
Each fraction (4 mL in total from each experiment, peaks A-C) was first concentrated 
by Millipore protein concentration devices to 500 µl volume, and then further concentrated 
by UPPATM protein concentration system (G-Biosciences) utilizing protein precipitation by 
organic solvents. Concentrated samples were separated by SDS-PAGE, and gel bands were 
visualized by both silver staining and far-Western.   
Figure 38 shows the silver stained gel and its far-Western equivalent of proteins eluted 
in peaks A-C onFigure 37. 
 
 
 
 
 
 
 
 
 
Figure 38. SDS-PAGE separation of proteins found in fractions eluted from affinity 
column. A – C peaks from Figure 37. M - protein molecular weight marker (from top: 97, 66, 
45, 31 kDa), 1, 5  – proteins from peak C; 2, 6 – proteins from peak B, 3 – crude extract, 4, 7- 
proteins from peak A. BM – biotinylated protein molecular weight marker (from top: 97, 66, 
45, 31 kDa). 
 
These results provided important information about the specificity of photoaffinity 
labeling. First of all several proteins were identified in peak C, which was detected by silver 
staining (lane C1). None of them, however, were detected by far-Western (lane C5). This 
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suggests that these proteins are not biotinylated, which was expected since the probe was not 
present during UV irradiation. Any proteins present in peak C can be therefore considered as 
ones that simply bind the column matrix non-specifically. Identification of all proteins 
present in bands 1-11 will be discussed further. 
Secondly, both silver staining and far-Western indicate the presence of at least four 
proteins bound to the column after incubation and irradiation with PBI 686. According to 
silver staining method (Figure 38), it appears that bands 1, 2, 3 correspond to the same 
proteins as in bands 4, 6 and 7. Only bands 5 and 9 appear as new protein in peaks B and A 
(on Figure 37). 
It is difficult to interpret far-Western results by comparing them to silver staining 
method. It is important to keep in mind that unlike silver staining, the far-Western method is 
not directly quantitative with respect to protein amounts. On the contrary, the band intensity 
is proportional to biotin quantity and therefore the extent of biotinylation. A good example of 
that phenomenon is band 16, which doesn’t appear on silver stained gel but is an intense 
band by far-Western. In addition there is approximately 100 fold difference in sensitivity 
between these two techniques with far-Western being more sensitive. Bands 1-3 likely do not 
correspond to the same proteins as any of the bands 12-20 detected by far-Western. This is 
based on comparing lanes C1 and C5, where the same protein sample was analyzed by two 
different techniques. All three proteins are visible by silver stain and not present on 
corresponding far-Western, are are most likely not biotinylated. It is suspected that far-
Western bands in lanes B6 and C7 are all associated with band B5. Multiplicity of bands on 
far-Western could be caused by protein degradation or aggregation processes being a result 
of high intensity UV exposure. Due to 100 fold difference in sensitivity between silver-
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staining and far-Western method, only one band is observed on silver-stained gel versus 3-4 
bands on far-Western blot. It is also possible that certain protein bands not observed on 
silver-stained gel are being detected by far-Western blot.   
Another band that attracts attention when comparing far-Western analysis is band 16. It 
is present in fraction B but doesn’t appear in fraction A.  The only explanation at this point 
would be the possibility of it being a degradation product from one of the higher molecular 
weight biotinylated protein (bands 12-15).  
To better understand the differences in protein composition in all three peaks (A-C 
Figure 37) bands 1-11 were identified by proteomic methods such as MALDI-TOF coupled 
peptide mass fingerprinting (PMF) or LC/MS/MS- Q-TOF coupled Mascot MS/MS ion 
search. The experimental masses of peptides resulting from tryptic digest were compared to 
peptide masses in a Mascot database. Obtained protein hits were then analyzed by Mascot 
based Mowse (Molecular Weight SEarch) scoring algorithm. Resulting scores are related to 
the probability (P) of a given match being a random event according to the following 
formula: Score = -10*log(P). Also P = E*N-1 where E = expect value, N = number of 
proteins in a database. If during the search 1.5 x 106 proteins fell within the search limits and 
the significance limit was set to E< 0.05 (less than 5% chance the peptide mass match is 
random) then the cutoff Mascot score would be S = -10*log [(1/1.5 x 106) (0.05)] = 74.7. 
With today’s databases, Mascot scores greater than 76 are significant (with E < 0.05). The 
significance of the result depends on the size of the database being searched. Mascot shades 
in green the insignificant hits using an E = 0.05 cutoff.  
In some cases peptide fragments from target proteins were sequenced using 
LC/MS/MS (Quadropole Time of Flight mass spectrometer – Q-TOF) coupled with Mascot 
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algorithm (weak bands). The peptide fragment sequences were sent to BLAST to be queried 
against a protein sequence database. Proteins having the highest number of sequence matches 
and the highest Mascot score were assigned identity. MS/MS ion search method was used in 
case of weak gel bands which could not be identified by PMF. MS/MS ion search provides 
more accurate sequence information as it not only searches for the parent ion of a given 
peptide but also uses the database to search for daughter ions each associated with a specific 
peptide fragment. This greatly increases the search scores and hit significance. Silver stained 
protein bands were cut off the gels, de-stained, trypsin-digested and resulting peptide signals 
were analyzed.   
Bands 3, 7, 11 (Figure 38) were associated with Carboxylic acid hydrolase - ESM1 
from Arabidopsis thaliana. The matching results are presented below. 
 
         1.  gi|15231805 - ESM1 (EPITHIOSPECIFIER MODIFIER 1); 
carboxylic ester hydrolase [Arabidopsis thaliana]  
Mass: 44374, Score: 1171, Queries matched: 69, Sequence coverage 48 %   
 
         2.  gi|18404748 - Myrosinase-associated protein,  
    putative [Arabidopsis thaliana], Mass: 43572,Score: 426, 
Queries matched: 13, Sequence Coverage: 36%  
 
    3. gi|18406229 - ZW9 [Arabidopsis thaliana], similar to meprin  
and TRAF homology domain-containing protein / MATH domain 
     -containing protein [Arabidopsis thaliana]  Mass: 45235 Score: 412,
Queries matched: 13, Sequence Coverage: 25% 
    
4.  gi|15235321- CRU3 (CRUCIFERIN 3);   
nutrient reservoir [Arabidopsis thaliana], Mass: 58541,  
Score: 403, Queries matched: 11, Sequence Coverage: 27% 
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ESM1 (EPITHIOSPECIFIER MODIFIER 1) coverage map: 
     1 MADNLNLVSV LGVLLVLTIF HNPIIVYAGE GVPNVALFTF GDSYYDAGNK  
    51 VFLSQRKDLP QTYWPYGKSR DYPNGKFSDG HIVPDFIADF ISIPNGVLPP  
   101 VLKPGVDISR GVSFAVADAS ILGAPVESMT LNQQVVKFKN MKSNWNDSYI  
   151 EKSLFMIYIG TEDYLNFTKA NPNADASAQQ AFVTNVINRL KNDIKLLYSL  
   201 GASKFVVQLL APLGCLPIVR QEYKTGNECY ELLNDLAKQH NGKIGPMLNE  
   251 FAKISTSPYG FQFTVFDFYN AVLRRIATGR SLNYRFFVTN TSCCGVGTHN  
   301 AYGCGKGNVH SKLCEYQRSY FFFDGRHNTE KAQEEMAHLL YGADPDVVQP  
   351 MTVRELIVYP TGETMREYWE PNNLAIRRRP SRDFYLGLAA YY 
 
The BLAST provided 6 significant matches, however the match with the highest score 
(hit 1) is well distant from all other matches, which gives us a very high confidence in 
identification of the protein. 
Bands 2, 6, 10 were associated with JR1 (Jacalin lectin family protein) from 
Arabidopsis thaliana.   
 
1. gi|30684083 -JR1(Jacalin lectin family protein),[Arabidopsis thaliana]
 Mass: 48524, Score: 766, Queries matched: 27, Sequence Coverage: 57% 
  
2. gi|15231805  - ESM1 (EPITHIOSPECIFIER MODIFIER 1);  
 carboxylic ester hydrolase [Arabidopsis thaliana] 
 Mass: 44374, Score: 358, Queries matched: 29, Sequence Coverage: 32% 
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JR1(Jacalin lectin family protein),sequence coverage map (hit 1): 
     1 MAKKLEAQGG RGGEEWDDGG AYENVKKVYV GQGDSGVVYV KFDYEKDGKI  
    51 VSHEHGKQTL LGTEEFVVDP EDYITSVKIY YEKLFGSPIE IVTALIFKTF  
   101 KGKTSQPFGL TSGEEAELGG GKIVGFHGSS SDLIHSVGVY IIPSTTPLTP  
   151 PVSGGLTKLE AQGGRGGDVW DDGGAYDNVK KVYVGQGDSG VVYVKFDYEK  
   201 DGKIVSLEHG KQTLLGTEEF EIDPEDYITY VKVYYEKLFG SPIEIVTALI  
   251 FKTFKGKTSQ PFGLTSGEEA ELGGGKIVGF HGTSSDLIHS LGAYIIPSST  
   301 PLTPSSNTIP AQGGDGGVAW DDGVHDSVKK IYVGQGDSCV TYFKADYEKA  
   351 SKPVLGSDHG KKTLLGAEEF VLGPDEYVTA VSGYYDKIFS VDAPAIVSLK  
   401 FKTNKRTSIP YGLEGGTEFV LEKKDHKIVG FYGQAGEYLY KLGVNVAPIA  
   451 K 
 
Bands 1, 4, 8 were associated with Beta-glucosidase precursor from Arabidopsis 
thaliana.  
1. gi|6651430 - Beta-glucosidase homolog [Arabidopsis thaliana], 
 Mass: 60904, Score: 784, Queries matched: 46, Sequence Coverage: 48% 
    
2. gi|984052  -  Thioglucoside Glucohydrolase [Arabidopsis thaliana], 
  Mass: 60222, Score: 663, Queries matched: 31, Sequence Coverage: 52% 
  
3. gi|5107821 - Arabidopsis thaliana Thioglucosidase  
 Mass: 61885, Score: 594, Queries matched: 16, Sequence Coverage: 35 
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Arabidopsis thaliana, Beta-glucosidase homolog sequence coverage map 
(hit1): 
     1 MVRFEKVHLV LGLALVLTLV GAPTKAQGPV CGAGLPDKFS RLNFPEGFIW  
    51 GTATAAFQVE GAVNEGCRGP SMWDTFTKKF PHRCENHNAD VAVDFYHRYK  
   101 EDIQLMKDLN TDAFRLSIAW PRIFPHGRMS KGINKVGVQF YHDLIDELLK  
   151 NNIIPLVTVF HWDTPQDLED EYGGFLSGRI VQDFTEYANF TFHEYGHKVK  
   201 HWITFNEPWV FSRAGYDNGK KAPGRCSPYI PGYGQHCQDG RSGYEAYQVS  
   251 HNLLLSHAYA VDAFRNCKQC AGGKIGIAHS PAWFEPQDLE HVGGSIERVL  
   301 DFILGWHLAP TTYGDYPQSM KDRVGHRLPK FTEAEKKLLK GSTDYVGMNY  
   351 YTSVFAKEIS PDPKSPSWTT DSLVDWDSKS VDGYKIGSKP FNGKLDVYSK  
   401 GLRYLLKYIK DNYGDPEVII AENGYGEDLG EKHNDVNFGT QDHNRKYYIQ  
   451 RHLLSMHDAI CKDKVNVTGY FVWSLMDNFE WQDGYKARFG LYYIDFQNNL  
   501 TRHQKVSGKW YSEFLKPQFP TSKLREEL 
 
Finally Bands 5 and 9, were associated with large subunit of ribulose-1,5-bisphosphate 
carboxylase/oxygenase (Rubisco) from Arabidopsis thaliana.  
 
1. gi|7525041 ribulose-1,5-bisphosphate carboxylase/oxygenase large       
   subunit [Arabidopsis thaliana], Mass: 53435, Score: 1153, Queries     
   matched: 82, Sequence Coverage: 49% 
    
2. gi|2997767 myrosinase-binding protein homolog [Arabidopsis     
   thaliana], Mass: 50110, Score: 444, Queries matched: 7, Sequence            
   Coverage:21% 
 
3.  gi|7525040 - ATP synthase CF1 beta subunit [Arabidopsis thaliana] 
Mass: 53957, Score: 286, Queries matched: 10,   Sequence Coverage: 23% 
    The F-ATPase is found in plasma membranes, mitochondrial inner    
    membranes and in chloroplast membranes. Possesses an  FTP binding 
site. 
 
 
 
 
 
 
  
 
Rubisco, sequence coverage map (hit 1): 
     1 MSPQTETKAS VGFKAGVKEY KLTYYTPEYE TKDTDILAAF RVTPQPGVPP  
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    51 EEAGAAVAAE SSTGTWTTVW TDGLTSLDRY KGRCYHIEPV PGEETQFIAY  
   101 VAYPLDLFEE GSVTNMFTSI VGNVFGFKAL AALRLEDLRI PPAYTKTFQG  
   151 PPHGIQVERD KLNKYGRPLL GCTIKPKLGL SAKNYGRAVY ECLRGGLDFT  
   201 KDDENVNSQP FMRWRDRFLF CAEAIYKSQA ETGEIKGHYL NATAGTCEEM  
   251 IKRAVFAREL GVPIVMHDYL TGGFTANTSL SHYCRDNGLL LHIHRAMHAV  
   301 IDRQKNHGMH FRVLAKALRL SGGDHIHAGT VVGKLEGDRE STLGFVDLLR  
   351 DDYVEKDRSR GIFFTQDWVS LPGVLPVASG GIHVWHMPAL TEIFGDDSVL  
   401 QFGGGTLGHP WGNAPGAVAN RVALEACVQA RNEGRDLAVE GNEIIREACK  
   451 WSPELAAACE VWKEITFNFP TIDKLDGQE 
 
These results strongly suggest that out of all four proteins eluted from the column only 
three of them are present in fraction due to their actual binding to the probe. There are also 
two other proteins which were found in the same band (bands 5 and 9 Figure 38) as Rubisco 
and those are: a myrosinase-binding protein, and an ATP synthase, both from Arabidopsis 
thaliana. There is a possibility that several proteins are found in one band on the gel due to 
all of them having close molecular masses. These proteins were also not found in 
experiments without the probe which indicates the possibility of them being selective 
towards ABA. All three proteins are also absent in fractions corresponding to control 
experiments without the probe during UV irradiation (Figure 37A).  All other proteins such 
as ESM1, JR1 and Beta-glucosidase precursor can be considered as non-specific.  
In order to check if it is possible to reduce non-specific binding of above proteins to the 
column matrix pre-elution step during FPLC run was applied. Just like before, the column 
was loaded with crude, UV-irradiated protein extract, then washed with running buffer (20 
column volumes) and was additionally washed with approximately 10 column volumes of 
0.1M citric acid at pH 2.0.  Under these conditions only biotinylated proteins would still 
remain on the column and lowered pH by citric acid would elute all other non-specifically 
bound proteins. 
In this experiment crude protein extract from 50 grams of fresh Arabodopsis leaf tissue 
was divided into two equal portions. First portion  was irradiated with UV  light in the 
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presence of 100 µM PBI 686. It was then applied to a sepharose-streptavidin affinity column 
(1 mL volume). Chromatography purifications were run at 1 mL/min flow rate, except during 
sample injection (0.3 mL/min). It was found that the areas of both peaks A and B were 
comparable meaning that a substantial amount of proteins are not biotinylated (peak A, 
Figure 39). Proteins eluted with citric acid should do not carry biotin as its interaction with 
steptavidin  is the strongst known non-covalent interaction (KD ~ 10-14 M) and can only be 
broken opon streptavidin denturation (heat, denaturating agents). 
 
 
 
 
 
 
   
 
 
 
 
 
Figure 39. FPLC trace of the experiment with citric acid pre-eluting step. Peak A 
corresponds to proteins eluted with citric acid. Peak B – biotinylated proteins eluted with 
Guanidine hydrochloride. A/B peak area ratio = 1.03 
 
The two most effective methods of breaking biotin-streptavidin interaction are 
treatment with 8M Guanidine hydrochloride at pH 2.0, or boiling the complex with 2% 
SDS.182Common method of pre-eluting of non-specific proteins utilizes a change of pH to 
either higher or lower than the pH of regular running/binding buffer. The pH of 
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binding/running buffer in this case was 7.6 and in order to strip off the non-specific proteins, 
lowering the pH was chosen as a pre-eluting step. Citric acid was used as its buffering 
capacity (pH 2-6) was suitable for this application. 
It was also important to test whether ABA could block the crosslinking reaction and 
therefore reduce the number of proteins bound to the column. The second portion of the 
protein cude extract (see previous page) was irradiated with UV light in the presence 100 µM 
PBI 686 and 5 mM (±) ABA. Figure 40 represents this experiment. The most striking 
difference between the two experiments with and without ABA is the change of ratio 
between peak areas (A/B = 1.03, C/D = 3.05). In the latter case the amount of biotinylated 
proteins has been reduced by almost 70% (peak area relative to pre-eluting peak). 
 
 
 
 
 
 
 
 
Figure 40.  FPLC trace of the experiment with citric acid pre-eluting step and 5 mM 
(±) ABA during UV irradiaiton. Peak C corresponds to proteins eluted with citric acid. Peak 
D – biotinylated proteins eluted with Guanidine hydrochloride. C/D peak area ratio = 3.05 
 
This strongly suggests that ABA does in fact block the photoaffinity labeling.  Both 
experiments were performed using the same set of conditions and the same amount of fresh 
0
100
200
300
400
500
600
700
10 20 30 40 50
[ml]
m
AU
Pre-eluting:  
0.1 M citric acid, 
pH 2.0 
8 M GU- HCl, 
pH 2.0 
C 
D 
88 
 
tissue was used to extract proteins. And if that is the case one could ask a question why both 
peak areas (A vs. C and B vs. D, Figure 39-40) have decreased in the presence of ABA if 
only biotinylated protein peak (D) should be reduced? Above situation would only apply if 
during the photoaffinity labeling reaction all available protein molecules would bind all 
probe molecules, meaning if the reaction was quantitative. Such condition cannot be applied 
since the protein/ligand ratio is not known nor is the reaction yield.  Therefore after the 
reaction, both the free protein and ligand will still be present in solution. If such crude 
reaction mixture is applied on streptavidin affinity column not only biotinylated proteins will 
retain on the column, but also some non-tagged proteins will bind the probe non-covalently. 
The free probe will also be captured by streptavidin. In summary one should expect to find 
potential ABA–binding proteins in both fractions, in peaks A and C (non-covalent binding) 
and in peaks B and D (probe bound covalently). ABA reduced both peak areas due to both 
blocking the PAL reaction as well as competing for the non-covalent specific interaction 
between the protein and the probe.  When comparing Figure 39 and Figure 40 it is clear 
however that there is a dramatic reduction of biotinylated protein (peaks B and D) in the 
presence of ABA. In order to confirm that fractions collected from peaks B and D were 
analyzed by far-Western blot.\ 
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Figure 41. far-Western analysis of fractions collected in peaks B  (Figure 39) and D 
(Figure 40). M – biotinylated protein molecular weight marker (from top: 97, 66, 45, kDa); 1 
– non-chromatographed crude protein extract, 2,4 (different gel loadings) – peak B (Figure 
39), 3 – peak D (Figure 40). 
 
Far-Western analysis of peaks B and D have confirmed that the crosslinking reaction is 
blocked by ABA at concentration being fifty fold higher than the concentration of PBI 686. 
When comparing lanes 2 and 4 on Figure 41 (fractions from two experiments) with lane 3 
there is a clear reduction of the amount of biotinylated protein down to the far-Western 
detection limit. 
Lane 1 (Figure 41) represents crude protein extract which was not incubated with PBI 
686, non-chromatographed but irradiated with UV light. Initially it was assumed that the 
protein band appearing in lane 1 was due to a biotinylated protein present in crude extract. 
However when such extract was affinity chromatographed the protein is no longer found in 
the eluted fractions (Figure 38A5). This suggests two possibilities. First that this protein is 
biotinylated and highly concentrated in the crude extract and it is therefore detected on far-
Western, whereas when chromatographed it becomes non-detectable due to dilution. Second 
that it is not biotinylated but rather being non-specifically detected by the far-Western 
system. Nonspecific protein bands on far-Western blots have been reported.183,184,185 The 
M     1       2       3       4         
crude    B     D      B 
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possibility of this protein band being probe-modified can be eliminated since this fraction has 
not been in contact with the probe.  
It was also attempted to compare the effect of (+) and (-)-ABA on crosslinking 
reaction. For this purpose two parallel experiments using the same conditions were run. The 
main protein extract was divided into three portions, one UV irradiated in the presence of 
PBI 686 only, the second and third with PBI 686 with addition of 5 mM (+) or (-)-
ABArespectively. Immediately after irradiation protein samples were chromatographed. 
FPLC chromatograms have shown that the area under peaks eluted with Guanidine 
hydrochloride from experiment with (+) and (-)-ABA was the same (Figure 42), and again 
significantly lower than from the corresponding experiment without ABA. 
The peak area ratios were the following: A/B/C = 2.60/1.06/1.00 In other words peak 
area corresponding to experiment with (-)-ABA was only 10% higher than its (+)-ABA 
equivalent. Proteins in peaks A-C were analyzed by far Western which has confirmed that 
both enantiomers of ABA effectively block the PAL reaction, and is is further demonstrated 
on Figure 43. 
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Figure 42. Ovelapped (and shifted for clarity) FPLC traces of proteins eluted from 
streptavidin affinity column. Peak A – experiment with 100 µM PBI 686 only, peak B - 100 
µM PBI 686 and 5 mM (-)-ABA, peak C - 100 µM PBI 686 and 5 mM (+)-ABA.  
 
 
 
 
 
 
 
Figure 43. far-Western analysis of fractions collected in peaks A-C (Figure 42). M – 
biotinylated protein molecular weight marker (from top: 97, 66, 45, 31, 20.1, 14.4 kDa) 1 – 
non-chromatographed crude protein extract, 2 – peak C – (+)-ABA present (Figure 42), 3 – 
peak B (-)-ABA present (Figure 42), 4- peak A- no ABA present (Figure 42). 
 
This was the first indication that this potential ABA-binding protein binds ABA with 
no stereospecific preference. The latter part of the thesis will present further evidence 
supporting that finding.  
0
500
1000
1500
2000
2500
3000
15 20 25 30 35
[ml]
m
A
U
PBI 686 
 
PBI 686 and (-) ABA 
PBI 686 and (+)-ABA 
  A 
B 
C 
92 
 
At this point identification of all three bands appearing in lane 4 on Figure 43 is 
necessary. For this purpose, the scale of the experiment was increased to 100 g of fresh tissue 
in order to obtain sufficient amount of protein in all bands to appear as a band on silver 
stained gel with band 4-5 (Figure 44) in particular. Protein quantities in bands visible on far-
Western blots are usually not sufficient to run peptide mass fingerprinting followed by 
MALDI-TOF. The crosslinking reaction in a presence of PBI 686 with proteins extracted 
from 100 g of tissue also yielded three protein bands this time visible on silver stained gel 
(Figure 44). 
 
 
 
 
 
 
Figure 44. Protein fractions (Figure 42) eluted from FPLC column visualized on a 
silver-stained gel. M - protein molecular weight marker (from top: 97, 66, 45, 31, 20.1, 14.4 
kDa), 1,2 -column fractions (different gel loadings) 
 
Proteins observed in lanes 1 and 2 correspond to column fractions collected during 
eluting step. Crude cytosolic protein extract was incubated with 100 µM PBI 686, irradiated 
with UV light and applied on affinity column (pre-eluting step used). All seven protein bands 
(bands 1-7 Figure 44) were analyzed by MALDI-TOF peptide fingerprinting and/or MS/MS 
ion search and the results are presented below.  All bands but 5 were associated with the 
    M        1         2 
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large subunit of Rubisco. Presented below are only the significant Mascot results and peptide 
coverage map for the highest score hit. 
 
Peptide coverage map for the highest score hit #1: 
     1 MSPQTETKAS VGFKAGVKEY KLTYYTPEYE TKDTDILAAF RVTPQPGVPP  
    51 EEAGAAVAAE SSTGTWTTVW TDGLTSLDRY KGRCYHIEPV PGEETQFIAY  
   101 VAYPLDLFEE GSVTNMFTSI VGNVFGFKAL AALRLEDLRI PPAYTKTFQG  
   151 PPHGIQVERD KLNKYGRPLL GCTIKPKLGL SAKNYGRAVY ECLRGGLDFT  
   201 KDDENVNSQP FMRWRDRFLF CAEAIYKSQA ETGEIKGHYL NATAGTCEEM  
   251 IKRAVFAREL GVPIVMHDYL TGGFTANTSL SHYCRDNGLL LHIHRAMHAV  
   301 IDRQKNHGMH FRVLAKALRL SGGDHIHAGT VVGKLEGDRE STLGFVDLLR  
   351 DDYVEKDRSR GIFFTQDWVS LPGVLPVASG GIHVWHMPAL TEIFGDDSVL  
   401 QFGGGTLGHP WGNAPGAVAN RVALEACVQA RNEGRDLAVE GNEIIREACK  
   451 WSPELAAACE VWKEITFNFP TIDKLDGQE 
 
As mentioned before all bands were associated with large (53435 Da) subunit of 
Rubisco (from Arabodopsis) except for band 5 which corresponds to Arabidopsis storage 
protein CRUCIFERIN 3 (CRU3, 58 541 Da). Bands 1,4 and 5 were found to match a set of 
proteins but their molecular weights did not match the band positions on the gel. An 
explanation for such phenomenon for bands 1 and 4 (identified as LS of Rubisco) can be 
found in the literature.    
The large subunit of this protein has been often found to form dimers (or aggregates) 
even after denaturating.186, 187  Ritamaki et al. reported that the separated large subunits of 
1. gi|7525041 
 ribulose-1,5-bisphosphate carboxylase/oxygenase  
 large subunit [Arabidopsis thaliana] Mass: 53435     
 Score: 218, Queries matched: 17, Sequence Coverage: 29% 
2. gi|13926229 
  F1O19.10/F1O19.10 [Arabidopsis thaliana], (Rubisco small subunit) 
 Mass: 14917, Score: 179, Queries matched: 7 Sequence Coverage: 47%   
3. gi|16195 
 ribulose bisphosphate carboxylase [Arabidopsis thaliana] 
 Mass: 20586, Score: 141, Queries matched: 5,Sequence Coverage: 22% 
4. gi|15235321 
 CRU3 (CRUCIFERIN 3); nutrient reservoir [Arabidopsis thaliana] 
 Mass: 58541, Score: 50, Queries matched: 2, Sequence Coverage: 4% 
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wheat Rubisco formed non-functional, high-molecular weight aggregates. Treatment with 
both SDS and thiol reductant was necessary to disrupt the aggregated structures, which 
indicates that the large subunits had been cross-linked by disulphide bridges. Since added 
thiol reductant did not prevent aggregation of the separated subunits during attempted 
reconstitution, oxidation of the sulfhydryl groups apparently took place on contact faces 
sheltered by the secondary and tertiary structures of the polypeptides. High concentration of 
large subunits or freezing and thawing of the solution stimulated the formation of disulphide 
cross-links between the large subunits. The results suggest that large subunits have a 
tendency to cross-link with disulphide bridges. Luo et al.187 reported that when the unfolded 
Rubisco in guanidine hydrochloride is diluted at 4 °C, a folding intermediate (Rubisco-I) is 
rapidly formed, which remains  in an unstable monomeric state and gradually  develops into  
folded monomer (Rubisco-M) at 4 °C but undergoes irreversible aggregation at 25 °C. 
Refolding of Rubisco-I to Rubisco-M is a very slow process, taking about 20 h for 70% 
conversion at 4 °C. Rubisco-M is stable at 4 °C and is capable of forming an active dimer
spontaneously when incubated at a temperature higher than 10 °C. The dynamic 
dimerization process has been measured in a temperature range of 4–35 °C by HPLC, and the 
results demonstrate that the dimerization is strongly facilitated by the temperature. 
Two large subunits of Rubisco would have a molar weight 107 kDa. It is therefore 
concluded that the position of the band above 97 kDa could correspond to the dimer. It has 
been previously reported that Rubisco is capable of refolding followed by dimer formation. 
187,188 It was also reported that both small and large subunits of Rubisco have been found to 
form aggregates.186 In addition precursors of large and small subunits can coexist with their 
corresponding mature forms.189 There are therefore several different reasons as to why the 
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large LS of Rubisco could appear as three bands (>100, 60, and 54 kDa, see Figure 44).  On 
the other hand this multiple band appearance of LS has not been observed in crude protein 
extracts which were not UV-irradiated, which strongly suggests that UV irradiation enhances 
the processes mentioned above. In fact it was possible to obtain experimental evidence 
supporting that hypothesis. As observed on Figure 41, 43 and 44, after UV irradiation in the 
presence of PBI 686 Rubisco LR appears as 2 bands on silver-stained gel and far-Western 
blot. MALDI-TOF spectra (collected in a typical for tryptic digests 700-3000 ion mass 
window) of bands 2 and 3 (Figure 44) exhibit the same major fragments as that of non-
irradiated protein. However, after careful comparison of MS spectra for bands 2-3 tryptic 
digests, three new signals were observed. Those signals are: 1351.6470 Da, 1365.6650 Da 
and 1009.5565 Da.  Comparison of both spectra (irradiated and non-irradiated protein) in 
different mass range windows is shown on Figure 45 and 46. 
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Figure 45.  Raw MALDI spectra traces of non-UV irradiated (top trace) and UV-irradiated (bottom trace) and trypsynized 
Rubisco. High resolution (reflectron) mode, with external calibration and mass accuracy of 20 ppm. 
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Figure 46. Deisotoped MALDI spectra traces of non-UV irradiated (top trace) and UV-irradiated (bottom trace) and trypsynized 
Rubisco. High resolution (reflectron) mode, with external calibration and mass accuracy of 20 ppm. 
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It was initially thought that the new peptide ions observed were associated with PBI 
686 adduct. However after thorough examination of MS spectra and analyzing all present 
peaks (Thanks to Dr. Andrew Ross) and performing a theoretical digest of both large and 
small Rubisco subunits, it appeared that these peptides belong to the small subunit of the 
peptide. Although the small subunit’s (SS) molecular weight is only 14 kDa, its tryptic 
peptides were found in a band equivalent to 60 kDa (bands 2 and 6, Figure 44). This 
indicated that a part of SS is somewhat associated with LS and explains the appearance of 
Rubisco’s LS as two bands after its UV irradiation, one being 54 kDa and second 
approximately 60 kDa. Combined molecular weight of SS and LS is approximately 70 kDa 
and appearance of the new Rubisco band (upon UV irradiation) around 60 kDa indicates that 
only a fragment of approximately 6 kDa of small subunit is covalently attached to the large 
subunit.  
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2.7.   Photolabeling of purified Rubisco 
 
 
Having done the photoaffinity labeling with crude extracts and learning that ABA is 
capable of blocking the probe from labeling Rubisco, further studies on this phenomenon 
were carried out using purified protein in order to obtain more evidence about ABA 
interaction with Rubisco. Purified Rubisco was mixed with other purified proteins (non-
specific to ABA or probe) all at the same concentration (mg/mL). In such a situation one 
would expect to observe only the specific protein being labeled, provided the molar ratio 
between the probe and the proteins does not exceed the previously mentioned value of 1:5 
(from photoaffinity labeling of anti-ABA mAb). For such control experiment a mixture of 
three proteins was used: Rubisco (LS 54 kDa, SS 14kDa), Ovalbumin (45 kDa) and Bovine 
Serum Albumin (BSA; 66 kDa). The molecular weights of proteins were chosen to be 
distinctly different to simplify the interpretation of far-Western results.   
In sample 1 proteins at 100 µg/mL each (total volume of the reaction mixture 5 mL; 
protein molar ratio approx 1:1:1) were incubated for 1h at 4 °C with 100 µM PBI 686 and 
then irradiated for 15 minutes with UV light. Sample 2 was processed in the same way with 
the exception that concentration of PBI 686 was lowered to 10 µM. Samples 3-4 contained 
10 µM PBI686 and 0.5 mM, 1 mM (+)-ABA respectively. Sample 5 contained only UV-
irradiated proteins, sample 6 - 10 µM PBI686 but was not irradiated by UV. Figure 47 
represents the results by far-Western analysis. Lanes 1-6 correspond to samples 1-6 described 
above. This experiment indicated that 45 kDa Ovalbumin and 66 kDa BSA did not crosslink 
with the probe even at its 100 µM concentration (lane 1). 
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Figure 47. far-Western blot analysis of photoaffinity labeling experiments with 
purified Rubisco, Ovalbumin and BSA at the same concentration. 1- 100 µM probe , 2- 10 
µM probe, 3- 10 µM probe and 0.5 mM (+)-ABA, 4 - 10 µM probe and 1 mM (+)-ABA,  5- 
UV irradiated proteins only, 6 - 10 µM probe without UV irradiation, 7- 10 µM probe 
(detailed description in text). 
 
At 10 µM PBI686 only bands corresponding to Rubisco LS and its dimer are detected 
(lane 2). The presence of (+)-ABA at both 0.5 mM (50 fold excess) and 1 mM (100 fold 
excess) almost completely blocked the crosslinking reaction.  Lanes 5-6 are negative controls 
(Figure 47). Lanes 2 and 7 correspond to the same sample. 
It was previously observed that tetralone-ABA (PBI 410) was capable of blocking the 
crosslinking reaction of the probe PBI686 to proteins in crude extracts.  Due to the presence 
of acetophenone moiety in PBI410 it is expected to crosslink in a similar manner with 
proteins just as well as the actual probe. It was also checked whether PBI410 is capable of 
blocking the photoaffinity labeling of purified Rubisco and also compare that to the effect of 
ABA (Figure 48). By comparing lanes 1 vs. 4, 2 vs. 5 and 3 vs. 6 on the above figure it is 
clear that tetralone-ABA is more efficient in displacing the probe than (+)-ABA. This 
phenomenon can be explained by the fact that unlike ABA, tetralone-ABA is capable of 
covalent binding upon UV irradiation (acetophenone moiety).  It will therefore be trapped 
97 kDa 
66 kDa 
 
 
45 kDa 
31 kDa 
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once bound to the protein and no other competitor will displace it, regardless of its binding 
affinity and concentration. This experiment has confirmed the initial hypothesis as discussed 
above (Figure 37).  
 
 
 
 
 
 
 
Figure 48. far-Western blot of samples resulting from Rubisco (0.14 mg/mL) 
crosslinking with the probe (100 µM ) in the presence of tetralone-ABA or ABA. M – protein 
molecular weight marker (from top: 97, 66, 45, 31, 20, 14.4 kDa). 1-3 - 100 µM probe + 0.5, 
1 and 2 mM (+)-ABA. 4-6 - 100 µM probe + 0.5, 1 and 2 mM tetralone-ABA. 7 - 100 µM 
probe, no UV irradiation. 
 
M    1      2     3     4     5    6    7  
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2.8.   Photolabeling and identification of membrane proteins in 
Arabidopsis leaf extracts 
 
 
In addition to cytosolic proteins, we also wanted to perform initial investigation that would 
tell us whether there are any hydrophobic proteins found in the crude extract that are capable of 
binding the probe.  
Up to this point, only cytosolic proteins were investigated, and crude protein extracts were 
not fractionated by ultracentrifugation, nor detergent was added to maintain the microsomal 
fraction of proteins solubilized. During cytosolic protein extraction, tissue homogenate is first 
filtered then proteins are precipitated with ammonium sulfate, followed by centrifugation to a 
pellet. Such pellet is then re-suspended in a small amount of buffer and applied on desalting 
column. Hydrophobic proteins will remain non-dissolved throughout the extraction process 
under these conditions. If a non-ionic detergent is added to the extraction buffer, the hydrophobic 
proteins will be solubilized. In order to compare the two experimental conditions (with or 
without the detergent) crude tissue homogenate was divided into two equal portions and a non-
ionic detergent DHPC (1,2-Diheptanoyl-sn-Glycero-3-Phosphocholine) was added to 0.01% w/v 
concentration to one portion.  DHPC preserves the native conformation and therefore the activity 
of the solubilized proteins.190  
In the absence of DHPC the protein composition in eluted fractions appeared the same as 
previously discussed (Figure 38). However in the presence of detergent we observed an 
additional protein band appearing on both silver-stained gel and far-Western blot (band 1, Figure 
49). The corresponding protein in band 1 was identified by MS/MS ion search method using Q-
TOF/MS. Below presented are the results. 
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Figure 49. SDS-PAGE separation of proteins found in fractions eluted from affinity 
column after UV irradiation of detergent-solubilized crude protein lysates in the presence of 
PBI686.  A (silver stain): M- protein molecular weight marker (from top: 97, 66, 45 kDa), 1-2 – 
proteins eluted in the presence of DHPC detergent during photolabeling reaction; 3-4 proteins 
eluted in the absence of detergent during photolabeling reaction. B – Corresponding far-Western 
blot (lanes 1-4 correspond to lanes 1-4 on A). 
 
1. gi|15235363   
DREPP plasma membrane polypeptide family protein [Arabidopsis thaliana]. 
Mass: 24569, Score: 131, Queries matched: 10    
  
2. gi|62319382 
   Fructose bisphosphate aldolase-like protein  [Arabidopsis thaliana]     
      Mass: 5249, Score: 69,Queries matched: 2  
  
3. gi|15232931  
meprin and TRAF homology domain-containing protein /MATH domain-containing 
protein [Arabidopsis thaliana]   Mass: 43031, Score: 67, Queries matched: 2, 
Sequence Coverage: 12% 
 
4. gi|14334740  
putative fructose bisphosphate aldolase  [Arabidopsis thaliana] 
Mass: 43033, Score: 65,Queries matched: 5, Sequence Coverage: 12% 
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Sequence Coverage for the highest score hit (DREPP): 46% 
 
     1 MGYWNSKVVP KFKKLFEKNS AKKAAAAEAT KTFDESKETI NKEIEEKKTE  
    51 LQPKVVETYE ATSAEVKALV RDPKVAGLKK NSAAVQKYLE ELVKIEFPGS  
   101 KAVSEASSSF GAGYVAGPVT FIFEKVSVFL PEEVKTKEIP VEEVKAEEPA  
   151 KTEEPAKTEG TSGEKEEIVE ETKKGETPET AVVEEKKPEV EEKKEEATPA  
   201 PAVVETPVKE PETTTTAPVA EPPKP 
 
Band 2 was associated with the large subunit of Rubisco, and band 3 with two other 
proteins, whose Mascot searches gave very similar scores. A common problem in protein 
identification using either PMF or MS/MS methods is coexistence of several proteins within one 
band.  If this is the case, the search results usually list several proteins with very similar scores. 
Below presented is the result of protein identification in band 3 which illustrates this problem. 
 
1.  gi|1944432  ribulose-bisphosphate carboxylase [Arabidopsis thaliana, 
Mass: 48008, Score: 187, Queries matched: 5 
  
2. gi|6651430  beta-glucosidase homolog [Arabidopsis thaliana], 
Mass: 60904, Score: 172, Queries matched: 6 
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The possibility for band 3 being associated with Rubisco or β-glucosidase is equal. On the 
other hand if such band appears just below 66 kDa marker lane (Figure 49 A1) it is more likely 
to be identified as β-glucosidase than Rubisco. As expected bands 4-8 (Figure 49 49A) were as 
sociated with the same proteins as in the discussion related to the experimental results shown in 
Figure 38. More specifically band 4 (ESM1- Arabidopsis thaliana), band 5 (Rubisco), bands 6 
and 8 (β-glucosidase precursor - Arabidopsis thaliana). As mentioned before ESM1 and β-
glucosidase precursor were disregarded as previously shown non-specific. 
In summary proteins which are present in fractions eluted from affinity column due to their 
possible specific binding with the probe include:  Rubisco, Myrosinase-binding protein, ATP 
synthase, all found in cytosolic extracts, and one membrane protein: DREPP (developmentally 
regulated endoplasmatic polypeptide). 
DREPP is interesting because it is a protein of unknown function, and it is membrane 
associated. The latter is often a feature of receptor proteins.  
DREPP belongs to a small family of plasma membrane proteins first discovered in 1997 by 
Logan et al. 191. Four highly homologous proteins termed P16-P19 were found to be abundant in 
the plasma membrane only at a specific developmental stage and in specific leaf-sets. Logan et 
al.191 reported the cloning of one unknown polypeptide (termed P19) which was one of a pair 
(the other, P18, displaying 93% identity with P19 in 5 amino acid sequences) that accumulate 
transiently at floral induction. Cloning and overexpression of a further two plasma membrane 
polypeptides (P16 and its twin P17) which were abundant in leaves only in the later stages of 
plant development was also reported. Unexpectedly, these two polypeptides were found to be 
highly homologous to P18 and P19. On the basis of immunological and sequence data, these four 
proteins were proposed to be members of a new family of developmentally regulated plasma 
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membrane polypeptides (DREPP). All four DREPPs share a striking amino acid composition and 
a structure consisting of a conserved putative trans-membrane domain flanked by a conserved 
and basic N-terminal region, and by an acidic C-terminal region of more variable length and 
containing small but highly conserved domains. It was found of particular interest that the 
expression of DREPP-1/2 during plant development contrasted with that of DREPP-3/4, the 
former being abundant only in late stages of development while the latter showed a peak in 
abundance at the time of floral induction. Furthermore, DREPP-1/2 were more abundant in lower 
leaves, while DREPP-3/4 were more abundant in upper, younger leaves. Sequence analysis 
provided no clues as to function of each DREPP, but plant DREPP homologues in Arabidopsis, 
rice and tobacco are present as ESTs and no homologues have been identified in other 
organisms. This suggests DREPPs uniqueness to plants. 
Kawamura et al.  has reported DREPP peptides as cold responsive in: “Mass spectrometric 
approach for identifying putative plasma membrane proteins of Arabidopsis leaves associated 
with cold acclimation”. 192 DREPP peptides were found to be more abundant in cold-treated 
plants. In addition their experimental molecular weight (35.2 kDa) was found fairly distant from 
the theoretical one (24.66 kDa). This is consistent with our observation (Figure 49A1). 
Kawamura has identified DREPP as one of 15 other proteins up-regulated by cold stress among 
which are found several proteins with calcium-binding ability and which could involve in the 
increase in freezing tolerance during cold acclimation Tobacco DREPP-like protein contains the 
possible Glu-rich site at the C-terminus that possesses a sequence similarity to that of the 
vacuolar Ca
2+
-binding protein in radish. Taken together with results that the amount of tobacco 
DREPP-like protein increased temporarily only after 1 day of cold acclimation it is possible that 
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this protein may be associated with Ca
2+ 
signal transduction pathway at the early stage of cold 
acclimation. There is no other evidence however to support that hypothesis.  
Although DREPP’s ability to bind ABA has not been further evaluated in this project it 
remains as one of future directions due to it being one of putative ABA receptors.   
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2.9.  Analysis of the binding interaction between ABA and 
Rubisco by Surface Plasmon Resonance (SPR) 
 
2.9.1. SPR as a technique chosen for studying ABA-Rubisco 
interaction 
 
Surface Plasmon Resonance is a label-free technology for monitoring biomolecular 
interactions as they occur. It is widely used to investigate small molecule-protein and/or protein-
protein interactions. The detection principle relies on surface plasmon resonance (SPR), an 
electron charge density wave phenomenon that arises at the surface of a metallic film when light 
is reflected at the film under specific conditions. The resonance is a result of energy and 
momentum being transformed from incident photons into surface plasmons, and is sensitive to 
the refractive index of the medium on the opposite side of the film from the reflected light.  
Changes in SPR signal are expressed in resonance units, RU where 1 RU is equivalent to one 
picogram (of analyte or ligand bound to the surface) per square millimeter of sensor surface. The 
response is directly proportional to the mass change of the surface. The phenomenon was first 
observed by Turbadar193 and fully evaluated by Otto194 and, Kretschmann.195 In this project, the 
BiacoreTM SPR system was used to monitor interactions on a biospecific surface by measuring 
changes in the solute (ABA) concentration at this surface as a result of the interactions. A typical 
SPR sensogram is depicted on Figure 50. 
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Figure 50. A typical binding cycle observed with an optical biosensor. A protein is 
immobilized on the sensor surface with appropriate coupling chemistry. At t=0 s buffer is 
applied to the protein through a micro-fluidic flow cell. At t=100 s a solution of analyte in the 
running buffer is passed over the protein. As the analyte binds to the surface, the refractive index 
of the medium adjacent to the sensor surface increases, leading to an increase in the resonance 
signal. Analysis of this part of the binding curve gives the observed association rate (kobs). If the 
concentration of the analyte is known, then the association rate constant of the interaction (kass) 
can be determined. At equilibrium, by definition, the amount of analyte associating and 
dissociating with the receptor is equal. The response level at equilibrium is related to the 
concentration of active analyte in the sample. At t=320 s the analyte solution is replaced by 
buffer and the receptor–analyte complex is allowed to dissociate. Analysis of this data gives the 
dissociation rate constant (kdiss) for the interaction. Many complexes in biology have considerable 
half-lives, thus a pulse of a regeneration solution (e.g. high salt, low pH, etc.) is used at t=420 s 
to disrupt binding and regenerate the free protein. The entire binding cycle is normally repeated 
several times at varying concentrations of analyte to generate a robust data set for global fitting 
to an appropriate binding algorithm. The affinity of the interaction can be calculated from the 
ratio of the rate constants (KD=1/KA=kdiss/kass) or by a linear or non-linear fitting of the response at 
equilibrium vs. varying concentration of analyte (figure and caption adapted from Matthew et 
al.196). 
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2.9.2. SPR scouting and protein immobilization 
 
 
To study the ABA-Rubisco interaction, CM5 (Biacore) sensor chips were used. The free –
COOH groups on the unmodified chip were activated with EDC and N-hydroxy-succinimide and 
then coupled to the protein’s free –NH2 groups forming a covalently modified surface. Before 
the protein was immobilized, a number of scouting experiments were performed. Pre-
concentration of the protein in the surface matrix is important for efficient immobilization of 
macromolecules. This is accomplished by electrostatic attraction between negatively charged 
sensor surface (carboxymethyl dextran), and a positively charged macromolecule. Because of the 
electrostatic attraction, it is important to place the macromolecule in a low ionic strength buffer 
(< 50 mM). The pH at which most protein is depositing on the surface is then used during the 
immobilization process. The scouting experiments are performed by mixing the protein solution 
(1:1 ratio by volume) with 10 mM sodium acetate buffer at pH 4.0, 4.5 and 5 correspondingly. 
The signal intensity during protein injection changes and the magnitude of that change is 
proportional to the amount of protein being pre-concentrated.  
Sodium acetate buffer at pH 5 mixed with the protein solution (pH 7.9) at ratio 1:1 gave 
the highest signal intensity and therefore was used as the optimal condition for pre-concentrating 
Rubsico. An example of a scouting experiment is presented on Figure 51. 
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Figure 51.  Scouting experiment showing the dependence of protein pre-concentration on 
pH. 
 
Once the optimal conditions for protein pre-concentration have been established the next 
step was to immobilize (covalently) the protein on the chip surface. This was done by coupling 
the protein to the chip surface through a formation of an amide bond. This procedure is depicted 
on Figure 52. 
 
 
 
 
 
 
Figure 52. Protein immobilization procedure. 
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Figure 53. Sensogram representing protein immobilization procedure. FC1- control flow 
cell, FC2 – modified flow cell.  
 
To avoid coupling of protein to a protein-free reference cell (FC1) it is closed during 
protein deposition and then re-opened during ethanolamine injection. Since only a certain 
fraction of all activated carboxyl groups is being modified by the protein, the remaining groups 
are being blocked by ethanolamine to avoid non-specific binding in further experiments. Protein 
solution is injected in 1 minute pulses which are repeated until an immobilization level of choice 
is achieved. The amount of protein to be immobilized depends on the application.  For binding 
specificity measurements, almost any ligand density will be sufficient as long as it gives good 
signal. Kinetics are investigated with lowest ligand density still giving good response without 
being disturbed by secondary factors such as mass transfer or steric hindrance.  Mass transfer 
limitation is an important factor which needs to be considered. Binding of analyte (A, 
immobilized) to the ligand (L, in solution) on the sensor chip can be described as: 
surface activation (NHS+ EDC)     protein deposition        ethanolamine blocking 
FC1 
FC2 
8000 RU  
immobilized 
113 
 
 
 
 
Where: Abulk = analyte in buffer Asurface = analyte at surface of sensor chip, km = coefficient 
for mass transfer, ka = rate constant for association, kd = rate constant for dissociation. 
The reaction is a two step event. First, the analyte is transferred out of the bulk solution 
towards the sensor chip surface. Second, the binding of the analyte to the ligand takes place. The 
first step is also known as mass transfer and is carried out by convection and diffusion.197 Both 
events have their own rate constants (km and ka/kd). The coefficient for mass transfer (km) is the 
same in both directions. With full or partial mass transfer, the diffusion from the bulk to the 
surface is slower than the rate of binding of the analyte to the ligand creating a shortage of 
analyte at the surface. The miniaturized flow cell in BIACORE reduces but cannot eliminate the 
potential contribution of mass transfer processes to the observed binding kinetics. However, 
there are several ways of reducing the mass transport contribution, one by using low surface 
density of the protein and if that is not possible due to low signal it is also recommended to 
perform the experiments using high buffer flow rates.  In this project both of these methods were 
used. For determination of binding specificity high density surface (approx. 8000 RU) was used 
and for investigating the binding kinetics the surface density was lowered  to 4000 RU  and high 
(100 µl/min) buffer flow rates were applied. 
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2.9.3.  SPR experiments with Rubisco and ABA, PA, and PBI 686 
 
 
Initial experiments with Rubisco immobilized on the surface and (+)-ABA as an analyte 
provided evidence of specific binding. Low density surface coverage and high concentration of 
ABA (5 µM) yielded a sensogram with good signal intensity. No signal was observed upon 
injecting the buffer in which ABA was dissolved. Figure 54 illustrates one such initial 
experiment. 
 
 
 
 
 
 
 
 
 
 
 
Figure 54. Initial SPR experiment with 4000 RU of protein immobilized and 5 µM (+)-
ABA injection vs. buffer injection. 
 
buffer 
buffer + ABA 
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The next step was to check for specificity of binding. For that purpose the signal observed 
during ABA injection was compared to that of trans-cinnamic acid (CA), a molecule unrelated to 
ABA and its function. Comparison of signals from both ABA and CA is shown on Figure 55. 
The lack of any signal observed upon the injection of CA was the first indication that the 
signal resulting from ABA injection is due to specific interaction with the protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55. Initial SPR experiment with 4500 RU of protein immobilized and 5 µM (+)-
ABA injection vs. 5 µM trans-cinnamic acid (CA). 
(+)-ABA 
CA 
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(+)-ABA 
(-)-ABA 
Subsequently the binding of ABA and its analogs/metabolites was further investigated 
by qualitative comparison of the equilibrium dissociation corresponding to each compound 
capable of binding Rubisco. (-)-ABA was found to bind yielding a similar signal intensity 
sensogram when injected at the same concentration as (+)-ABA. This phenomenon is in 
agreement with previous finding where (-)-ABA blocked photoaffinity labeling of Rubisco as 
efficiently as (+)-ABA, which was the first indication of Rubisco binding both enantiomers. 
Although the SPR signal intensity for (-)-ABA seems to be slightly lower than for (+)-ABA. 
The sensogram in Figure 56 also indicated that the dissociation rate (kd) of (-)-ABA is 
detectibly lower than that of (+)-ABA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56. SPR sensograms resulting from 5 µM (+) and (-)-ABA injections. 4500 RU 
of protein immobilized. 
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500 nM (+)-ABA 
 
 
 
 
 
 
50 nM (+)-ABA 
 
 
 
500 nM PA 
50 nM PA 
This is observed by the slight shift of the sensogram to the left at the end of injection, 
which indicates faster dissociation of (-)-ABA than (+)-ABA. In addition slightly more (+)-
ABA was found to be retained by the protein after the injection, the difference was minimal 
but detectable. The ability to bind both ABA enantiomers confirms the selective rather than 
specific nature of this interaction. PA, a biologically inactive metabolite of ABA was also 
injected and no signal was observed using the low density surface. The same experiment 
carried out using the high density surface (8000 RU of protein immobilized) and two 
different PA concentrations yielded a relatively small signal. This is shown in comparison to 
the signals observed for (+)-ABA at the same concentrations of both analytes (Figure 57).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 57. An overlay of SPR sensograms resulting from 50 and 500 nM PA and (+)-
ABA. Rubisco surface density 10 000RU. 
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A dramatic difference between these two molecules was observed which suggests that 
unlike (+)-ABA, PA binding affinity to Rubisco is significantly lower. This has confirmed 
the hypothesis that binding of ABA and Rubisco is selective but not stereospecific.  
The next step in this study was a quantitative evaluation of binding kinetics between 
(+)-ABA, (-)-ABA, PA and the probe PBI 686. Kinetic evaluations of ABAs were done 
using low density surfaces (4000-4500 RU) and high buffer flow rates (100 µl/min). For PA 
and PBI 686 high surface densities were used as no signal was observed at lower densities. 
For these two latter compounds mass transport correction was utilized for kinetics evaluation 
to minimize the impact of mass transport on evaluation of binding parameters. 
Binding kinetics of (+)-ABA were evaluated using 5 sensor chips. Equilibrium 
dissociation constants were obtained using BiaEvaluation software, using 1:1 Langmuir fit 
algorithm which yielded the best fit. Equilibrium dissociation constants are calculated from 
the dissociation/association rate ratio (kd/ka). An example of SPR sensogram obtained for (+) 
and  (-)-ABA using a chip surface density of 4500RU is presented on Figure 58. Results from 
five different chips (for (+)-ABA) were averaged yielding the following equilibrium 
dissociation constant: KD (+)-ABA = 5.3 ± 1.6 nM. Equilibrium dissociation constant for (-) -
ABA was also evaluated using one sensor chip and it was KD (-)-ABA = 7.1 nM. 
 
 
 
 
 
 
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 58. SPR sensograms resulting from A - (+) and B - (-)-ABA injections. ABA 
concentrations ranging from 0.2 to 50 nM. Rubisco surface density 4500 RU. 
 
B ka = 2.43 x 106 M-1 s-1 
kd = 0.0175 s-1 
KD = 7.1 x 10-9 M 
5 nM (-)-ABA 
150 nM (-)-ABA 
A 
5 nM (+)-ABA 
150 nM (+)-ABA  
ka = 3.64 x 106 M-1 s-1
kd = 0.0173 s-1 
KD = 4.8 x 10-9 M 
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Figure 59. SPR sensograms resulting from (+)-ABA injections. ABA concentrations 
ranging from 0.2 to 50 nM. Rubisco surface density 8000 RU. 
 
Table 2. Kinetic parameters resulting from SPR measurements on five Rubisco-
crosslinked  CM5 sensor chips for (+)-ABA interactions. 
Sensor chip # ka [M-1 s-1] kd [s-1] KD [nM] 
1 3.64 x 106 1.73 x 10-2 4.76 
2 1.84 x 104 1.02 x 10-4 5.55 
3 1.33 x 106 4.56 x 10-3 3.42 
4 1.30 x 106 6.33 x 10-3 4.86 
5 8.36 x 105 6.59 x 10-3 7.88 
Average (± stdev.) 1.42 ± 1.35 x 106 6.98 ± 6.33  x 10-3 5.29 ± 1.64 
 
0.2 nM (+)-ABA 
50 nM (+)-ABA 
ka = 1.33 x 106 M-1 s-1
kd = 0.00456 s-1 
KD = 3.4 x 10-9 M 
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Rmax is the maximal feasible signal in Response Units (RU) which is dependent on the 
number of binding places (ligand concentration and valency (V) and the size (MW) relation 
between ligand and analyte. Where RL is the surface density  
Rmax = (MWA/ MWL) x RL x VL 
 
It was previously found that ABA binds to large Rubisco subunits (LS), and there are 
eight LS in the entire protein complex. Assuming that one molecule of ABA binds to one LS 
and protein surface density is 4500 RU, the theoretical Rmax value would be: 
Rmax = (264 g mol-1/560 000 g mol-1)  x 4500 RU x 8 = 17 RU (Figure 58) 
For protein surface density of 8000 RU: 
Rmax = (264 g mol-1/560 000 g mol-1) x 8000 RU x 8 = 30 RU (Figure 59) 
Observed Rmax values (sensograms from Figure 58) are approximately 15 and 11 RU 
for (+) and (-)-ABA correspondingly. Rmax observed on Figure 59 on the other hand is 
approximately 30 RU, and the surface density is doubled (8000 RU).  The experimental Rmax 
(surface density 4500 RU, Figure 58) suggests that the protein: ligand ratio is approximately 
1:7. Experimental Rmax value was found to be very close to the theoretical one and indicated 
protein:ligand ratio 1:8. The experimental signal intensity being lower (Figure 58) than the 
theoretical one, is most likely due to the fact that a fraction of binding sites do not have 
binding functionality or are not accessible to ABA during the experiment.  
The above results suggest that each large Rubisco subunit binds one molecule of ABA, 
and that assumption is based on the fact that all large subunits are identical, previous finding 
that only large subunits are capable of binding ABA and finally supported by the 
experimental evidence by SPR.  
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Binding kinetics of other compounds such as PA and PBI 686 were also evaluated. PA 
was found to bind at high concentrations yielding the signal when using high density surfaces 
(8000 RU). The equilibrium dissociation constant of PA was found to be 46 µM, which is 
9200 fold higher than that of ABA (5 nM). This confirms the previous finding of PA binding 
affinity to Rubisco being dramatically lower than ABA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 60. SPR sensogram resulting from PA injections ranging from 0.045 µM to 28 
µM. Surface density 8000 RU. 
 
It was also of interest to evaluate the binding kinetics of the probe PBI 686 since it was 
used as a tool for isolation of Rubisco from crude extracts and exhibited selective binding 
capability to Rubisco.  
 
 
ka = 41.1 M-1 s-1 
kd = 1.88 x 10-3 s-1 
KD = 46 x 10-6 M 
45 nM 
28 µM
CO2HO
OHO
Phaseic acid (PA)
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Figure 61. SPR sensogram resulting from PBI 686 injections ranging from 0.05 µM to 
100µM. Surface density 8000 RU. 
 
The above experiment (Figure 61) indicated that the affinity of PBI686 to Rubisco is 
relatively high, and unlike PA, PBI 686 exhibits a low equilibrium dissociation constant of 
0.4 µM, which is 77 fold higher than that of ABA but 115 fold lower than PA. 
In summary, testing Rubisco-ABA interaction by SPR has provided good and 
reproducible data, and yielded kinetic parameters indicating high affinity of both ABA 
enantiomers to Rubisco. Interaction of PA was also investigated, and the results suggested 
PA affinity being 9200 fold lower than that of ABA, which is an important finding in 
relevance to physiological meaning. PA is a biologically inactive metabolite of ABA and its 
affinity to Rubisco is too low for it to have any physiological relevance in plants, in other 
words an equilibrium dissociation constant of PA being on the order of 46 µM would have 
COOHOH
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O
N
H
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ka = 98.1 M-1 s-1
kd = 7.52 x 10-5 s-1 
KD = 0.4 x 10-6 M 
0.05 µM 
100 µM 
124 
 
little impact on Rubisco as concentrations of PA in plant tissues do not exceed 10 µM 
threshold. 
A reverse approach which involves immobilization of the probe on the chip surface and 
running solution of Rubisco through the system did not provide acceptable results due to high 
background signal caused by non-specific binding of the protein to the chip surface. 
In this project SPR was used as one of the methods for studying Rubisco-ABA 
interaction and the resulting KD value will be then further confirmed by an alternative 
method such as radioligand binding assays.  
 
2.9.4. Literature examples of studying protein-small molecule        
interactions by SPR 
 
 
There are many literature examples of investigating small molecule-protein interactions 
that rely on SPR as a technique for determination of binding kinetics.198,199 Casper et.al198 has 
investigated the interaction between small molecule inhibitors and p38α mitogen-activated 
protein kinase. This research group has developed a real-time, label free method to study 
protein kinase inhibitor binding kinetics using SPR. Utilizing p38α mitogen-activated protein 
kinase as a model system, they studied the binding properties of two known small molecule 
p38α inhibitors (Figure 62). Direct coupling of p38α to the biosensor surface in the presence 
of a reversible structure-stabilizing ligand produced greater than 90% active protein on the 
biosensor surface. The dissociation and kinetic constants derived using Biacore method were 
in very good agreement with values determined by other solution-based methods.200,201 
p38α kinase is a well characterized target for inflammatory disease therapy. It is widely 
expressed in many mammalian tissues and is activated as a part of signal transduction 
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cascades that respond to inflammatory stimuli. The kinetic parameters were evaluated at 
various temperatures, from SPR sensograms using BiaEvaluation software. The average 
equilibrium dissociation constants describing SB-203580/p38α interaction were found to be 
dependent on temperature and were 3.8, 6.7 11.5 and 29 nM at 5, 15, 25, and 35°C 
correspondingly.  
 
 
 
 
 
 
Figure 62. Chemical structures of two known p38α protein kinase inhibitors198 
 
 
 
Figure 63. Temperature dependence of SB-203580 binding to p38α protein kinase 
(figure copied from198 with permission). 
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In this project it was not possible to evaluate the kinetics of Rubisco-ABA interaction 
at various temperatures due to incapability of the instrument used to run experiments at 
variable temperatures. 
 
2.9.5.   SPR vs. other techniques 
 
 
In 2004, a number of authors performed studies to establish the reliability of 
information obtained using SPR biosensor technology.202 These investigations determined 
the reproducibility of kinetic and affinity parameters reported by different researchers and 
compared the affinities obtained from kinetic and equilibrium analyses, as well as those 
measured using the biosensor and solution-based methods. As illustrated on Figure 64, the 
kinetic parameters obtained by SPR are in good agreement with other techniques. 
The year 2004 also saw 36 different investigators analyze an identical small 
molecule/enzyme interaction under similar conditions203 in order to test the experimental 
variability associated with Biacore analysis.  Acetazolamide  (222 g/mol) binding to carbonic 
anhydrase II (CAII; 30,000Da) was chosen as a model system. Both reagents were stable and 
their interaction posed a challenge to measure because of the low molecular weight of the 
small molecule that was used as the analyte and the fast association rate constant. Each 
investigator created three different density surfaces of CAII and analyzed interaction of an 
identical dilution series of acetazolamide (ranging from 4.1 to 1000 nM) with these. The 
greatest variability in the results was observed during the enzyme immobilization step since 
each investigator provided their own surface activating reagents. Variability in the quality of 
the acetazolamide binding responses was likely a product of how well the investigators’ 
instruments had been maintained. 
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Figure 64. Plot of equilibrium dissociation rate determined for a variety of biological 
systems (denoted by the different symbols) by both SPR and analytical centrifugation (blue), 
isothermal calorimetry (green), fluorescence (red), NMR (pink), or KinExA (orange),  The 
diagonal dashed line represents a correlation of 1. constants (figure copied from202 with 
permission). 
 
To determine the reaction kinetics, the responses from the different density surfaces 
were fit globally to a 1:1 interaction model that included a term for mass transport. The 
averaged association and dissociation rate constants were (3.1 ± 1.6) × 10-6 M-1 s-1 and (6.7 ± 
2.5) × 10-2  s-1, respectively, which corresponded to an average equilibrium dissociation 
constant (KD) of (2.6 ± 1.4) × 10-8 M. The results provide a benchmark of variability in 
interpreting binding constants from the biosensor and highlight keys areas that should be 
considered when analyzing small molecule interactions.202,203 
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Figure 65. Enzyme/inhibitor model system. (A) Ribbon diagram of the crystal 
structure of carbonic anhydrase II bound with a sulfonamide inhibitor. (B) Chemical 
structure of the CAII inhibitor acetazolamide that was used in the analysis. (figure copied 
from203 with permission). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 66. Correlation of maximum binding response with the CAII immobilization 
level. The maximum binding response obtained on each surface versus the amount of CAII 
immobilized on the flow cell for group 1 (A) and group 2 (B) (figure copied from203 with 
permission). 
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Thirty-six different Biacore users were provided similar samples of an analyte and 
ligand, along with a detailed protocol on how to set up and carry out their analysis203. Each 
investigator immobilized CAII enzyme at three different surface densities and analyzed the 
binding of acetazolamide over a 250-fold concentration range in triplicate. The participants 
evaluated the interaction under the same buffer conditions, at 25 °C. Data collected from the 
experiments were processed and analyzed in an identical manner. The results presented here 
provide a foundation to compare the ability of various users and the quality of data 
obtained from different instrument platforms. Applying SPR biosensors to study small 
molecules reacting with larger biomolecules is still relatively new. Small molecule 
interactions can be challenging to characterize because the signals are inherently smaller than 
those observed for protein/protein interactions, due to the low mass of the analyte. Proper 
analysis of a small molecule system requires careful instrument preparation, experimental 
design, and data analysis. It also requires a high-density surface for detecting the small 
molecule binding which can introduce mass transport effects. The distribution of the 
dissociation rate constants is shown in B, where the average was (6.7 ± 2.5) × 10-2 s-1 and 
corresponds to a CV (coefficient of variation) of 37% The histogram plot shown in Figure 
67C indicates the distribution of the equilibrium dissociation constants. The interaction 
affinity was determined by the quotient KD= kd/ka, and an average of (2.6 ±1.4) × 10-8 M was 
determined for the KD of the binding interaction. 
 
 
 
 
 
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 67. Distribution of the kinetic rate constants and equilibrium dissociation 
constant for each of the participants. (A) Histogram plot of the association rate constant 
determined from the fit of each data set. (B) Histogram plot of the dissociation rate constant 
determined by the fit of each data set. (C) Histogram plot of the equilibrium dissociation 
constant determined from the fit of each data set. The black dashed horizontal line indicates 
the average of the constants and the solid black horizontal lines denote the boundaries of the 
calculated standard deviation. The error bars for each participant denote the standard 
deviation for nonlinear least squares analysis (figure copied from Matthew et al).196 
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2.10.   Rubisco – structure and enzymatic activity  
 
 
Rubisco catalyses the carboxylation of D-ribulose-1,5-bisphosphate  (RuBP).204-208 
This conversion of inorganic CO2 into carbohydrate is considered a rate-limiting step in the 
synthesis of most of the world’s biomass.  Rubisco is a key enzyme in the Calvin cycle which  
catalyzes the first step of carbon fixation, a process by which the atoms of atmospheric 
carbon dioxide are made available to plants in the form of energy-rich molecules such as 
sucrose. The enzyme can catalyze both the carboxylation or the oxygenation of ribulose-1,5-
bisphosphate (RuBP) with carbon dioxide or oxygen correspondingly. Rubisco is very 
important in terms of biological impact because it catalyzes the most commonly-used 
chemical reaction by which inorganic carbon enters the biosphere. It is also the most 
abundant protein in leaf chloroplasts, and it is often referred to as the most abundant protein 
on Earth.204 Given its important role in the biosphere, it is an important target of genetic 
engineering to create crop plants that would contain more efficient Rubisco.  
Rubisco is the major enzyme in Calvin cycle – a series of reactions during which 
carbon dioxide and water are used to produce organic compounds. This reaction is also called 
“carbon fixation”. Calvin cycle is illustrated in Figure 68. 
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Figure 68. Calvin cycle.  
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Rubisco is made of 8 large subunits of 54 kDa each and eight small subunits of 14 kDa 
each. In spite of its biological importance, Rubisco is an inefficient catalyst, particularly at 
lowered CO2 concentrations. Its turnover number of 3 s-1 is situated at the bottom end of 
turnover number range (10-1000 s-1) for most enzymes.207 In addition, the efficiency of 
Rubisco-catalyzed carbon assimilation is further limited by the fixation of O2, which can 
compete with CO2 for addition to ribulose-P2. It is not clear why such an important enzyme 
is so slow and nonspecific.209 There is also a great amount of uncertainty in the literature 
about how Rubisco is regulated, especially under abiotic stress conditions such as drought 
and high   temperature.204,205,210-212 It has been established that Rubisco activity is modulated 
in vivo by reaction with CO2 and Mg2+ to carbamylate a lysine residue in the catalytic site, or 
by binding of inhibitors within the catalytic site. Binding of inhibitors blocks either activity 
or the carbamylation of the Lysine201 residue crucial to activity. During the night, 2-
carboxyarabinol-1-phosphate (CA1P) is formed which was found to bind tightly to Rubisco, 
and reduce catalytic activity. The mechanisms of Rubisco regulation have been recently 
reviewed by Parry et al.213  Rubisco activity in vivo can be regulated by several possible 
mechanisms. First, carbamylation of catalytic lysine residue followed by stabilization of the 
resulting carbamate product by Mg2+ ion, which leads to formation of catalytically active 
ternary complex (Enzyme-CO2-Mg2+), and a second type of regulation could proceed through 
the tight binding of low molecular weight inhibitors (I).  The inhibitors can either bind before 
(Enzyme-I) or after carbamylation (Enzyme-CO2-Mg2+-I), and block the active site of the 
enzyme by limiting the substrate binding or carbamylation reaction. Rubisco activase is 
required to remove the bound inhibitors from the catalytic site of carbamylated or 
decarbamylated forms of Rubisco. The activase becomes responsible in this way for 
maintaining Rubisco active and free of inhibitors.  
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Figure 69. A- Principles of Rubisco catalytic activity regulation, proposed by Perry et 
al. [E]- unmodified (decarbamylated) enzyme, [E.I] – decarbamylated enzyme with RuBP 
bound at active sites – in this context RuBP acting as an inhibitor [I]; [E.CO2.Mg2+], complex 
with catalytically active site; [E.CO2.Mg2+ I*] – carbamylated enzyme with catalytic site 
occupied by tight binding inhibitor (I* = CAP1, PDBP and/or KABP). B- reversible 
inhibition of carbamylated Rubisco by CAP1, showing light-dependent removal and 
dephosphorylation of CA1P, performed by Rubisco activase and CA1P phosphatase, 
respectively. CA is rephosphorylated to CA1P during dark period (figure and caption adapted 
from Parry et al. 213). 
 
Crystallographic data provided evidence that most structural changes after substrate 
binding occur in loop 6 (Figure 71), which is located at the mouth of a large subunit 
alpha/beta barrel, in which this loop folds or slides over the active site and loses its mobility. 
This allows two conformations, with residues on the C-terminal tail and the loops on N-
terminal domain of the adjacent large subunit being responsible for maintaining the closed 
conformation. The cleavage of the C2-C3 bond upon reaction between bound RuBP and CO2 
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leads to active site opening. It is postulated that a number of naturally existing sugar-
phosphates which are assumed to be tight-binding inhibitors and structurally similar to the 
substrate, force the active site of Rubisco to adopt a closed conformation, which is a current 
rationale for Rubisco regulation. Structures of naturally occurring inhibitors isolated to date 
are presented on Figure 70. 
 
 
 
 
 
 
 
 
 
 
Figure 70. Naturally occurring Rubisco inhibitors identified up to date213. RuBP – 
ribulose-1,5-bisphosphate; KABP – 3-ketoarabinol-1,5-bisphosphate; XuBP – D-xylulose-
1,5-bisphosphate, PDBP – D-glycero-2,3-pentodiulose-1,5-bisphosphate; CTBP – 2-
carboxytetritol-1,4-bisphosphate; CA1P – 2-carboxy-D-arabinol-1-phosphate (figure adapted 
from Parry et al.213). 
 
Capturing of tight-binding inhibitors is challenging. Prolonged dialysis or gel filtration 
are often insufficient to release them from the catalytic site of purified Rubisco. It is also 
proposed that other sugar phosphates and some inorganic anions also interact with the 
catalytic site in vitro which can affect the carbamylation reaction. These are often called 
effectors and act as competitive inhibitors with respect to RuBP. The literature presents a 
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striking lack of experimental evidence for most compounds referred to as inhibitors. No 
kinetic parameters of inhibition/binding such as inhibition constant Ki or equilibrium 
dissociation constant KD are yet reported. 
Marcus et al.214,215 reported allosteric effects of orthophosphate ion on cyanobacterial 
Rubisco. X-ray analysis of the enzyme in complex with orthophosphate revealed that this 
anion binds at three sites: two sites are those normally occupied by 1P and 5P (groups of 
RuBP and the third site (the “latch site”) in the pocket made of positively charged residues, 
which is involved in active-site closure during catalysis. The role of the latch site and 5P sites 
was examined in terms of cyanobacterium Rubisco activation and catalysis by site-directed 
mutagenesis. Mutations at both sites abolished the Pi-stimulated Rubisco activation. 
Substitution of residues at the 5P site, but not the latch site, significantly exaggerated the Pi 
inhibition of Rubisco catalysis. Point mutations within the latch site decreased the catalytic 
turnover and increased Rubisco Km (RuBP) which was probably due to alterations in catalytic 
site closure. 
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Figure 71. A- diagram of the three Phosphate (Pi)-binding sites in Rubisco large 
subunit. Three Pi ions are in red, and residues directly associated with Pi are in green. Lys201 
residue is in magenta. Moving elements (C-tail and loops 6) participating in closure of the 
catalytic site are in blue. B- space-filled model of Pi bound to the latch site if tobacco 
Rubisco (figure and caption copied from Marcus et al. 215 with permission). 
 
 
1P and 5P sites       Latch-site 
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The inhibition of Rubisco by Pi was found to be competitive with respect to RuBP. The 
inhibitory effect was elevated upon point mutations at the 5P site. However mutations on the 
latch site had no effect on the phosphate inhibition constant.  
 
Table 3. Kinetic properties of Rubisco mutants. 
Protein  Site  kcat (min-1) Km(RuBP) (µM) Ki(Pi) (mM)  
Wild type   545  140  5.8  
R134A  Latch  178  212  6.0  
K305E  Latch  185  242  5.7  
K305A  Latch  177  199  NM  
H310D  Latch  185  387  NM  
H310A  Latch  540  179  NM  
H298A  5P  43  267  6.3  
H327Q  5P  92  490  0.67  
 
Regardless of the minor effects on the rate of photosynthesis (indicated by Ki), in most 
cases the mutations at the latch site reduced catalytic turnover (kcat)  by two-thirds,  and 
increased the Km (RuBP). These findings indicate that the mutations at the latch site affect 
the kcat and Km (RuBP) of Rubisco by affecting the mechanism of the catalytic site closure. 
The latch site has been proven to be an important structural feature of the enzyme, 
especially in terms of enzyme regulation by affecting the access to the catalytic site. This 
suggests that binding of ABA to the latch site could have a significant impact on Rubisco 
regulation.  
In order to visualize the binding site of ABA, docking experiments of ABA to Rubsico 
large subunit were performed using AutoDock software. Energy optimized ABA structure 
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was obtained using Chem3D software and Rubisco (large subunit from Nicotiana tabacum) 
crystallographic data obtained from the RSCB PROTEIN DATABANK (PTB file: 1EJ7). 
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Figure 72. View of ABA (red) docked into the latch site of Rubisco large subunit. Catalytic residue Lys201 (pink). 
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Figure 73. Surface view on ABA (top), and PBI 686 (bottom) docked in Rubisco latch site.  
ABA in latch site 
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Figure 74. View of PBI686 (green) docked into the latch site of the Rubisco large subunit. Catalytic residue Lys201 is shown in pink.
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Table 4. Binding energies and corresponding inhibition constants predicted by 
AutoDock software.  
Compound Binding Energy (kcal/mol)      Predicted Ki  
(+)-ABA      -5.4 108 µM 
PA      -3.8 1.6 mM 
trans-(+)-ABA      -5.1 185 µM 
PBI 686      -6.4 22.2 µM 
 
Predicted binding energy for ABA being lower than its structural analogs PA and 
trans-(+)-ABA is in agreement with binding experiments using radiolabeled ABA, described 
in later sections of the thesis. The binding energy of PBI686 being lower than that of ABA, 
may be due to the probe’s additional interactions with Rubisco (such as H-bonding of biotin 
moiety) not attributed to its ABA-like structural features. 
In summary, the software-predicted binding pocket of ABA within the Rubisco latch 
site suggests the possible function of ABA in contributing to the process of catalytic site 
opening and/or closure. 
2.10.1.   Effect of ABA on Rubisco enzymatic activity 
 
In order to investigate the significance of ABA binding to Rubisco, the enzyme 
catalytic activity was measured in the presence of ABA and compared to that in the absence 
of ABA. This was evaluated by coupling the activity of the enzyme (the conversion of RuBP 
to 3-phosphoglycerate) to NADH oxidation using PGA kinase and GAP dehydrogenase.206 
The oxidation of NADH was monitored spectrophotometrically (λ = 340 nm) over time for 5 
min. The reaction was initiated by addition of Rubisco and the A340 was measured at 5 s 
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intervals. Absorbance values were converted to NADH concentration using an extinction 
coefficient of 6.22 mM-1. The coupled enzyme assay employed is depicted in Figure 75. 
 
 
 
 
 
 
 
 
Figure 75. Coupled enzyme Rubisco activity assay. 
 
A series of experiments were performed using the above system. An example of one 
reaction showing the difference in initial reaction rates (Vi) observed in the presence and 
absence of ABA, at a fixed substrate concentration is presented below. 
 
 
 
 
 
 
 
 
 
Figure 76. Change of NADH concentration against time. Rate of NADH oxidation, 
evaluated from the slope corresponds to the rate of Rubisco catalysis reaction.  
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The slopes on the plot of [NADH] vs. time correspond to the rate of NADH oxidation 
expressed in nmol/min. This rate can be extrapolated to the velocity of CO2 incorporation by 
Rubisco. The rates of CO2 can be calculated by division of NADH oxidation rate by factor of 
two; due to the fact that there are two molecules of NADH oxidized per one molecule of 
RuBP (see  
Figure 75). In the presence of ABA, Rubisco rate of CO2 incorporation is clearly 
reduced which indicates the inhibitory effect of ABA. Since there are two enzymes other 
than Rubisco used in this assay, it was important to perform a control experiment and check 
if ABA can inhibit these enzymes.  If ABA does not affect the activity of other enzymes this 
would assure that reduced NADH oxidation rates in the presence of ABA are only due to 
changes in Rubisco kinetics. This control experiment was done by eliminating Rubisco and 
RuBP from the assay, adding 3-phosphoglyceric acid (3-PGA) instead, and monitoring the 
NADH oxidation rates in the presence and absence of ABA.  It showed that ABA does not 
inhibit PGA kinase nor GAP dehydrogenase and the slope remains unaffected in the presence 
of 10 mM ABA. The results of NADH oxidation assay with and without ABA and at fixed, 
500 µM 3-phosphoglyceric acid concentration are listed in Table 5. 
Table 5. Results of control experiments of NADH oxidation assay without Rubisco 
and RuBP. 
no ABA   10 mM ABA   
slope x 10-4 velocity [nmol/min] slope x 10-4 velocity [nmol/min] 
2.86 17.16 3.15 18.90 
3.51 21.06 3.46 20.76 
3.56 21.08 3.49 20.94 
Average: 3.31 19.77 3.36  20.20 
 
Subsequently, Rubisco activity changes in the presence of ABA at different 
concentrations were further evaluated. First, kinetic parameters were calculated by measuring 
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rates at various RuBP concentrations, from 10 µM to 1200 µM (10, 20, 50, 100, 200, 400, 
800, 1200 µM) in the absence of ABA. Subsequently, rates were measured with the addition 
of ABA (1, 2, 5, and 10 mM). Plots of initial velocity (Vi) vs. substrate concentration (RuBP) 
show a significant change in the presence of ABA in a concentration dependent manner 
(Figure 78). 
Non-linear regressions were performed by GraphPad PrismTM software which was able 
to fit the experimental data into two different models.  One is a competitive inhibition model 
based on the Michaelis-Menten kinetic equation. The second, based on a sigmoidal shape of 
Vi vs. [RuBP] plot, is an allosteric inhibition model, with Hill coefficient being >1. Based on 
the goodness of both fits, a comparison of both models indicated that allosteric inhibition is 
preferred. When comparing Vi vs. [RuBP] plot curves for an experiment without ABA to the 
one in the presence of 10 mM ABA it becomes noticeable that the curve adopts a sigmoidal 
shape which is a strong indication of allostery. 
 
 
 
 
 
 
 
 
 
 
Figure 77. Initial velocity Vi vs. substrate concentration [RuBP] plot showing the 
shapes of fit curves obtained in the presence and absence of ABA.  
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 Table 6. Comparison of kinetic parameters obtained by fitting the experimental values 
into competitive and allosteric inhibition models using GraphPad Prism enzyme kinetics 
evaluation. Vmax – maximum reaction velocity, Kprime – parameter related to the Km, but not 
equal the substrate concentration needed to achieve a half-maximum enzyme velocity. H-hill 
coefficient. P- probability of the measurements being a coincidence. 
 
 
 
 
 
 
 
 
Comparison of Fits   
Null hypothesis Competitive inhibition
Alternative hypothesis Allosteric sigmoidal  
P value 0.0034 
Conclusion (alpha = 0.05) Reject null hypothesis
Preferred model 
Allosteric 
sigmoidal 
Allosteric sigmoidal       no ABA       1 mM ABA      2 mM ABA      5 mM ABA     10 mM ABA 
Best-fit values       
Vmax [nmol/min] 32.98 30.92 28.59 24.29 20.98
H 1.298 1.330 1.426 1.604 1.805
Kprime 527.8 925.6 1374 7549 32736
Std. Error       
Vmax [nmol/min] 1.045 1.331 1.499 2.259 2.042
H 0.1067 0.1306 0.1915 0.3232 0.3777
Kprime 240.5 539.9 1191 12060 64202
Goodness of Fit       
R² 0.9968 0.9961 0.9930 0.9869 0.9869
Absolute Sum of Squares 3.257 3.578 6.096 7.773 5.630
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Competitive inhibition       
Best-fit values       
VMAX [nmol/min] 36.29 35.51 33.48 32.41 33.28
Km [µM] 156.9 237.4 230.4 479.2 779.8
Ki  [µM] 1930 1930 1930 1930 1930
Std. Error       
Km [µM] 15.55 15.55 15.55 15.55 15.55
Ki [µM] 251.6 251.6 251.6 251.6 251.6
Vmax 1.003 1.003 1.003 1.003 1.003
Goodness of Fit       
R² 0.9897 0.9891 0.9761 0.9680 0.9736
Absolute Sum of Squares 10.37 10.12 20.74 19.02 11.35
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Figure 78. A - Initial velocity (Vi) vs. substrate concentration [RuBP] plot at various ABA concentrations (competitive inhibition 
model, Michaelis-Menten equation), B- the corresponding double reciprocal plot, C- Vi vs. [RuBP] plot showing sigmoidal fit (allosteric 
inhibition model), D- shape of plot C at low RuBP concentrations. Points represent data, lines represent fits.
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Enzyme 
  I 
Let us briefly compare the two proposed mechanisms. There are two kinds of 
competitive inhibition: first the classical competition for the active site binding, and second 
competitive inhibition by conformational change. 
In most cases, a competitive inhibitor is a compound which structurally resembles the 
substrate of the enzyme. Because of this similarity the inhibitor binds to the active site in 
place of the substrate. The competitive inhibitor binding site does not always have to be the 
same as the active site.  Upon binding, the inhibitor blocks substrate access to the active site, 
so that it can no longer bind to it. Both substrate and inhibitor compete for binding to the 
enzyme. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 79. A- competitive inhibition, B- allosteric inhibition. C- allosteric (mixed) 
inhibition) D- diagram representing two different types of inhibition, black path- classical 
competitive, red path – allosteric (mixed) inhibition, the ESI complex may or may not be a 
dead-end complex. Competitive inhibition occurs when substrate (S) and inhibitor (I) both 
bind to the same site on the enzyme. In effect, they compete for the active site and bind in a 
mutually exclusive fashion. (A). There is another type of inhibition that would give the same 
kinetic data.  If S and I bound to different sites, and S bound to E and produced a 
conformational change in E such that I could not bind (and vice versa), then the binding of S 
and I would be mutually exclusive. This is called allosteric competitive inhibition (B). In 
mixed inhibition, the inhibitor also binds to a site different from the active site where the 
substrate binds, however the inhibitor can bind to either free enzyme or the enzyme-substrate 
complex (C). 
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Allosteric inhibition concerns a protein containing two or more distinct binding sites 
which interact functionally with each other.  The binding of an inhibitor at one site alters the 
properties of the substrate-binding site. 
Most allosteric proteins are allosteric enzymes, in that they are capable of catalyzing 
reactions but some, such as hemoglobin, are simply binding proteins.  
Allosteric inhibitors and activators are commonly referred to as allosteric effectors. 
Alteration of the rate of enzyme catalyzed reactions by inhibition and activation is the basis 
of methods controlling the metabolism. Figure 80 below demonstrates the way in which 
effectors change the kinetic plot of a typical allosteric enzyme. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 80. Vi vs. [Substrate] plot showing the effect of allosteric activator and inhibitor.  
 
The central line in the graph shows a typical sigmoid plot in the absence of any 
effector. The presence of an activator increases the reaction rate at any given substrate 
concentration, whereas an inhibitor decreases the reaction rate. The inhibitor has increased 
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the sigmoid shape, lengthening the toe, and the activator has caused the opposite effect. This 
means that an allosteric inhibitor increases the concentration of the substrate required to 
achieve the original reaction velocity while an activator decreases it. It is also important to 
mention that there are two kinds of allosteric interactions: homotropic and heterotropic. In 
homotropic allosteric interaction the activity of the enzyme is regulated by its substrate. 
Homotropic modulators are often allosteric activators, which means that they typically up-
regulate the activity of the enzyme. They can do so by inducing the conformational change of 
the multi-subunit allosteric protein from the inactive state (Tense state) to the active state 
(Relaxed state). A heterotropic allosteric interaction is considered when the activity of the 
enzyme is regulated by a molecule other than the protein's substrate. 
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When the mechanism of ABA-Rubisco inhibition was being analyzed it became 
apparent that the inhibition constant Ki of 1.93 mM resulting from competitive inhibition 
model was substantially different from previously obtained equilibrium dissociation constant 
KD of 5 nM. The inhibition constant was calculated using the following equations. 
 
 
 
 
 
 
 
 
Figure 81. Equations used to calculate kinetic parementers for A-classical competitive, 
B- allosteric competitive inhibition with substrate cooperativity. 
 
It is important to mention that if ABA binds to an allosteric site in Rubisco, it is 
possible that its equilibrium dissociation constant will be different in the absence than that in 
the presence of the substrate. This could provide an explanation of the difference between KD 
measured in the absence of RuBP being 5 nM and Ki measured in the presence of RuBP 
being 1.93 mM. The resuts indicate that upon binding of RuBP, Rubisco affinity for ABA is 
dramatically reduced. It was therefore not possible to achieve complete Rubisco inhibition in 
the presence of ABA at concentrations as high as 10 mM, as this concentration is only five 
fold higher than Ki. The solubility of ABA at concentrations above 10 mM was a limitation 
of this experiment. 
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It is also important to note that the concentration of enzyme used for the in vitro 
activity assays is relatively higher than in vivo. More specifically, the concentration of 
Rubisco used in the assay was approximately 0.71 µM (each complex has 8 active sites), and 
therefore it would take 5.7 µM ABA to obtain enzyme-inhibitor molar ratio of 1/1. In other 
words in each assay sample, ABA being at 1 mM concentration is only in 175 fold molar 
excess. In addition, Michaelis-Menten plot indicated that the substrate saturates Rubisco at 
0.8 mM concentration where enzyme velocity plateaus. Competitive effect of ABA with 
respect to the substrate RuBP is only observed when ABA concentration is greater than its 
competitor’s. 
Local concentrations of ABA in plants range from nanomolar to micromolar and never 
reach milimolar levels.225-227 This remains in conflict with previously mentioned Ki value 
being 1.93 mM. There are two possible explanations to this problem, first the concentrations 
of Rubisco and ABA as well as their molar ratio in vivo are unknown and might be very 
different than that used in vitro and therefore cannot be compared. The experiments were 
performed on the “large scale” meaning that substantial amounts of the enzyme its substrate 
and lastly high concentrations ABA had to be used in order to observe and measure changes 
in NADH oxidation. Second, Ki value obtained experimentally might be biased by 
experimental conditions being much different than those in vivo. And third, it might be 
possible that ABA acts on photosynthesis by fine regulation of Rubisco activity, and not 
inhibiting the enzyme completely. At micromolar concentrations of ABA, Rubisco activity 
would be still lowered, (ABA’s effect on the enzyme activity is observed), but the extent of 
inhibition remains putative. Complete inhibition of Rubisco by ABA may not be desirable for 
the plant because functioning Rubisco is crucial for plant’s survival. Even small changes in 
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the activity of the major photosynthetic enzyme still could have a significant impact on its 
growth and adaptation to stress.  
As previously discussed, it is likely that the ABA binding site is remote from the 
enzyme catalytic site. This indicates that ABA inhibition of Rubisco can be due to 
conformational change of the enzyme. If the ABA binding site is located in the latch-site 
(part of loop 6), a channel though which the substrate gains access to the active site, the 
binding of ABA could produce allosteric competitive inhibition kinetics. In addition, 
conformational changes within loop 6 of Rubisco large subunit lead to opening or closure of 
the catalytic site, 214,215 behavior similar to multiple-unit allosteric enzymes. In addition, the 
allosteric model of inhibition gave a better goodness of fit for non-linear regression 
performed by GraphPad Prism (see   Table 6) 
Allosteric inhibition is often reported for enzymes consisting of multiple identical
subunits.228-230 In addition allosteric enzymes are usually positioned at key metabolic steps 
which can be regulated to activate or inhibit whole pathways.  Aspartate transcarbamoylase 
can serve as an example of multiple-unit enzyme, regulated by allosteric mechanism.231,232 
Aspartate transcarbamoylase plays an important role in biosynthesis of pyrimidine 
nucleotides. The structure and allosteric properties of the enzyme have been very extensively 
studied. It catalyses a reaction between aspartic acid and carbamoyl phosphate to generate N-
carbamoyl aspartate with the release of inorganic phosphate.  
The complete, active enzyme consists of 12 different subunits. It contains two catalytic 
components each made up of three identical subunits. These components are arranged next to 
each other effectively forming the two main faces of the whole enzyme. The rest of the 
enzyme is composed of three regulatory components each comprising two subunits. These 
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components form the corners of the enzyme which has a roughly triangular shape.  The 
catalytic and regulatory components can be separated. If they are, the catalytic components 
are found to be capable of catalyzing the reaction in the usual way except that they have no 
allosteric properties. They show no sign of substrate cooperativity and no reaction with 
allosteric effectors. The regulatory components are unable to carry out catalysis, but can bind 
the usual effectors of ATCase, CTP (an inhibitor) and ATP (an activator).  
 
 
 
 
 
 
 
 
Figure 82. Tense (T) and relaxed (R) states of aspartate transcarbamoylase. T-state 
shown with allosteric inhibitor bound to regulatory subunits, R-state shown with substrate 
bound to catalytic subunits. 
 
Figure 82 represents two different states ATCase can adopt. One of them is the enzyme 
with the inhibitor CTP bound to it. This maintains it in the tense, low substrate affinity state. 
The other one has a substrate analogue bound which maintains it in the relaxed, high affinity 
state. It is noticeable that the relaxed enzyme is "swollen" compared with the tense one, with 
the two catalytic components pushed further apart. The substrate is deeply buried within the 
T-state                                                R-state 
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overall enzyme structure, it's almost invisible; presumably this swelling makes the active site 
more accessible to it which explains why the affinity for the substrate is increased. Upon 
binding of allosteric inhibitor, it is expected that the substrate affinity will be lowered which 
would then be reflected by a significant change in Km.  
A similar scenario could be applied in case of Rubisco which is similar to aspartate 
transcarbamoylase in terms of its architecture, meaning both enzymes consist of multiple 
identical subunits, divided into two different functionalities. Significant reduction of Rubisco 
activity in the presence of ABA is observed which clearly indicates the effect of ABA on the 
enzyme catalytic efficiency. The only difference from the carbamoylase example is the 
binding site of ABA which was found to be located within the same subunit (large subunit) 
of Rubisco as its catalytic site. It is known that Rubisco adopts two different conformations 
(open and closed) of the large subunit. The open conformation corresponds to activated 
enzyme, and the closed conformation to deactivated enzyme. Changes within loop 6 are 
responsible for the regulation of substrate’s access to the active site. Similarly to aspartate 
transcarbamoylase, deactivated Rubisco could correspond to the tense state, and activated 
form to relaxed state. ABA binding to Rubisco in the tense state would be consistent with 
allosteric inhibition model. It is important to mention that all ABA binding studies were 
performed with deactivated Rubisco, meaning in the absence of both substrates CO2 and 
RuBP. In addition, the ABA docking studies were also performed with the inactivated 
Rubisco structure, and AutoDock was able to find the binding site within the enzyme’s latch 
site. An allosteric inhibition model of Rubisco by ABA is consistent with numerous reports 
in the literature, suggesting the presence of allosteric regulatory sites within the 
enzyme.206,233  
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As mentioned before, Perry et al. 205,213,234 studied tobacco Rubisco activity during 
abiotic stress and have suggested that the enzyme activity under drought stress is not 
primarily the result of changes in activation by CO2 and Mg2+ but due rather to the presence 
of tight-binding inhibitors. The amounts of inhibitor present in leaves of droughted tobacco 
based on the decrease in Rubisco activity per mg soluble protein were found to be much 
greater than the amounts of the known inhibitors (CA1P and “daytime inhibitor”) that can be 
recovered in acid extracts. This suggests the presence of other inhibitor(s) that were not 
discovered to date.  
Parry et al. have indicated the presence of Rubisco inhibitor during drought stress205 
that was  undetectable (using methods reported) in plants under normal growing conditions. 
This finding is consistent with the fact that ABA levels are elevated during drought stress235-
243 and suggests a possibility that is functions as a “stress inhibitor” of Rubisco.  
In addition there are numerous reports on simultaneous and independent effects of 
abscisic acid on stomata and the photosynthetic apparatus.244-247 Some studies with intact 
leaves have shown that ABA appears to affect growth by reducing photosynthesis, not only 
by closing the stomata but also by affecting the photosynthetic machinery. There is also 
evidence to suggest that there is a direct effect of water stress on the photochemical process 
and/or Calvin cycle of photosynthesis. Daley et al.248 reported the effect of ABA on 
photosynthesis by measuring leaf gas exchange. The results showed that Ci (CO2 
concentration in leaves) remained unchanged while leaf carbon dioxide assimilation declined 
upon exogenous ABA treatment. This result led to the conclusion that the effect of ABA on 
photosynthesis must also be mediated through non-stomatal factors such as a direct effect on 
photosynthetic machinery. Lauer and Boyer et al. 249 have developed a system which allowed 
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measurement of internal CO2 concentration. With this method they found that when plants 
were subjected to drought stress, stomatal conductance and biochemical activity for 
photosynthesis were simultaneously reduced. The role of ABA in the regulation of 
photosynthesis may also depend on how leaf water deficit is developed. Decrease of stomatal 
conductance caused by increase of xylem ABA usually occurred before a decrease in leaf 
water potential250-252 and any inhibition of photosynthesis at that time should be attributed to 
the effect of ABA. 
Raschke et al.  also reports that stomata closure and reduction of photosynthesis are 
two simultaneous and independent effects of ABA. Saturation curves of photosynthesis with 
respect to the partial pressure of CO2 in the intercellular spaces indicated that application of 
ABA causes a reduction of the initial slope of the saturation curve which indicates 
diminished carboxylation efficiency and causes a reduction of the level of CO2-saturated rate 
of assimilation which indicates a reduction of Rubisco regeneration capacity.  
Based on measurements of Rubisco activity at various CO2 and RuBP concentrations 
Bota et al.253 conclude that the reduction of RuBP/CO2 content has a minimal impact on 
photosynthesis and that Rubisco activity becomes noticeably impaired only under severe 
drought conditions. The lack of Rubisco sensitivity to lowered substrate concentrations could 
be explained by increased/positive catalytic site cooperativity caused by ABA bound to 
allosteric sites. In other words ABA would increase enzyme affinity for the substrate through 
improvement of cooperativity between catalytic sites located in adjacent subunits. During 
severe stress, ABA concentrations are substantially increased; RuBP and CO2 concentrations 
on the other hand are dramatically reduced. In this situation ABA binding to the allosteric 
sites could induce positive substrate cooperativity and help to maintain photosynthesis at 
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minimal sustainable level during abiotic stress. Photosynthesis is progressively diminished 
during drought, but the mechanistic basis for this reduction remains unclear. While many 
authors suggest that diffusional (stomatal and mesophyll) limitations are most important for 
most drought situations,254 other reports suggest that decreased Rubisco activity205 and 
impaired capacity for RuBP regeneration as the main cause,255 are the main limitations to 
photosynthesis under drought conditions. 
In summary, all above literature reports indicate the dual action of ABA on 
photosynthesis, one through stomata closure, and a second through direct biochemical effect 
on photosynthesis. Based on experimental evidence obtained in this project it can be 
concluded that binding of ABA to Rubisco leads to the inhibition of the enzyme which 
mostly resembles competitive allosteric inhibition with positive substrate cooperativity. This 
interaction could directly contribute to regulation of photosynthesis, especially under severe 
stress conditions where endogenous ABA concentration is significantly increased. 
2.11. Studies of ABA and Rubisco interaction by [3H]-ABA   
binding assays 
 
Radioligand binding assays are most often used in receptor binding studies to 
determine the affinity of various drugs/ligands for a receptor as well as the binding site 
density (Bmax) of receptor families and their subtypes in different tissues or samples256. 
Receptor binding studies help in mapping the distribution of receptors in different areas of 
the body, as well as the effects of physiological and pathological conditions on the 
expression of the receptors. This methodology can also be used to study the interaction of 
other proteins with their corresponding ligands.257 The reason why it is most often utilized 
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for receptor binding assays is because it allows quick and preliminary identification of a 
given receptor in a mixture with other proteins or tissue samples.258 
There are two types of binding experiments: saturation and competition.259 Saturation 
experiments are used to determine the ligand affinity (KD) for a given receptor as well as 
Bmax (maximum amount of radioligand bound per unit of tissue) in various tissues or 
samples. The latter one is not relevant however in cases where assays are performed with 
purified protein. Competition studies on the other hand can be used for measuring the affinity 
of various unlabelled ligands for a given protein/receptor. The basis of the protein binding 
study is the binding of ligand (L) to the protein (P). The ligand-protein complex is classically 
referred to as Bound, meaning the amount of ligand that is bound to the receptor. The 
unbound ligand (L) is referred to as Free, meaning the amount of ligand that is free and able 
to interact with the protein. The parameter measured is the amount of radioactive ligand that 
is bound to the protein. This requires separation of the free ligand from the bound ligand after 
the reaction has reached steady-state conditions (Figure 83). KD is a measure of the affinity 
of a ligand for a given protein and is equal to ka/kd, where ka is the association rate constant 
and kd is the dissociation rate constant.  
 
 
 
Figure 83. Basic concepts in protein-ligand binding studies. 
 
KD is the concentration of radioactive ligand required to occupy 50 % of the receptors 
in a given tissue sample or if the experiment is performed with purified protein it corresponds 
Protein (P) + Ligand  (L)
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to 50% of all binding sites. It is important to note at this point that the approach assumes 100 
% binding capacity of the protein, in other words that all binding sites for a given ligand are 
functional during the assay and that there is no loss of such binding functionality upon 
separation of bound ligand from the free ligand.260 The latter is often a major problem which 
will be discussed further. Scheme on Figure 84 depicts the major steps that need to be 
undertaken in radioligand binding assay. 
 
 
 
 
 
Figure 84. Steps undertaken in radioligand-binding assay. 
 
The radioactive ligand used should have high affinity for the protein being studied and 
high specific activity (30 Ci/mmol or higher). The higher the ligand affinity for a given 
protein, the easier it is to measure the equilibrium dissociation constant. Higher affinity 
ligands have lower dissociation constants, which allows reasonable time for the experiment 
to be performed without significant loss of bound ligand during sample preparation. 
Isotopes such as [3H] or [125I] are most often used due to their high specific activity 
rather than low specific activity isotopes such as [14C]. The amount of protein used in the 
assay is based on the affinity of the radioligand for the protein, the specific activity of the 
radioligand and the ligand/protein binding ratio. Ideally, 100 to 500 disintegrations per 
minute (dpm) which is well above background should be due to ligand bound to the protein 
Binding of radioactive (or nonradioactive)
ligand to the protein
Separation of Bound from Free
Measurement of the amount of
radioactivity bound
Analysis of the results
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of interest at the lowest concentration of radioligand used in the assay. The amount of signal 
corresponding to bound radioligand can be enhanced by either increasing the protein 
concentration or using radioactive ligand with higher specific activity. Less than 10% of total 
radioligand added should be bound to the protein because the equations for analysis of 
saturation experiment are based on the assumption that the free concentration of ligand does 
not change.  
The protein is incubated with radioactive ligand until steady-state conditions are 
reached. The time required to reach a steady-state may be minutes to hours. The incubations 
can be done at various temperatures depending on the stability of the radioactive ligand and 
the protein. It should be noted that the affinity of the protein for the radioligand may be 
temperature-dependent. 
Once steady-state conditions have been reached, the bound radioactive ligand is 
separated from the free ligand using various techniques, such as filtration, centrifugation or 
precipitation. The important principle to keep in mind is that the method needs to be rapid to 
minimize ligand dissociation from the receptor. This is often a major obstacle as the 
separation of bound from free ligand disturbs the steady-state equilibrium in a very short 
time. The amount of ligand dissociated depends on the time of the separation as well as on 
the type of separation. When radioligand binding assays are performed with membrane 
proteins a filtration method is often used. It functions by trapping the protein-ligand complex 
on the filter, whilst allowing the free ligand to pass through. In this project the filtration 
method itself could not be employed due to the fact that Rubisco is a soluble protein, and 
therefore a precipitation followed by filtration method was chosen. The amount of 
radioactive ligand bound can be determined by scintillation counting. When using the filter to 
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separate bound from free, the filter is simply placed in a scintillation fluid and incubated for 
at least 12h.  
Protein binding data is analyzed by non-linear regression analysis using Microsoft 
Excel and/or GraphPad Software. In saturation experiment, various concentrations of the 
radioligand are incubated with the same amount of protein, producing increasing 
concentrations of the protein-ligand complex. The equation for the resulting hyperbola is: 
 
 
As the concentration of radioactive ligand increases, a point is reached where the 
amount of ligand bound no longer increases. The amount of bound radioactivity accounts for 
the ligand bound specifically and non-specifically and it is called total binding.  
Radioactive ligands usually bind to more than one type of binding site. The site that is 
being studied is referred to as the specific site, or specific binding. All other binding sites are 
referred to as non-specific sites. Some non-specific binding sites are saturable others are not. 
In order to distinguish binding to specific sites from binding to non-specific sites, a second 
set of incubations is run simultaneously using radioactive ligand and unlabeled ligand at a 
concentration sufficient to block the binding of the radioactive ligand to the specific sites, but 
not the non-specific sites. The amount of radioactive ligand bound in the presence of 
unlabeled ligand is referred to as the total binding. Binding in the presence of the unlabeled 
ligand is referred to as non-specific binding. The difference between the two corresponds to 
specific binding. 
In this project the separation of free from bound radioligand was done in two steps. 
First Rubisco-[3H] (±)-ABA complex was applied on SPN™ spin columns (G-biosciences) 
Bound   =
Bmax  x  Free
KD  + Free
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and then  precipitated using chilled proprietary solvent buffer (OrgoSolTM, G-biosciences) 
specifically developed for efficient precipitation of protein solutions with minimal disruption 
to the protein structure and biological activity.  Precipitated protein remains on the column 
which is then washed twice with cold OrgoSolTM buffer to remove unbound [3H] (±)-ABA. 
The column matrix was then placed in a scintillation fluid and incubated overnight. 
Subsequently, the radioactivity corresponding to bound [3H] (±)-ABA was measured using 
the scintillation counter. Total binding was measured after incubating Rubisco with [3H] (±)-
ABA at various concentrations. 
 
 
 
 
 
 
 
 
 
Figure 85. Total and non-specific binding of [3H] (±)-ABA to Rubisco. 
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Figure 86. Saturation curve and Scatchard plot representing specific binding of [3H] 
(±)-ABA, as a difference between total and non-specific binding signal. 
 
The non-specific binding was measured by addition of 10,000 fold excess of non-
radiolabeled (cold) ABA. The amount of non-specific binding was composed of [3H] (±)-
ABA remaining on the column matrix (90% of non-specific signal) after the washings and 
[3H] (±)-ABA remaining bound to the protein in the presence of 10 000 fold excess of cold 
ABA. It is noticeable that the total binding curve on Figure 85 begins to level off at 25 nM 
[3H] (±)-ABA but the difference between total and non-specific signal becomes lower than at 
25 nM  than it is at 20 nM concentration. Unlike non-specific binding, the specific binding is 
saturable and at certain concentration no more signal will be observed, the non-specific 
signal however is non-saturable and keeps rising with concentration. At a certain point these 
two lines will intersect and the difference between specific and non-specific signal will begin 
to decline. For that reason the saturation curve representing the specific bound signal only 
was constructed using [3H] (±)-ABA concentrations up to 20 nM. The equilibrium 
dissociation constant (KD) was evaluated using GraphPad PrismTM software using non-linear 
regression and was found to be 4.7 (± 1.3) nM. The percentage of bound [3H] (±)-ABA 
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(bound/free) did range from 3% to a maximum of 10 % (Scatchard plot, Figure 86) and 
therefore no signal depletion was accounted for during data analysis. All analyses presented 
depend on the assumption that a very small fraction of the ligand binds to the protein.  It is 
therefore assumed that the free concentration of ligand is approximately equal to the 
concentration added. If a fraction larger than 10% of added radioligand is bound by the 
protein, then ligand depletion needs to be accounted for and incorporated in non-linear 
regression equations.261 
From previous studies it became apparent that Rubisco binds ABA in a selective 
(nonstereospecific) manner and therefore in all radioligand binding assays, racemic [3H] 
ABA was used rather than (+) and (-) [3H] ABA separately. 
Literature provides examples of radioligand binding assays with recent report of ABA 
receptor proteins and their equilibrium dissociation constants evaluated by this technique.  
Pandey et al. has reported two proteins (see Figure 15) GRG1 and GTG2 which 
showed saturation kinetics with [3H] (±)-ABA and equilibrium dissociation constants of 35.8 
nM and 41.2 nM respectively. The binding was found to be stereospecific which was 
confirmed by the inability of (-)-ABA to displace [3H] (±)-ABA. 
Liu et al.122  has reported the binding of G protein-coupled receptor as the first plasma 
membrane ABA receptor with KD value being 20.1 nM and ligand/protein molar binding 
ratio of 0.8 mol mol-1 protein. These results have been disputed by Gao et al.262 who showed 
that GCR2 is not a 7- trans-membrane G protein coupled receptor as claimed by Liu et al. In 
addition the SPR studies on interaction between GCR2 and GPA1 by Liu have been 
contradicted by Johnson et al.263  who has also suggested that GCR2 is not plant specific but 
rather a plant homolog of bacterial lanthionine synthetase. 
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Shen et al. reported an Mg-chelatase H subunit form barley as an abscisic acid 
receptor, exhibiting high affinity (KD = 32 nM) and specificity of binding towards (+)-ABA 
and ligand/protein molar binding ratio of 1.28 mol mol-1 protein. This report was 
contradicted by Mueller and Hanson125 who reported that barley Mg-chelatase did not bind 
ABA, they also found that Arabidopsis equivalent did show saturation kinetics. The 
inconsistency of results obtained with two different plant species is being investigated. 
When analyzing the experimental conditions used in previously reported radioligand 
binding assays of ABA receptors it becomes noticeable that often more protein than ligand is 
used in the assays. The mole ratio protein to ligand used in the assay by Shen et al. it is 
235/1. This raises a question whether reporting the protein ligand binding stoichiometry is 
appropriate. In order to determine the binding molar ratio it would be necessary to run 
binding assays with an excess of ligand rather than protein. Determination of binding ratio is 
a difficult task due to two factors. First, a substantial loss of bound ligand during the 
separation of “bound” from “free”. This step disturbs the steady state equilibrium and leads 
to a significant loss of bound ligand. Second it is often reported that receptor or other 
proteins studied retain only a fraction of binding functionality and therefore it is often 
required to use more (non- stoichiometric amounts) protein in order to maintain the amount 
of bound ligand at the detectable level. Waldo et al.260 have studied agonist binding to 
purified human P2Y receptor protein and reported that the density of binding sites in purified 
protein was only 10-15% of the theoretical binding, and reported experimental evidence for 
the loss of binding functionality during protein purification and loss of bound ligand during 
the separation of “free” from “bound”. The evaluation of binding stoichiometry carries 
smaller error in case the radioligand binding assays are performed with tissue expressed and 
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non-purified protein although the extent of ligand loss during “free” from “bound” separation 
remains unchanged. 
In this project greater amount of protein than ligand was used due to Rubisco fractional 
binding functionality and loss of bound ligand during the separation of “free” from “bound” 
[3H] (±)-ABA. The protein precipitation and subsequent washings greatly reduced the 
amount of bound ABA although its fraction remaining bound throughout the procedure was 
sufficient to obtain substantial signal due to selective binding and allowed the construction of 
saturation plot and evaluation of equilibrium dissociation constant. This experiment was not 
however used to evaluate the stoichiometry of binding for reasons discussed above. This 
information was provided by Surface Plasmon Resonance experiments indicating the 
Rubisco/ABA molar binding ratio of approximately 1:8, which is rationalized by the 
presence of 8 large identical subunits being the only part of the entire protein complex 
capable of binding ABA. 
The final step in evaluating the binding between ABA and Rubisco utilizing 
radioisotope was the determination of binding specificity. Such experiment was performed 
by preparing mixtures of the protein and [3H] (±)-ABA at the saturating concentration (25 
nM, Figure 86) and addition of non-radiolabeled (+)-ABA, (-)-ABA, PA and trans- (+)-ABA 
at 100, 1000 and 10,000 fold excess with respect to [3H] (±)-ABA. Samples were treated in 
the same way as the ones used for constructing the saturation curve (Figure 86). Bound [3H] 
(±)-ABA was separated from free [3H] (±)-ABA by two OrgoSolTM washings of the SPN 
column matrix as described previously. The displacement of radiolabeled ABA by any 
compound listed above would indicate its ability for selective binding to Rubisco. Lack of 
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[3H] (±)-ABA displacement by compounds other than ABA indicates the selectivity of ABA-
Rubisco interaction. Figure 87 represents the results. 
 
 
Figure 87. Displacement of [3H] (±)-ABA by non-radiolabeled (+)-ABA, (-)-ABA, PA 
and trans-(+)-ABA. 
 
As mentioned before, Rubisco exhibits binding capability for both (+) and (-)-ABA as 
observed by SPR, and also by photoaffinity labeling experiments where (+) and (-)-ABAs 
both blocked the PAL reaction. This is confirmed here by the ability of both enantiomers to 
displace [3H] (±)-ABA as demonstrated on Figure 87. It is also noticeable and consistent with 
previous SPR experiments that PA only exhibits weak affinity for Rubisco. It is not however 
able to displace [3H] (±)-ABA completely even at 10,000 fold excess with respect to ABA. 
Trans-(+)-ABA is almost completely incapable of ABA displacement. No signal due to 
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binding of of trans-(+)-ABA was observed by SPR (data not shown).  The consistency of 
results obtained by SPR with radioligand binding technique is particularly satisfying and 
provides strong evidence for selective binding between ABA and Rubisco. 
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3. Experimental Procedures 
3.1.  Gel electrophoresis 
  
 
Acrylamide gels were used for electrophoresis in denaturing conditions (SDS-PAGE). 
The concentration of a stacking gel was 4%, and the running gel 10%, the thickness of a gel 
was 1 mm.  Running buffer for electrophoresis contained of: 0.1 M Tris, 1.0 M Glycine, 
0.5% SDS.  Samples were mixed with  Laemmli buffer (4% SDS, 20 % Glycerol, 10% 2-
mercaptoethanol, 0.004% bromophenol blue, 0.125 M Tris-HCl) then boiled for 5 minutes 
and vortexed.  
3.2.   Gel silver staining 
 
 
Gels were stained using FOCUS-FAST silver kit from G-biosciences. After 
electrophoresis, the gel was fixed in a solution containing 30% ethanol and 10 glacial acetic 
acid. After 30 minutes the gel was washed twice, 5-10 minutes, in 10% ethanol, and then 
washed three times 5-10 minutes with de-ionized water.  The gel was then soaked in prepared 
Silver Stain solution (Genotech) for 20-30 minutes with gentle rocking. After staining it was 
quickly rinsed with de-ionized water and soaked in Developer-Sensitizer solution (provided 
in the kit) for the amount of time required to observe all protein bands. As soon as the 
intensity reached an acceptable level, the development was stopped decanting the developer 
solution and soaking the gel in 2% acetic acid. 
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3.3. Far-Western blotting 
 
 
After electrophoresis the gel was soaked in Protein Transfer Buffer (PTB) (3.03 g 
Trizma-base, 14.4 g Glycine, 200 mL methanol, 650 mL de-ionized water) for 10-20 
minutes. Sheet of Hybond-P PVDF membrane (Amersham Bioesciences) of the same size as 
the gel was cut and soaked for 10 seconds in methanol and washed 5 minutes in water 
followed by equilibration in PTB for at least 10 minutes. The membrane and the gel were 
then assembled in electroblotting cassette and placed in the blotting unit filled with PTB. The 
assembly was placed in a cooler to prevent overheating. In addition an ice block was 
immersed in the electroblotting unit. Protein transfer into the membrane was done either for 
30 minutes at 120V or overnight at 20V. 
After blotting the membrane was soaked in a phosphate buffered saline solution (PBS-
T) with 0.1% v/v Tween (pH 7.5) and 3% w/v BSA with gentle rocking for 1h. The 
membrane can also be stored in this solution.  The blot was then washed with PBS-T two 
times 5 minutes. Streptavidin-HRP conjugate was then diluted 1:1000 in PBS-T to a final 
volume of 5 mL. Washed blot was incubated on an orbital shaker with Streptavidin-HRP 
solution for 1h at RT. The membrane was then briefly rinsed with PBS-T with two changes 
of buffer and then washed again for 15 minutes, followed by rinsing for 3 x 5 minutes with 
fresh changes of wash buffer at RT. Extensive washing is crucial for eliminating the 
background signal. The blot was then removed from the wash buffer the excess of which was 
drained onto a paper towel. The membrane was placed protein side up on a sheet of 
SaranWrapTM. 5 mL of previously mixed detection reagents (ECL plus Western Blotting 
Detection Reagents, Amersham Biosciences) were poured on the membrane and incubated 
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for 5 minutes at RT. The membrane was then dried and placed on a fresh piece of 
SaranWrapTM, wrapped up and air bubbles gently removed. Wrapped blot was then placed 
protein side up in an x-ray film cassette and a sheet of Hyperfilm ECL (Amersham 
Bioseciences) was placed on top of the membrane in a dark room. The exposure time 
depends on the amount of biotinylated proteins loaded into the gel. (usually 10-30 seconds). 
After which the film was developed and proteins modified by PBI686 were identified.  
Biotinylated marker (ECL protein marker, Amersham Biosciences) was used as molecular 
weight reference. 
 
3.4. Protein extraction procedure  
  
 
Proteins were maintained in their native form throughout the experiment to maintain 
proper folding. For that reason proteins are not frozen, no ionic detergents are added and 
protein extracts are kept at 0-4ºC.  
First 40-80 g of fresh  aerial tissue wild of type Arabidopsis (Columbia, grown in a 
growth chamber using 12 h photoperiod and temperature of 23-25°C) leaf tissue was ground 
with glass beads (500 micron, Aldrich) in 100 mM Sodium Phosphate buffer at pH 7.6 with 
0.33 M sucrose, 40 mM ascorbate and 0.5 EDTA and protein inhibitor cocktail (CompleteTM 
Roche). The homogenate was filtered through cheesecloth and centrifuged at 20,000 g for 10 
min. The supernatant was collected (200 and 400 mL) and proteins were concentrated by 
precipitation with 75% ammonium sulfate. The precipitated proteins were centrifuged at 
5000g for 30min and re-dissolved in 3-6 mL of phosphate buffer (pH 7.6) with 0.3% non-
ionic detergent DHPC (1,2-Diheptanoyl-sn-Glycero-3-Phosphocholine) (Avanti Polar Lipids) 
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to help re-solubilize hydrophobic proteins. At this point the protein concentration of such 
solubilized crude extract is in 3-6 mg/mL range (concentration determined using SPNTM 
Protein Assay kit from G-biosciences). To remove any remaining ammonium sulfate the 
extract was then run through desalting column (PD-10 Amersham Biosciences). Before 
analysis samples were concentrated using the protocol supplied with UPPA- Protein -
ConcentrateTM kit from G-biosciences. 
 
3.5. Heterologous expression of CYP707A1 in yeast 
 
 
The full-length cDNA of CYP707A1 (Dr. Adrian Cutler’s laboratory, PBI/NRC) in 
pBluescript sk- was excised with and KpnI/SstI and isolated using Qiagen’s gel extraction 
kit. The yeast expression vector, YeDP60, was generously provided by Denis Pompon 
(CNRS-Centre de Génétique Moléculaire).  Upon sequencing, the multiple cloning site 
(MCS) of YeDP60 was found to contain a start codon and 2 ClaI sites after the BamHI site at 
the 5’ end.  The entire MCS was removed and replaced with the MCS from pUC19. The 
open reading frame of CYP707A1 from the pBluescript construct was directionally cloned 
into the modified YeDP60 vector using the enzyme pairs indicated above. The resulting 
constructs were used to transform the WAT11 strain of Saccharomyces cerevisae (Pompon et 
al., 1996). Transformants were grown overnight in selection media (SC-URA with 2% 
glucose, 60mg/l adenine and 40mg/l tryptophan), collected by centrifugation and 
resuspended in YPG media (1% yeast extract, 1% bactopeptone, 2% glucose) and grown for 
a further 24 hours at 28°C. The yeast was pelleted by centifugation, washed three times with 
inducing media (YPL - 1% yeast extract, 1% bactopeptone, 2% galactose) and used to 
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inoculate YPL media to a final optical density of 0.5. The yeast were grown in inducing 
media for a further 16 hours before microsomal extraction. 
3.6. Yeast microsome preparation 
 
Yeast microsomes were prepared following the methods outlined by Urban et al. 28 
with the following modifications:  Yeast cells (with YeDP60 and CYP707A1)  were 
harvested by centrifugation at 10,000g for 10 minutes and washed in ice-cold, filter-sterilized 
extraction buffer (0.1%BSA, 0.33M Sucrose, 40mM ascorbate, 20mM EDTA, 200mM 
potassium phosphate buffer, pH 7.6).  The pellet was resuspended (0.3g/ml) in extraction 
buffer and PMSF was added to a final concentration of 0.5mM.  Cell walls were disrupted 
using an ice cooled bead beater with 0.45mm-0.5mM glass beads.  Cells were pulverized 
three times at one minute each allowing extract to cool between treatments.  Cell extract was 
collected and centrifuged at 10,000g for ten minutes.  The supernatant was collected and 
microsomes precipitated on ice for 30 minutes after the addition of PEG3500 (10g/ml) and 
NaCl (0.15M).  Extracts were centrifuged at 13,000rpm in a Sorval SS-34 rotor for 20 
minutes at 4°C.  Microsomal pellet was resuspended in cold 100mM potassium phosphate 
buffer and 40mM ascorbate and protein content determined using Biorad protein 
determination kit.   
Shortly before applying the extract on the affinity column 1 ml of 1 % DHPC detergent 
from Avanti Polar Lipids was added in order to completely dissolve proteins.  
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3.7. Isolation of 8’-ABA-hydroxylase from yeast 
microsomes using affinity probe PBI 686 
 
Microsomes isolated from yeast suspension cultures overexpressing both ABA-
8’hydroxylase gene (CYP707A1) and one not overexpressing this protein (YeDP60) as 
control were re-dissolved in 1% CHAPS detergent in affinity binding buffer (see above). 
Each solution was run through a separate probe-modified affinity column (5 ml volume, pre-
conditioned as described above) three times at 0.4 ml/min. Then the columns were washed 
three times with 20 ml of binding buffer followed by washing with 5 mM (±) ABA. The 
three buffer wash fractions as well as ABA wash fractions were collected and concentrated 
down to 100µl using Amicon Ultra-4 centrifugal Filter Devices purchased form Millipore. 
The concentrated fractions were then checked for the presence of proteins by SDS-PAGE.  
 
3.8. UV crosslinking of anti-ABA monoclonal antibodies 
 
 
A mixture of anti-ABA mAb and ovalbumin (in phosphate buffer  pH 7.6) at 30 µg/mL 
each, was combined with PBI 686 at different concentrations (1µM, 5µM, 10µM, 30µM, and 
60µM) in 2.0 mL volume for each sample. In addition another set of samples were prepared 
where (±) ABA was added at concentration from 10 to 50 times higher than PBI 686. 
Samples were then placed in Pyrex glass test tubes and irradiated by UV light using Hanovia 
medium  pressure mercury lamp for 10 min at RT at the distance of 10 cm from the lamp. 
Immediately after irradiation samples were placed on ice or frozen and further analyzed by 
far-Western (see Figure 35). 
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3.9. UV crosslinking of peptides with PBI686 
 
 
Three different peptides were UV-irradiated in the presence of PBI686. Peptide #1 
TDRAKRKAVSLSKVC (MW = 1660.94), Peptide # 2 (fragment of bradykinin): Arg-Pro-
Pro-Gly-Phe (MW = 572.65), peptide # 3: adrenocorticotropic hormone) Ser-Tyr-Met-Glu-
His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg (MW = 2093.40). A solution of each 
peptide was mixed with PBI686 at 1 mM concentration (peptide: probe molar ratio 1:1). The 
mixtures were irradiated with UV light for 15 minutes.  Another set of peptide solutions was 
prepared and without addition of PBI686 and also UV- irradiated. 
Samples were then analyzed by MALDI-TOF spectrometry in linear (low resolution), 
positive ionization mode ( 
 
Figure 28-32), using MALDI-TOF MS equipped with a nitrogen laser (337 nm; 
Voyager-DE STR; Applied Biosystems, Foster City, CA, USA). The sample matrix used was 
α-Cyano-4-hydroxycinnamic acid 
 
3.10. UV crosslinking of proteins from plant extracts 
 
 
10 mL of a clear solution resulting from extraction procedure (section 3.4) was split 
into 5 Pyrex glass test tubes. Three of them contained the probe PBI 686 at 100 µM 
concentration, and the remaining two were used as negative control. One contained no probe, 
and one contained the probe but was set aside and not exposed to UV light.  Such mixture 
was incubated for 1h on ice and then irradiated (except for one) with high- intensity UV light 
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using Hanovia medium pressure mercury lamp for 15 min at RT at the distance of 10 cm 
from the lamp. Immediately after irradiation samples were placed on ice. Proteins covalently 
linked with the probe were then separated from non-modified proteins by affinity 
chromatography (section 3.9). Another set of samples was prepared as above with an 
addition of (+)-ABA to 1 mM final concentration before UV exposure. 
 
3.11. Photoaffinity labeling of purified Rubisco by PBI 686 
 
 
Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) purchased from Aldrich 
was used for photoaffinity crosslinking with the probe PBI686.  Rubisco, ovalbumin and 
BSA were combined in one solution at 100 µg/mL each. Proteins were dissolved in 100 mM 
phosphate buffer, 0.15 M NaCl, pH 7.6.  Six samples were prepared, each containing the 
protein and the following: #1- 100 µM PBI686, #2- 10 µM PBI686, #3- 10 µM PBI686 + 0.5 
mM (+)-ABA, #4- 10 µM PBI686 + 1 mM (+)-ABA, #5 – proteins only, #6- 10 µM PBI686.  
All samples but #6 were then irradiated with UV light for 5 minutes, quickly cooled and 
analyzed by far-Western (see Figure 47-48). 
 
3.12. Affinity chromatography 
 
 
Affinity chromatography was done using HiTrap streptavidin matrix column and 
AKTATM Explorer FPLC system (Amersham Bioesciences).  The column (1 mL matrix 
volume) was first conditioned by running 30 mL of running buffer (20 mM sodium 
phosphate, 0.15 M NaCl, pH 7.5) at 1 mL/min flow rate. Then 5-10 mL of the extract (30-60 
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mg of protein) was injected on the column at 0.3 mL/min. After injection another 30-50 mL 
of buffer was run through the system to wash out unbound proteins, followed by 10 mL of 
0.1 M Citric Acid (pH 2) to strip off the non-specifically bound proteins. Chromatography is 
then finalized by running 8M Guanidine-HCl (Aldrich) at pH 2 and collected fractions (1 mL 
each) were immediately run through PD-10 desalting columns (GE Healthcare)  to remove 
Gu-HCl and bring pH to 7.6.  Proteins from collected fractions were then concentrated using 
AmiconTM Ultrafree filtering devices (Millipore). Samples were then further concentrated 
using UPPA- Protein -ConcentrateTM kit (Genotech).  
 
3.13.  Surface Plasmon Resonance (SPR) 
 
 
SPR was performed using CM5 sensor chips (Biacore) and Biacore X SPR instrument. 
All buffers were filtered and degassed prior to use. Free carboxyl groups on the chip surface 
were activated with EDC and N-hydroxy-succinimide and then coupled to the protein’s free -
NH2 groups. The following procedure was used to immobilize protein (ligand) on the chip 
surface.  First scouting experiments on an unmodified chip were done to find optimal pH for 
protein pre-concentration on the chip surface by inducing electrostatic interactions. Optimal 
pre-concentration was found when protein solution (0.5 mg/mL in 10 mM HEPES, pH 7.9) 
was mixed with Sodium acetate buffer at pH 5 at ratio 1:1. Once optimal pH for 
immobilization was found the chip surface was then washed by several 1 minute injections of 
0.05 % SDS  then 50 mM NaOH followed by several 100 µl injections of running buffer (10 
mM HEPES, 100 mM NaCl, 10 mM MgCl2, pH 8). The chip surface was then activated by 
injecting a 1:1 mixture of NHS and EDC (running both chip cells open). NHS/EDC 
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activation mixture is injected for 7 minutes at 5 µl/min flow rate. Then flow cell 1 (FC1) was 
closed and ligand solution (mixture of protein solution with Sodium Acetate pH 5) was 
injected in manual mode (1 minute pulses) 4-6 times on flow cell 2 (FC2). The injector was 
washed and subsequently a solution of ethylamine (EA) was injected on both flow cells for 7 
minutes. At this point 4000-8000 resonance units (RU) were immobilized (compare FC1 and 
FC2 baselines). 
It is important to perform chip activation and ligand immobilization in less than 10 
minutes. Once the surface was activated the protein had to be injected immediately. The pH 
of protein solution is lowered just before the injection to prevent protein damage. 
High density surface (8000 RU immobilized) is only recommended if a given 
experiment is only expected to determine if the ligand binds the analyte. Experiments 
yielding binding kinetics information use lower density surfaces and therefore fewer protein 
injections on the chip surface during immobilization would be required (4000 RU). Signal 
from the unmodified cell is automatically subtracted from the modified cell signal. It is also 
very important to maintain the composition of the running buffer identical to the buffer in 
which the sample is injected. If the two buffers were slightly different a bulk buffer shift will 
be observed during the injection. The magnitude of a bulk shift is usually several times 
higher than the signal due to binding of analyte with the ligand. It is therefore required to test 
the system by injecting running buffer as a sample several times to check for bulk shift. If a 
buffer injection doesn’t disturb the baseline, then the actual sample of an analyte ((+)ABA, (-
)-ABA, PA, trans-ABA, PBI686 or cinnamic acid) was injected at various concentrations 
ranging from 5 nM to 5 µM and a flow rate of 50-100 µl/min. The injection was run until 
signal saturation, usually between 100 -120 s. As soon as signal saturated, injections were 
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stopped and running buffer was run again at 100 µl/min. If during analyte dissociation the 
signal did not return to the baseline within 3-5 minutes the undissociated analyte was then 
stripped from the surface by injecting of 2.5 M NaCl for 30 seconds followed by running 
buffer. If this procedure still did not remove all analyte from the surface, NaCl injections 
were repeated several times. Also the system was washed with running buffer to remove 
analyte remaining in the injector component.  
Sensograms obtained during analyte concentration were analyzed by Biacore 
evaluation software, yielding KD values, calculated from the ratio between association rate 
(ka) and dissociation rate (kd). Analytes were injected at different concentrations (usually 100 
fold difference between the lowest and the highest concentration). Langmuir binding fit 
model was used for data evaluation and no mass transfer was observed when injecting buffer 
at different flow rates. Five CM5 chips were used to evaluate dissociation constant (KD) of 
ABA binding to Rubisco and all KD values were averaged yielding 5 (± 2) nM value. 
 
3.14.  Protein identification using MALDI-TOF peptide 
mass fingerprinting (PMF) 
 
 
Protein bands visible on silver-stained gels were excised and then subjected to 
alkylation and tryptic digestion using a modified procedure of Jensen et al.. (1999). The gel 
pieces containing proteins were washed two times with a solution containing 20 mM EDTA 
and 100 mM NH4HCO3 in 30% (v/v) acetonitrile, dried and then re-hydrated with a reducing 
solution (10 mM EDTA, 10 mM dithiothreitol, and 100 mM NH4HCO3) for 1 h at 60°C. 
After cooling to room temperature, the gel pieces were dried and then re-hydrated with 
alkylating solution (10 mM EDTA, 10 mM iodoacetamide, and 100 mM NH4HCO3) for 30 
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min at room temperature. The gel pieces were washed two times with water and were then 
minced. The minced gel pieces were dried and then re-hydrated in a digestion solution 
containing 100 mM NH4HCO3 and 10 mM CaCl2 with 0.1±0.2 mg of trypsin at 37°C 
overnight. After the trypsin digestion, the minced gel pieces were separated from the 
digestion solution and successively washed with 0.1% (v/v) trifuoroacetic acid (TFA), 0.1% 
TFA in acetonitrile, 0.1% TFA in 50% (v/v) acetonitrile, and 0.1% TFA in acetonitrile at 
room temperature in order to further extract the peptides from the minced gel pieces. Pooled 
extracts (including the digestion solution and both the aqueous and organic washes) were 
concentrated using a centrifugal concentrator and then desalted by a ZipTipC18 (Millipore, 
Billerica, MA, USA). Trypsin-digested peptide masses were measured using a MALDI-TOF 
MS equipped with a nitrogen laser (337 nm; Voyager-DE STR; Applied Biosystems, Foster 
City, CA, USA). A solution of peptides was mixed with the same volume of a matrix 
solution consisting of saturated α-cyano-4-hydroxycinnamic acid (CHCA) in 50% (v/v) 
acetonitrile/0.1% (v/v) TFA. After the peptides were co-crystallized with CHCA by 
evaporating organic solvents, the peptide masses of the peptides were measured. All MALDI 
spectra were externally calibrated using a standard peptide mixture: angiotensin I, 
angiotensin II, neurotensin, and adrenocorticotropic hormone fragment 1±17 (Sigma). 
Monoisotopic masses from all spectra recorded for a given peptide were selected and 
analyzed. Matching of experimental mass spectra with theoretical mass spectra obtained from 
various Arabidopsis databases was performed using a sequence database search program, 
MASCOT PMF. Database queries were carried out for monoisotopic masses using the 
following parameters: peptide mass tolerance of ±50 p.p.m. (p.p.m = [experimental mass (in 
Daltons) - theoretical mass/theoretical mass], expressed in parts per million), equivalent to 
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0.1 Da for a 2-kDa peptide; the maximum number of missed tryptic cleavages of 1 or 2; and 
modifications, including conversion of oxidation of Met. The maximal molecular mass was 
restricted to 300 kDa for the protein over 60 kDa, 100 kDa for the protein below 60 kDa or, 
sometimes, 50 kDa for the protein below 30 kDa to avoid hits of very large proteins. No 
strict pI filters were applied to find possible breakdown products, unexpected splicing, or 
post-translational modification such as phosphorylation.  
3.15.   Rubisco Activity Assays 
 
 
Stock solution of pre-purified Rubisco (Sigma) from spinach was prepared by 
dissolving 2-5 mg of protein in a buffer containing 15 mM MgCl2 and 25 mM NaHCO3 at 
pH 8.0.  Each assay (total volume, 1.0 mL) contained 50 mM Bicine (pH 8.0), 15 mM 
MgCl2, 10 mM NaCl, 5 mm DTT, 5 mM phosphocreatine, 5 mM ATP, 5 mM 
phosphoenolpyruvate, and 25 mM NaHCO3. This mixture was prepared before each set of 
experiments using distilled water. Five minutes before initiating the reaction with activated 
Rubisco, stock solutions were added to produce final concentrations as follows: 0.1 -1 mM 
RuBP (10 samples at 0.1 mM intervals), 0.4 mM NADH, 20 units mL-1 of glyceraldehyde-3-
phosphate dehydrogenase, 20 units mL--1 of 3-phosphoglycerate kinase, and 2 units mL-1 of 
creatine phosphokinase. Following the addition of Rubisco to a final concentration of 0.3 mg 
mL-1, NADH concentration was measured spectrophotometrically (λ = 340 nm) over time for 
5 min. A340 was measured at 5s intervals and recorded. Absorbance values were converted 
to NADH concentrations using an extinction coefficient of 6.22 mM-1. Reaction rates were 
evaluated from the slope of absorbance vs. time curve and plotted against concentration of 
Rubisco substrate (RuBP). Initial velocity (Vi) vs. substrate concentration [RuBP] plot was 
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constructed using GrapPad PrismTM software which based on experimental reaction rates (Vi) 
and RuBP concentrations and fitted the experimental date into two different inhibition 
models (competitive and allosteric) All experiments were performed in the absence of ABA 
(control) and with ABA at four concentrations: 1, 2, 5 and 10 mM.  
 
3.16.  [3H] (±)-ABA binding assays 
 
3.16.1.   Hot saturation 
 
Stock solution of pre-purified Rubisco (Sigma) was prepared by dissolving 2-5 mg of 
protein in binding buffer (50 mM Bicine, 15 mM MgCl2, 20 mM NaCl, pH 7.9) and placed 
on ice. Total volume for each assay sample was 30 µL and each contained approx 30 µg of 
protein.  Protein solution was mixed with 3H (±)-ABA (specific activity 37 Ci mmol -1 hot: 
cold ratio 1.8:1, purchased from GE biosciences). Radioactive ABA was added at different 
concentrations: 2, 5, 10, 15, 20, 25 nM. In addition another set of samples containing 2-25 
nM (±) [3H] (±)-ABA and 500 µM [1H] (+)-ABA were prepared. Samples containing 30 µg 
of protein, [3H] (±)-ABA with and without [1H] (+)-ABA were incubated at RT for 30 
minutes then amounts of bound  [3H] (±)-ABA were measured.  The following method was 
used to separate the bound from unbound [3H] (±)-ABA. 15 µL samples from each reaction 
were transferred into SPN columns (G-biosciences), allowed to soak into the column matrix. 
Subsequently 100 µL of cold (chilled at -20° C) non-denaturing and precipitating OrgoSolTM 
buffer (G-biosciences) was added to the column. Samples were quickly paced in centrifuge 
and spun at 12,000 rpm for 10 seconds and another 100 µL portion of cold OrgoSolTM buffer 
was added to the column, and centrifuged again for 20 seconds at 12,000 rpm. Column 
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matrix from each sample was then removed from the column and placed in scintillation vials 
containing AqasolTM scintillation fluid. Column matrices containing protein with bound [3H] 
(±)-ABA were then soaked in scintillation fluid for at least 24 hours followed by counting 
radioactivity using Beckman Cutler Multi Purpose Scintillation Counter. A set of control 
samples not containing the protein but different concentrations of [3H] (±)-ABA were also 
prepared and counted. Radioactivity remaining on the column matrix in the absence of 
protein was used as background and subtracted from samples containing the protein (matrix 
non-specific binding). Signal corresponding to specific ABA binding was calculated from the 
difference between samples with [3H] (±)- ABA and those containing 1000 fold excess of  
non-radiolabeled (+)-ABA. Each sample was replicated 5-10 times and readings averaged. 
3.16.2.   Cold saturation 
 
Cold saturation was performed similarly to hot saturation. The concentration of  [3H]- 
(±)-ABA was 25 nM in all samples, and non-radiolabeled (+)-ABA was added to each 
sample at increasing concentrations ranging from 10 to 10000 fold higher than radiolabeled 
ABA. The same procedure was applied when using non-radiolabeled (-)-ABA, PA, and 
trans-ABA.  Similarly to the above specific binding was calculated from the difference 
between readings from samples with [3H] (±)-ABA and samples containing both hot and cold 
ABA. Each sample was replicated 5-10 times and the readings averaged. 
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4. Conclusions and future work 
 
The primary objective of this project was isolation and identification of new ABA-
binding proteins in plants. This was to be achieved by employing a biologically active ABA 
derivative, which served as both an affinity and a photoaffinity probe. It has been proven that 
this probe was recognized by known ABA-binding proteins. Subsequently the probe was 
used to isolate putative ABA–binding proteins, and this led to the discovery of Rubisco as a 
new ABA binding protein, among several other potential candidates. The binding of ABA to 
Rubisco was confirmed by various techniques and it was found that in addition to specific 
binding, ABA also affects Rubisco’s enzymatic activity. This suggests that ABA may act as 
modulator of photosynthesis through the inhibition of this enzyme.  
Ability of non-radioactive (+) and (-)-ABA to displace [3H] (±)-ABA, indicated that 
Rubisco binds ABA in a non-stereospecific manner. However the that fact that PA and trans-
(+)-ABA were incapable of [3H] (±)-ABA displacement, suggest that certain structural 
features present in ABA are required for binding. Modifications of ABA 8’ carbon (present 
in PA) or changes in its side-chain configuration (present in trans-ABA) eliminate binding. 
Following this, the investigation of the binding ability of other ABA metabolites or synthetic 
analogs remains within future research directions. Screening a number of ABA analogs could 
possibly provide more information about the structural requirements of Rubisco towards its 
ABA-like binding partners. 
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There are several other questions to be answered by future research work. First, is the 
exact location of ABA binding site within the multi-subunit protein. This could be achieved 
through either co-crystallization ABA and Rubisco and detailed crystallographic studies of 
the complex, or further MS analysis of Rubisco-PBI686 tryptic digests.  
ABA-binding site identification by MS methods would be possible though performing 
experiments using precursor ion scanning in a low energy collision-induced dissociation 
mode. This can be done by obtaining an MS/MS fragmentation pattern of PBI686 and 
choosing product ions highly characteristic for the probe (reporter ions).  Trypsin digestion of 
PBI686-tagged-Rubisco would result in a mixture of peptides and also containing PBI686-
tagged-peptide(s). The peptide mixture could be then subjected to MS/MS analysis and 
searched for PBI686 reporter ions. These reporter ions are also precursors of the probe-
peptide adducts. Precursor ions could then be associated with the parent ion of the adduct and 
allow identification of the MS signals belonging to PBI686-tagged peptide(s). MS/MS 
analysis of these “new” peptides through de novo sequencing would reveal the identity of 
amino acid residue being covalently modified by PBI686. This approach could lead to 
identification of ABA binding site within Rubisco complex. In addition, the finding of ABA 
binding site would allow creating recombinant Rubisco and alterations in plant sensitivity to 
ABA under abiotic stress conditions.  
Using the approach described above it would also be possible to identify other putative 
ABA-binding proteins/receptors as well as their ABA-binding sites. In addition to binding 
studies, the MS methods could be employed to identify the ABA-binding sites of other 
proteins (e.g. DREPP) identified in this project.  
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